0001144204-13-061966.txt : 20131114 0001144204-13-061966.hdr.sgml : 20131114 20131114164752 ACCESSION NUMBER: 0001144204-13-061966 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 11 CONFORMED PERIOD OF REPORT: 20130930 FILED AS OF DATE: 20131114 DATE AS OF CHANGE: 20131114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN SHARED HOSPITAL SERVICES CENTRAL INDEX KEY: 0000744825 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 942918118 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-08789 FILM NUMBER: 131220910 BUSINESS ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 BUSINESS PHONE: 415-788-5300 MAIL ADDRESS: STREET 1: FOUR EMBARCADERO CENTER STREET 2: SUITE 3700 CITY: SAN FRANCISCO STATE: CA ZIP: 94111-4107 10-Q 1 v359320_10q.htm FORM 10-Q
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC  20549
________________________
 
FORM 10-Q
 
(Mark One)
 
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended September 30, 2013 or
 
 
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _______________ to _______________.
 
Commission file number 1-08789
________________________
 
American Shared Hospital Services
(Exact name of registrant as specified in its charter)
 
 
California
94-2918118
 
 
(State or other jurisdiction of
(IRS Employer
 
 
Incorporation or organization)
Identification No.)
 
 

Four Embarcadero Center, Suite 3700, San Francisco, California

94111

(Address of Principal Executive Offices)
(Zip Code)
 
Registrant’s telephone number, including area code:  (415) 788-5300
 
Indicate by check mark whether the registrant:  (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes x  No ¨
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  Yes x  No ¨
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company.  See definition of “large accelerated filer”, “accelerated filer”, and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
  Large Accelerated Filer ¨    Accelerated Filer ¨    Non-Accelerated Filer ¨   Smaller reporting company x
 
As of November 1, 2013, there are outstanding 4,608,870 shares of the Registrant’s common stock.
 
 
 
 
 
PART I - FINANCIAL INFORMATION
 
ITEM 1.   FINANCIAL STATEMENTS
 
AMERICAN SHARED HOSPITAL SERVICES 
CONDENSED CONSOLIDATED BALANCE SHEETS 
 
 
 
(unaudited)
 
 
 
 
 
ASSETS
 
September 30, 2013
 
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
1,955,000
 
 
$
1,564,000
 
Restricted cash
 
 
50,000
 
 
 
50,000
 
Certificate of deposit
 
 
9,000,000
 
 
 
9,000,000
 
Accounts receivable, net of allowance for
 
 
 
 
 
 
 
 
doubtful accounts of $100,000 in 2013
 
 
 
 
 
 
 
 
and $100,000 in 2012
 
 
4,715,000
 
 
 
3,706,000
 
Other receivables
 
 
298,000
 
 
 
401,000
 
Prepaid expenses and other current assets
 
 
615,000
 
 
 
925,000
 
Current deferred tax assets
 
 
316,000
 
 
 
310,000
 
 
 
 
 
 
 
 
 
 
Total current assets
 
 
16,949,000
 
 
 
15,956,000
 
 
 
 
 
 
 
 
 
 
Property and equipment:
 
 
 
 
 
 
 
 
Medical equipment and facilities
 
 
85,489,000
 
 
 
84,453,000
 
Office equipment
 
 
738,000
 
 
 
694,000
 
Deposits and construction in progress
 
 
7,560,000
 
 
 
9,754,000
 
 
 
 
93,787,000
 
 
 
94,901,000
 
Accumulated depreciation and
 
 
 
 
 
 
 
 
amortization
 
 
(42,265,000)
 
 
 
(41,224,000)
 
Net property and equipment
 
 
51,522,000
 
 
 
53,677,000
 
 
 
 
 
 
 
 
 
 
Investment in common stock
 
 
2,701,000
 
 
 
-
 
Investment in preferred stock
 
 
-
 
 
 
2,687,000
 
Other assets
 
 
982,000
 
 
 
1,003,000
 
 
 
 
 
 
 
 
 
 
Total assets
 
$
72,154,000
 
 
$
73,323,000
 
 
LIABILITIES AND
 
 
(unaudited)
 
 
 
 
 
SHAREHOLDERS' EQUITY
 
 
September 30, 2013
 
 
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
Accounts payable
 
$
867,000
 
 
$
263,000
 
Employee compensation and benefits
 
 
217,000
 
 
 
168,000
 
Customer deposits/deferred revenue
 
 
722,000
 
 
 
747,000
 
 
 
 
 
 
 
 
 
 
Other accrued liabilities
 
 
1,591,000
 
 
 
801,000
 
Current portion of long-term debt
 
 
4,379,000
 
 
 
3,932,000
 
Current portion of obligations under capital leases
 
 
3,843,000
 
 
 
3,742,000
 
 
 
 
 
 
 
 
 
 
Total current liabilities
 
 
11,619,000
 
 
 
9,653,000
 
 
 
 
 
 
 
 
 
 
Long-term debt, less current portion
 
 
11,187,000
 
 
 
13,837,000
 
Long-term capital leases, less current portion
 
 
12,884,000
 
 
 
13,173,000
 
Advances on line of credit
 
 
8,740,000
 
 
 
8,550,000
 
 
 
 
 
 
 
 
 
 
Deferred income taxes
 
 
3,280,000
 
 
 
3,280,000
 
 
 
 
 
 
 
 
 
 
Shareholders' equity:
 
 
 
 
 
 
 
 
Common stock (4,609,000 shares at September 30, 2013
 
 
 
 
 
 
 
 
and 4,606,000 shares at December 31, 2012)
 
 
8,578,000
 
 
 
8,578,000
 
Additional paid-in capital
 
 
4,971,000
 
 
 
4,902,000
 
Accumulated other comprehensive income (loss)
 
 
(424,000)
 
 
 
(357,000)
 
Retained earnings
 
 
6,508,000
 
 
 
6,806,000
 
Total equity-American Shared Hospital Services
 
 
19,633,000
 
 
 
19,929,000
 
Non-controlling interest in subsidiary
 
 
4,811,000
 
 
 
4,901,000
 
Total shareholders' equity
 
 
24,444,000
 
 
 
24,830,000
 
 
 
 
 
 
 
 
 
 
Total liabilities and shareholders' equity
 
$
72,154,000
 
 
$
73,323,000
 
 
See accompanying notes  
 
 
2

 
 
AMERICAN SHARED HOSPITAL SERVICES 
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS 
(Unaudited)  
 
 
 
Three months ended September 30,
 
 
Nine months ended September 30,
 
 
 
2013
 
 
2012
 
 
2013
 
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Medical services revenue
 
$
4,396,000
 
 
$
4,236,000
 
 
$
13,647,000
 
 
$
12,923,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Costs of revenue:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Maintenance and supplies
 
 
470,000
 
 
 
383,000
 
 
 
1,317,000
 
 
 
1,102,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
 
1,615,000
 
 
 
1,532,000
 
 
 
4,658,000
 
 
 
4,481,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other direct operating costs
 
 
730,000
 
 
 
626,000
 
 
 
2,080,000
 
 
 
1,935,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2,815,000
 
 
 
2,541,000
 
 
 
8,055,000
 
 
 
7,518,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gross Margin
 
 
1,581,000
 
 
 
1,695,000
 
 
 
5,592,000
 
 
 
5,405,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selling and administrative expense
 
 
887,000
 
 
 
960,000
 
 
 
3,275,000
 
 
 
3,093,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest expense
 
 
532,000
 
 
 
525,000
 
 
 
1,459,000
 
 
 
1,638,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Operating income
 
 
162,000
 
 
 
210,000
 
 
 
858,000
 
 
 
674,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Loss on foreign currency transactions
 
 
(306,000)
 
 
 
-
 
 
 
(840,000)
 
 
 
-
 
Interest and other income
 
 
11,000
 
 
 
10,000
 
 
 
19,000
 
 
 
25,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income (loss) before income taxes
 
 
(133,000)
 
 
 
220,000
 
 
 
37,000
 
 
 
699,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Income tax expense (benefit)
 
 
-
 
 
 
28,000
 
 
 
40,000
 
 
 
52,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss)
 
 
(133,000)
 
 
 
192,000
 
 
 
(3,000)
 
 
 
647,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Less: Net income attributable to non-controlling interests
 
 
(1,000)
 
 
 
(183,000)
 
 
 
(227,000)
 
 
 
(614,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to American Shared Hospital Services
 
$
(134,000)
 
 
$
9,000
 
 
$
(230,000)
 
 
$
33,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) per share:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per common share - basic
 
$
(0.03)
 
 
$
-
 
 
$
(0.05)
 
 
$
0.01
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Earnings (loss) per common share - assuming dilution
 
$
(0.03)
 
 
$
-
 
 
$
(0.05)
 
 
$
0.01
 
 
See accompanying notes
 
 
3

 
AMERICAN SHARED HOSPITAL SERVICES
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
 
 
 
 
Three months ended September 30,
 
 
Nine months ended September 30,
 
 
 
2013
 
2012
 
 
2013
 
 
2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income (loss) attributable to American Shared Hospital Services
 
$
(134,000)
 
$
9,000
 
 
$
(230,000)
 
 
$
33,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
 
 
(51,000)
 
 
(120,000)
 
 
 
(111,000)
 
 
 
(120,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Total comprehensive income (loss)
 
 
(185,000)
 
 
(111,000)
 
 
 
(341,000)
 
 
 
(87,000)
 
Less comprehensive income (loss) attributable to
     the non-controlling interest
 
 
(22,000)
 
 
(52,000)
 
 
 
(44,000)
 
 
 
(52,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Comprehensive income (loss) attributable to
     American Shared Hospital Services
 
$
(163,000)
 
$
(59,000)
 
 
$
(297,000)
 
 
$
(35,000)
 
 
See accompanying notes
 
 
4

 
AMERICAN SHARED HOSPITAL SERVICES
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY
 
 
 
PERIODS ENDED DECEMBER 31, 2011 AND 2012 AND SEPTEMBER 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accumulated
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Additional
 
 
Other
 
 
 
 
 
 
 
 
 
 
Non-controlling
 
 
 
 
 
 
 
Common
 
 
Common
 
 
Paid-in
 
 
Comprehensive
 
 
Retained
 
 
Sub-Total
 
 
Interests in
 
 
 
 
 
 
 
Shares
 
 
Stock
 
 
Capital
 
 
Income (Loss)
 
 
Earnings
 
 
ASHS
 
 
Subsidiaries
 
 
Total
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances at January 1, 2011
 
 
4,597,000
 
 
$
8,606,000
 
 
$
4,703,000
 
 
$
-
 
 
$
6,262,000
 
 
$
19,571,000
 
 
$
3,473,000
 
 
$
23,044,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock based compensation expense
 
 
14,000
 
 
 
-
 
 
 
125,000
 
 
 
-
 
 
 
-
 
 
 
125,000
 
 
 
-
 
 
 
125,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment in subsidiaries by non-controlling interests
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
1,509,000
 
 
 
1,509,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash distributions to non-controlling interests
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(996,000)
 
 
 
(996,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
506,000
 
 
 
506,000
 
 
 
983,000
 
 
 
1,489,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances at December 31, 2011
 
 
4,611,000
 
 
 
8,606,000
 
 
 
4,828,000
 
 
 
-
 
 
 
6,768,000
 
 
 
20,202,000
 
 
 
4,969,000
 
 
 
25,171,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Repurchase of common stock
 
 
(9,000)
 
 
 
(28,000)
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(28,000)
 
 
 
-
 
 
 
(28,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock based compensation expense
 
 
4,000
 
 
 
-
 
 
 
74,000
 
 
 
-
 
 
 
-
 
 
 
74,000
 
 
 
-
 
 
 
74,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment in subsidiaries by non-controlling interests
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
217,000
 
 
 
217,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cumulative translation adjustment
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(357,000)
 
 
 
-
 
 
 
(357,000)
 
 
 
(280,000)
 
 
 
(637,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash distributions to non-controlling interests
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(780,000)
 
 
 
(780,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
38,000
 
 
 
38,000
 
 
 
775,000
 
 
 
813,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances at December 31, 2012
 
 
4,606,000
 
 
 
8,578,000
 
 
 
4,902,000
 
 
 
(357,000)
 
 
 
6,806,000
 
 
 
19,929,000
 
 
 
4,901,000
 
 
 
24,830,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock based compensation expense
 
 
3,000
 
 
 
-
 
 
 
69,000
 
 
 
 
 
 
 
-
 
 
 
69,000
 
 
 
-
 
 
 
69,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investment in subsidiaries by non-controlling interests
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(68,000)
 
 
 
(68,000)
 
 
 
207,000
 
 
 
139,000
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cumulative translation adjustment
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(67,000)
 
 
 
-
 
 
 
(67,000)
 
 
 
(44,000)
 
 
 
(111,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash distributions to non-controlling interests
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(480,000)
 
 
 
(480,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(230,000)
 
 
 
(230,000)
 
 
 
227,000
 
 
 
(3,000)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balances at September 30, 2013 (unaudited)
 
 
4,609,000
 
 
$
8,578,000
 
 
$
4,971,000
 
 
$
(424,000)
 
 
$
6,508,000
 
 
$
19,633,000
 
 
$
4,811,000
 
 
$
24,444,000
 
 
See accompanying notes
 
 
5

 
AMERICAN SHARED HOSPITAL SERVICES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
 
 
 
Nine Months ended September 30,
 
 
 
2013
 
 
2012
 
Operating activities:
 
 
 
 
 
 
 
 
Net (loss) income
 
$
(3,000)
 
 
$
647,000
 
 
 
 
 
 
 
 
 
 
Adjustments to reconcile net income to net cash from operating activities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Depreciation and amortization
 
 
4,746,000
 
 
 
4,563,000
 
 
 
 
 
 
 
 
 
 
Deferred income tax
 
 
(6,000)
 
 
 
-
 
 
 
 
 
 
 
 
 
 
Cumulative translation adjustment and other
 
 
840,000
 
 
 
-
 
 
 
 
 
 
 
 
 
 
Stock based compensation expense
 
 
69,000
 
 
 
62,000
 
 
 
 
 
 
 
 
 
 
Loss (gain) on sale of assets
 
 
-
 
 
 
3,000
 
 
 
 
 
 
 
 
 
 
Changes in operating assets and liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Receivables
 
 
(966,000)
 
 
 
(372,000)
 
 
 
 
 
 
 
 
 
 
Prepaid expenses and other assets
 
 
193,000
 
 
 
(542,000)
 
 
 
 
 
 
 
 
 
 
Customer deposits/deferred revenue
 
 
(25,000)
 
 
 
263,000
 
 
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
 
 
1,437,000
 
 
 
(228,000)
 
 
 
 
 
 
 
 
 
 
Net cash from operating activities
 
 
6,285,000
 
 
 
4,396,000
 
 
 
 
 
 
 
 
 
 
Investing activities:
 
 
 
 
 
 
 
 
Payment for purchase of property and equipment
 
 
(3,293,000)
 
 
 
(4,103,000)
 
 
 
 
 
 
 
 
 
 
Investment in subsidiaries by non-controlling interests
 
 
139,000
 
 
 
169,000
 
 
 
 
 
 
 
 
 
 
Payment for repurchase of common stock
 
 
-
 
 
 
(29,000)
 
 
 
 
 
 
 
 
 
 
Investment in convertible preferred stock
 
 
(14,000)
 
 
 
(31,000)
 
 
 
 
 
 
 
 
 
 
Net cash from investing activities
 
 
(3,168,000)
 
 
 
(3,994,000)
 
 
 
 
 
 
 
 
 
 
Financing activities:
 
 
 
 
 
 
 
 
Principal payments on long-term debt
 
 
(2,584,000)
 
 
 
(2,946,000)
 
 
 
 
 
 
 
 
 
 
Principal payments on capital leases
 
 
(2,916,000)
 
 
 
(2,796,000)
 
 
 
 
 
 
 
 
 
 
Long term debt financing on property and equipment
 
 
3,109,000
 
 
 
3,925,000
 
 
 
 
 
 
 
 
 
 
Advances on line of credit
 
 
269,000
 
 
 
950,000
 
 
 
 
 
 
 
 
 
 
Payments on line of credit
 
 
(79,000)
 
 
 
(600,000)
 
 
 
 
 
 
 
 
 
 
Distributions to non-controlling interests
 
 
(480,000)
 
 
 
(679,000)
 
 
 
 
 
 
 
 
 
 
Net cash from financing activities
 
 
(2,681,000)
 
 
 
(2,146,000)
 
 
 
 
 
 
 
 
 
 
Effect of changes in foreign exchange rates on cash
 
 
(45,000)
 
 
 
(120,000)
 
 
 
 
 
 
 
 
 
 
Net change in cash and cash equivalents
 
 
391,000
 
 
 
(1,864,000)
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents at beginning of period
 
 
1,564,000
 
 
 
2,580,000
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents at end of period
 
$
1,955,000
 
 
$
716,000
 
 
 
 
 
 
 
 
 
 
Supplemental cash flow disclosure:
 
 
 
 
 
 
 
 
Cash paid during the period for:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interest
 
$
1,522,000
 
 
$
1,782,000
 
 
 
 
 
 
 
 
 
 
Income taxes
 
$
42,000
 
 
$
147,000
 
 
 
 
 
 
 
 
 
 
Schedule of non-cash investing and financing activities
 
 
 
 
 
 
 
 
Acquisition of equipment with capital lease financing
 
$
2,625,000
 
 
$
264,000
 
 
See accompanying notes
 
 
6

 
 
AMERICAN SHARED HOSPITAL SERVICES
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
 
 
Note 1. Basis of Presentation
 
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly American Shared Hospital Services’ consolidated financial position as of September 30, 2013 and the results of its operations for the three and nine month periods ended September 30, 2013 and 2012, which results are not necessarily indicative of results on an annualized basis.  Consolidated balance sheet amounts as of December 31, 2012 have been derived from audited financial statements.
 
These unaudited consolidated financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2012 included in the Company’s 10-K filed with the Securities and Exchange Commission.
 
These financial statements include the accounts of American Shared Hospital Services (the “Company”) and its wholly-owned subsidiaries:  OR21, Inc. (“OR21”); MedLeader.com, Inc. (“MedLeader”); and American Shared Radiosurgery Services (“ASRS”); ASRS’ majority-owned subsidiary, GK Financing, LLC (“GKF”); GKF’s wholly-owned subsidiaries, GK Financing U.K., Limited (“GKUK”) and Instituto de Gamma Knife del Pacifico S.A.C. (“GKPeru”); ASHS’ majority owned subsidiary, Long Beach Equipment, LLC (“LBE”), GKF’s majority owned subsidiaries, Albuquerque GK Equipment, LLC (“AGKE”), Jacksonville GK Equipment, LLC (“JGKE”) and EWRS, LLC (“EWRS”), and EWRS’ wholly owned subsidiary, EWRS Tibbi Cihazlar Ticaret Ltd Sti (“EWRS Turkey”).
 
The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to nineteen medical centers as of September 30, 2013 in the states of Arkansas, California, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas and Wisconsin, and in Turkey.
 
GKF also provides radiation therapy equipment to the radiation therapy department at the Gamma Knife site in Turkey.  The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (“IMRT”), Image Guided Radiation Therapy (“IGRT”) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.
 
The Company formed the subsidiaries GKUK, GKPeru, EWRS and EWRS Turkey for the purposes of expanding its business internationally into the United Kingdom, Peru and Turkey; LBE to provide proton beam therapy services in Long Beach, California; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida.  AGKE and EWRS Turkey began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011.  GKPeru is expected to begin operation in the latter part of 2014.  GKUK is inactive and LBE is not expected to begin operations in 2013.
 
 
7

 
During 2012 and 2013, the Company’s partner in its Turkey operation, its partners in the Jacksonville Gamma Knife operation and the Albuquerque Gamma Knife operation have made investments in EWRS, JGKE, and AGKE respectively. These investments are included in the line item “Non-controlling interests in subsidiaries” in the Company’s financial statements.
 
Based on guidance provided in accordance with ASC 830, Foreign Currency Matters (“ASC 830”), the Company analyzes its operations outside the United States to determine the functional currency of each operation.  Management has determined that these operations are initially accounted for in U.S. Dollars since the primary transactions incurred are in U.S. Dollars and the Company provides significant funding towards the startup of the operation.  When Management determines that an operation has become self-sufficient, the Company may change its accounting for the operation to the local currency from the U.S. Dollar, depending on the facts and circumstances. The Company determined that effective in the third quarter 2012, the functional currency for its Turkish operation, EWRS Turkey, was the Turkish Lira.  Therefore, in accordance with ASC 830, EWRS Turkey’s balance sheet accounts were translated at rates in accordance with guidance provided under ASC 830, and accumulated gains and losses and translation differences were recorded in accumulated other comprehensive income (loss), which is a separate component of equity.
 
As of September 30, 2013 and December 31, 2012, EWRS Turkey’s balance sheet accounts were translated at rates in effect as of those dates, respectively, and income and expense accounts were translated at the weighted average rates of exchange during those respective periods. Translation adjustments resulting from this process were also recognized under accumulated other comprehensive income (loss).  Gains and losses from foreign currency transactions are listed in the Company’s Consolidated Statements of Operations.  The Company recorded a net foreign currency loss of $306,000 and $840,000 for the three and nine month periods ended September 30, 2013, respectively, and a net foreign currency gain of approximately $133,000 for the year ended December 31, 2012.
 
Based on guidance provided in accordance with 280 Segment Reporting (“ASC 280”), the Company has analyzed the factors that define an operating segment and determined that there is only one operating segment.  The nineteen locations are aggregated into one reportable segment because, in the Company’s judgment, these operating segments have similar historical economic characteristics and are expected to have similar economic characteristics in the future. Furthermore, each operating segment utilizes the same business model and technologies, servicing the same end users (radiation therapy patients).  All significant intercompany accounts and transactions have been eliminated in consolidation.
  
 
8

 
 
 
Note 2.                   Per Share Amounts
 
Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding.  For the three and nine months ended September 30, 2013 basic earnings per share was computed using 4,609,000 common shares, and diluted earnings per share was computed using 4,612,000 and 4,613,000 common shares and equivalents, respectively.  For the three and nine months ended September 30, 2012 basic earnings per share was computed using 4,606,000 and 4,610,000 common shares respectively and diluted earnings per share was computed using 4,630,000 and 4,635,000 common shares and equivalents, respectively.
 
The computation for the three and nine month periods ended September 30, 2013 excluded approximately 580,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during those periods.  The computation for the three and nine month periods ended September 30, 2012 excluded approximately 310,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during the periods.

Note 3.
Stock-based Compensation
 
On June 2, 2010, the Company’s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the “2006 Plan”). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the “Plan”) and increased the number of shares of the Company’s common stock reserved for issuance under the Plan by an additional 880,000 shares from 750,000 shares to 1,630,000 shares. The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors. The Plan serves as successor to the Company’s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans. The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans. Under the Plan, there have been 115,000 restricted stock units granted, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, and there are 609,000 options granted, of which 576,000 options are vested as of September 30, 2013.
 
Compensation expense associated with the Company’s stock-based awards to employees is calculated using the Black-Scholes valuation model. The Company’s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates. The estimated fair value of the Company’s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award. The estimated fair value of the Company’s options is amortized over the period during which an employee is required to provide service in exchange for the award, usually the vesting period. Accordingly, stock-based compensation cost before income tax effect in the amount of $11,000 and $69,000 is reflected in net income for the three and nine month periods ended September 30, 2013, compared to $3,000 and $62,000 in the same periods in the prior year, respectively. There were 3,500 options issued and no options exercised during the three month period ended September 30, 2013. There were 21,500 options issued and no options exercised during the nine month period ended September 30, 2013. There were no excess income tax benefits to report.
 
 
9

 
Note 4.
Common Stock Investment
 
                As of September 30, 2013 the Company has a $2,701,000 investment in the common stock of Mevion Medical Systems, Inc. (“Mevion”), formerly Still River Systems, Inc., representing an approximate 0.77% interest in Mevion. At December 31, 2012 the investment was $2,687,000 which represented a 1.0% interest in the convertible preferred stock of Mevion. The Company’s investment was converted to common stock in April 2013 when it declined to participate in a new financing round. Therefore the Company’s investment was converted from preferred stock to common stock in April 2013. The Company accounts for this investment under the cost method.
 
In June 2013 Mevion announced that it had secured a $55 million round of financing which will be used to accelerate the manufacturing and deployment of the Mevion S250. The funds were raised from existing equity investors, as well as from debt financing. The Company invested an additional $14,000 in this round.
 
The Company reviews its investment for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may not be recoverable. The Company evaluated this investment for impairment at December 31, 2012 and reviewed it at September 30, 2013 in light of both current market conditions and the ongoing needs of Mevion to raise cash to continue its development of the first compact, single room PBRT system. Based on its analysis, the Company estimates that there is currently an unrealized loss (impairment) of approximately $2.4 million.
 
In assessing whether the impairment is other than temporary, we evaluated the length of time and extent to which market value has been below cost, the financial condition and near term prospects of Mevion and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value. Although the investment is not without risk, and the manufacture of the first unit has taken longer than originally anticipated, the Company believes that the current market value is a temporary situation brought on solely due to the delays in treating the first clinical patient.
 
During the second quarter of 2012, Mevion announced that it had received FDA 510(k) clearance for its MEVION S250 system, which enables users of the system to treat patients immediately upon completion of system installation. Mevion had previously announced that it had received the CE Mark certification which enables Mevion to market, sell and install these systems through the European Union and any country that recognizes the CE Mark. Based on the continuing progress being made by Mevion toward the manufacture and installation of the first single room PBRT system, the Company believes that our investment in Mevion is not other than temporarily impaired, and the fair value will increase so that the carrying value will be recovered.
   
 
10

 
Note 5.
Line of Credit
 
The Company has a $9,000,000 renewable line of credit with a bank that has been in place since June 2004 and has a maturity date of August 1, 2015.  The line of credit is drawn on from time to time as needed for equipment purchases and working capital.  Amounts drawn against the line of credit are at an interest rate per year equal to the Bank’s prime rate minus 0.5 percentage point, or alternately, at the Company’s discretion, the LIBOR rate plus 1.0 percentage point, and are secured by the Company’s cash invested with the Bank.  The Company is in compliance with all debt covenants under the agreement.  The weighted average interest rate during the first nine months of 2013 was 1.44%.  At September 30, 2013, $8,740,000 was borrowed against the line of credit, compared to $8,550,000 at December 31, 2012.

Note 6.
Fair Value of Financial Instruments
 
The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels.  Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date.  Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.  Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.
 
The estimated fair value of the Company’s assets and liabilities as of September 30, 2013 and December 31, 2012 were as follows (in thousands):
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
Carrying Value
 
September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
11,005
 
 
 
 
 
 
 
 
 
 
$
11,005
 
$
11,005
 
Receivables
 
 
5,013
 
 
 
 
 
 
 
 
 
 
$
5,013
 
 
5,013
 
Common stock investment
 
 
 
 
 
 
 
 
 
 
300
 
 
$
300
 
 
2,701
 
Total
 
$
16,018
 
 
$
-
 
 
$
300
 
 
$
16,318
 
$
18,719
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and other accrued liabilities
 
$
3,397
 
 
 
 
 
 
 
 
 
 
$
3,397
 
$
3,397
 
Advances on line of credit
 
$
8,740
 
 
 
 
 
 
 
 
 
 
$
8,740
 
$
8,740
 
Debt obligations
 
 
 
 
 
 
 
 
 
 
31,870
 
 
$
31,870
 
 
32,293
 
Total
 
$
12,137
 
 
$
-
 
 
$
31,870
 
 
$
44,007
 
$
44,430
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
10,614
 
 
 
 
 
 
 
 
 
 
$
10,614
 
$
10,614
 
Receivables
 
 
4,107
 
 
 
 
 
 
 
 
 
 
$
4,107
 
 
4,107
 
Preferred stock investment
 
 
 
 
 
 
 
 
 
 
1,300
 
 
$
1,300
 
 
2,687
 
Total
 
$
14,721
 
 
$
-
 
 
$
1,300
 
 
$
16,021
 
$
17,408
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and other accrued liabilities
 
$
1,979
 
 
 
 
 
 
 
 
 
 
$
1,979
 
$
1,979
 
Advances on line of credit
 
$
8,550
 
 
 
 
 
 
 
 
 
 
$
8,550
 
$
8,550
 
Debt obligations
 
 
 
 
 
 
 
 
 
 
34,577
 
 
$
34,577
 
 
34,684
 
Total
 
$
10,529
 
 
$
-
 
 
$
34,577
 
 
$
45,106
 
$
45,213
 
 
 
11

 
 
Note 7.
Repurchase of Common Stock
 
In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008.  There were no shares repurchased in the first nine months of 2013.  In 2012, the Company repurchased 9,000 shares at an average price of $3.26 per share.  There are approximately 72,000 shares remaining under this repurchase authorization.

 
Note 8.
Income Taxes
 
We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annual effective income tax rate expected to be applicable for the full fiscal year.  However, when a reliable estimate of the annual effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the year-to-date period.  Our effective income tax rate is highly influenced by the amount of the nondeductible stock-based compensation associated with grants of our common stock options.  A small change in estimated annual pretax income (loss) can produce a significant variance in the annual effective income tax rate given the expected amount of these items.  Because of this variability, a reliable estimate of the annual effective income tax rate for 2013 cannot be made.  As a result, we have computed our provision (benefit) for income taxes for the three and nine month periods ended September 30, 2013 by applying the actual effective tax rate to income (loss) for the period. 

Note 9.
Reclassification
 
Certain comparative amounts in the consolidated financial statements have been reclassified to conform to the current quarter’s presentation.

Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations 
 
This quarterly report to the Securities and Exchange Commission may be deemed to contain certain forward-looking statements with respect to the financial condition, results of operations and future plans of American Shared Hospital Services, which involve risks and uncertainties including, but not limited to, the risks of the Gamma Knife and radiation therapy businesses, the risks of developing The Operating Room for the 21st Century® program, and the risks of investing in a development-stage company, Mevion, without a proven product. Further information on potential factors that could affect the financial condition, results of operations and future plans of American Shared Hospital Services is included in the filings of the Company with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K for the year ended December 31, 2012 and the definitive Proxy Statement for the Annual Meeting of Shareholders held on June 11, 2013.
 
The Company had nineteen Gamma Knife units in operation on September 30, 2013 and eighteen Gamma Knife units in operation on September 30, 2012. Four of the Company’s customer contracts are through subsidiaries where GKF or its subsidiary is the majority owner and managing partner. Eleven of the Company’s nineteen current Gamma Knife customers are under fee-per-use contracts, and eight customers are under retail arrangements. The Company’s two contracts to provide radiation therapy and related equipment services to existing Gamma Knife customers are considered retail arrangements. Retail arrangements are further classified as either turn-key or revenue sharing. Revenue from fee per use contracts is recorded on a gross basis as determined by each hospital’s contracted rate. Under turn-key arrangements, the Company receives payment from the hospital in the amount of its reimbursement from third party payors, and is responsible for paying all the operating costs of the equipment. Revenue is recorded on a gross basis and estimated based on historical experience of that hospital’s contracts with third party payors. For revenue sharing arrangements the Company receives a contracted percentage of the reimbursement received by the hospital. The gross amount the Company expects to receive is recorded as revenue and estimated based on historical experience.
  
 
12

 
In July 2013, The Centers for Medicare and Medicaid (“CMS”) proposed to reimburse hospitals for a complete course of treatment comprised of a single session of Stereotactic Radiosurgery (“SRS”) at $8,576 effective January 1, 2014. In August 2013, CMS revised its proposed SRS rate to $5,615. This payment level would apply to single session treatment for all forms of SRS – Cobalt-60 SRS (Gamma Knife), robotic linear accelerator (LINAC) SRS or non-robotic LINAC SRS. By comparison, effective April 1, 2013, the Gamma Knife was reimbursed by CMS at $3,300 and during the period January 1, 2013 to March 31, 2013 at $7,910. The CMS proposed 2014 reimbursement rate is subject to comments from interested parties, and could change. Final CMS reimbursement rates are anticipated to be issued in late November 2013.
 
Medical services revenue increased by $160,000 and $724,000 to $4,396,000 and $13,647,000 for the three and nine month periods ended September 30, 2013 from $4,236,000 and $12,923,000 for the three and nine month periods ended June 30, 2012, respectively. The increases for both the three and nine month periods are primarily due to two new contracts that began operation in the second quarter 2012 and first quarter 2013, and increased volume at the Company’s existing Gamma Knife sites. The increase in Gamma Knife revenue was offset by a decrease in radiation therapy revenue. The decrease was due to a decline in volume at the existing radiation therapy sites. Revenue from the Company’s radiation therapy contracts decreased for the three and nine month period by $89,000 and $318,000 to $361,000 and $1,099,000, respectively. 
 
The number of Gamma Knife procedures increased by 70 and 171 to 632 and 1,918 for the three and nine month periods ended September 30, 2013 from 523 and 1,564 in the same periods in the prior year, respectively. The increase is primarily due to the start of operations of two new Gamma Knife sites, one in the second quarter of 2012, and one in the first quarter of 2013. For the three and nine month period, volume at the Company’s sites where Perfexion units have been installed increased by 18% and 23% respectively. Much of this increase is due to addition of new Perfexion units.
 
Total costs of revenue increased by $274,000 and $537,000 to $2,815,000 and $8,055,000 for the three and nine month periods ended September 30, 2013 from $2,541,000 and $7,518,000 for the three and nine month periods ended September 30, 2012, respectively. Maintenance and supplies increased by $87,000 and $215,000 for the three and nine month periods ended September 30, 2013 compared to the same periods in the prior year, due to higher contract maintenance expense for Gamma Knife units. Depreciation and amortization increased by $83,000 and $177,000 for the three and nine month periods ended September 30, 2013 compared to the same periods in the prior year, primarily due to the start of two new sites that began operation in the second quarter 2012 and first quarter 2013. Furthermore, there were two upgrades performed at existing sites during the first and second quarters of 2013. Other direct operating costs increased by $104,000 and $145,000 for the three and nine month periods ended September 30, 2013 compared to the same periods in the prior year. The increase for the three month period is due to higher property taxes and retail operating costs. For the nine month period, the increase is primarily due to higher property taxes and marketing costs.  
 
 
13

 
Selling and administrative costs decreased by $73,000 for the three month period ended September 30, 2013 to $887,000 from $960,000 in the three month period ended September 30, 2012, and increased $182,000 for the nine month period ended September 30, 2013 to $3,275,000 from $3,093,000 for the nine month period ended September 30, 2013. For the three month period the decrease is due to lower salary expense, office rent and travel expense. This reduction was offset by higher marketing expenses. For the nine month period the increase was primarily due to higher marketing expenses, legal and consulting fees and rent expense, partially offset by reduced travel costs. The higher rent expense is due to accrued rent expense of approximately $115,000 in the first quarter 2013, relating to a sublease of a portion of the Company’s office space. The rent accrual is required because the Company subleased a portion of its existing office space through the remainder of its lease term at a rate lower than its lease rate, which resulted in a cumulative loss through the remainder of the lease term.
 
Interest expense increased by $7,000 to $532,000 for the three month period ended September 30, 2013 from $525,000 for the same period ended September 30, 2012. Interest expense increased due to the new unit that began operation in the second quarter. For the nine month period ended September 30, 2013, interest expense decreased by $179,000 to $1,459,000 from $1,638,000 for the nine month period ended September 30, 2012. For the nine month periods, lower interest expense was driven by lower expense related to the more mature units. The mature units have lower interest expense because interest expense decreases as the outstanding principal balance of each loan is reduced.
 
Interest and other income increased by $1,000 to a gain of $11,000 for the three month period ended September 30, 2013. For the nine months interest and other income decreased by $6,000 to a gain of $19,000 for the nine month period ended September 30, 2013. For the nine month period, the decrease was primarily due to the write off of net book value for disposed assets of $20,000 in second quarter 2013.
 
The loss from foreign currency transactions was $306,000 for the three month period ended September 30, 2013 and $840,000 for the nine month period ended September 30, 2013 due to unfavorable exchange rate variances.
 
The Company had income tax expense of $0 and of $40,000 for the three and nine month period ended September 30, 2013, respectively, compared to income tax expense of $28,000 and $52,000 for the three and nine month periods ended September 30, 2012, respectively. The nine month period ended September 30, 2013 included an estimate for state income taxes of $27,000.
  
 
14

 
Net income attributable to non-controlling interest decreased by $182,000 and $387,000 to $1,000 and $227,000 for the three and nine month periods ended September 30, 2013 from $183,000 and $614,000 for the three and nine month periods ended September 30, 2012. Non-controlling interest primarily represents the 19% interest of GK Financing owned by a third party, as well as non-controlling interests in subsidiaries of GK Financing owned by third parties that began operations in 2011. Variances in net income attributable to non-controlling interest represent the relative increase or decrease in profitability of GKF and these ventures. For the three and nine month periods, the decrease in net income attributable to non-controlling interest was primarily due to the loss on unfavorable exchange rate variances.
 
The Company had a net loss of $134,000, or ($0.03) per diluted share, and $230,000, or ($0.05) per diluted share, for the three and nine month periods ended September 30, 2013, compared to net income of $9,000, or $0.00 per diluted share, and $33,000, or $0.01 per diluted share, in the same periods in the prior year, respectively. For the three and nine month period, the decrease in net income was primarily due to the loss on unfavorable exchange rate variances.
 
Liquidity and Capital Resources
 
The Company had cash and cash equivalents of $1,955,000 at September 30, 2013 compared to $1,564,000 at December 31, 2012.  The Company’s cash position increased by $391,000 due to an increase of cash from operating activities of $6,240,000, capital contributions of $139,000, net advances on the Company’s line of credit with a bank of $190,000 and long term debt financing on the purchase of equipment of $3,109,000. These increases were offset by payments for the purchase of property and equipment of $3,293,000, principal payments on long term debt and capital leases of $5,500,000, distributions to non-controlling interests of $480,000, and investment in convertible preferred stock of $14,000. 
 
As of September 30, 2013, the Company has a $9,000,000 principal investment in a certificate of deposit with a bank at an interest rate of 0.10% and a maturity date in August 2014.  At maturity date, the Company intends to roll over the certificate of deposit.
 
The Company has a two year renewable $9,000,000 line of credit with a bank, available as needed for equipment purchases and working capital.  Amounts drawn against the line of credit are secured by the Company’s cash invested with the bank.  At September 30, 2013 there was $8,740,000 drawn against the line of credit, compared to $8,550,000 at December 31, 2012.
 
The Company has scheduled interest and principal payments under its debt obligations of approximately $5,290,000 and scheduled capital lease payments of approximately $4,790,000 during the next 12 months.  The Company believes that its cash flow from operations and cash resources are adequate to meet its scheduled debt and capital lease obligations during the next 12 months.
 
The Company as of September 30, 2013 had shareholders’ equity of $24,444,000, working capital of $5,330,000 and total assets of $72,154,000.
  
 
15

 
Commitments
 
The Company has a $2,701,000 common stock investment in Mevion, a development stage company, which is considered a long-term investment on the balance sheet and is recorded at cost.  As of September 30, 2013, the Company also has $3,000,000 in non-refundable deposits toward the purchase of three MEVION S250 proton beam radiation therapy (PBRT) systems from Mevion. The Company has entered into an agreement with a radiation oncology physician group which has contributed $400,000 towards the deposits on the third system. The Company’s first PBRT system has an anticipated delivery date in the first half of 2014.
 
The Company has made non-refundable deposits totaling $1,945,000 towards the purchase of a LGK Model 4 Gamma Knife unit to be installed at a site in Peru, a Perfexion unit at an existing customer site, and two Perfexion units scheduled to be installed at sites yet to be determined.
 
Including the commitments for the three MEVION S250 systems, the three Perfexion units, and the LGK Model 4 Gamma Knife unit, the Company has total remaining commitments to purchase equipment in the amount of approximately $40,000,000. It is the Company’s intent to finance the remaining purchase commitments as needed. However, due to the current economic and credit market conditions it has been more difficult to obtain financing for some of the Company’s projects. The Company expects that it will be able to obtain financing on the commitments for the remaining Perfexion units. The Company also expects that it will be able to obtain financing from lenders for its PBRT systems now that Mevion has obtained FDA approval on the MEVION S250. However, there can be no assurance that financing will be available for the Company’s current or future projects, or at terms that will be acceptable to the Company.
 
Item 3.
Quantitative and Qualitative Disclosures about Market Risk
 
The Company does not hold or issue derivative instruments for trading purposes and is not a party to any instruments with leverage or prepayment features. The Company does not have affiliation with partnerships, trusts or other entities whose purpose is to facilitate off-balance sheet financial transactions or similar arrangements, and therefore has no exposure to the financing, liquidity, market or credit risks associated with such entities. At September 30, 2013 the Company had no significant long-term, market-sensitive investments.
 
 
16

 
Item 4.
Controls and Procedures
 
Under the supervision and with the participation of our management, including our chief executive officer and our chief financial officer, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Act is accumulated and communicated to the issuer’s management, including its principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Based on that evaluation, our chief executive officer and our chief financial officer concluded that, as of September 30, 2013, our disclosure controls and procedures are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Securities Exchange Act of 1934 is accumulated and communicated to the chief executive officer and the chief financial officer, and recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms. 
 
There were no changes in our internal control over financial reporting during the three months ended September 30, 2013 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
PART II - OTHER INFORMATION
 
Item 1.
Legal Proceedings.
 
None.
 
 
Item 1A.
Risk Factors.
 
There are no changes from those listed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2012.
 
 
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds.
 
None.
 
 
Item 3.
Defaults Upon Senior Securities.
 
None.
 
 
Item 4.
[Removed and Reserved.]
 
 
Item 5.
Other Information.
 
None.
 
 
Item 6.
Exhibits.
 
 
(a)
Exhibits
 
 
The following exhibits are filed herewith:
 
 
 
 
 
 
10.66
ADDENDUM FIVE TO LEASE AGREEMENT FOR A GAMMA KNIFE UNIT dated effective as of May 18, 2012, entered into between GK Financing, LLC, and Sunrise Hospital and Medical Center, LLC. (Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.)
 
 
17

 
31.1 
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
31.2 
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
32.1
Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
 
 
 
 
101.
The following materials from the Quarterly Report on Form 10-Q for American Shared Hospital Services for the quarter ended September 30, 2013, filed on November 14, 2013, formatted in XBRL: Condensed Consolidated Balance Sheets as of September 30, 2013 (unaudited) and December 31, 2012; Unaudited Condensed Consolidated Statements of Operations for the three and nine months ended September 30, 2013 and 2012; Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the nine months ended September 30, 2013 and 2012; Condensed Consolidated Statement of Shareholder’s Equity for the periods ended December 31, 2011 and 2012 and nine months ended September 30, 2013 (unaudited); Unaudited Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2013 and 2012; and Notes to the Unaudited Condensed Consolidated Financial Statements, detail tagged.
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
AMERICAN SHARED HOSPITAL SERVICES
Registrant
 
Date:
November 14, 2013
/s/ Ernest A. Bates, M.D.
 
 
 
Ernest A. Bates, M.D.
 
 
 
Chairman of the Board and Chief Executive Officer
 
Date:
November 14, 2013
/s/ Craig K. Tagawa
 
 
 
Craig K. Tagawa
 
 
 
Senior Vice President
 
 
 
Chief Operating and Financial Officer
 
  
 
18

 
EX-10.66 2 v359320_ex10-66.htm EXHIBIT 10.66

 

Exhibit 10.66

 

Confidential material appearing in this document has been omitted and filed separately with the Securities and Exchange Commission in accordance with Rule 24b-2, promulgated under the Securities and Exchange Act of 1934, as amended. Omitted information has been replaced with asterisks.

 

ADDENDUM FIVE

 

TO LEASE AGREEMENT FOR A GAMMA KNIFE UNIT

 

This ADDENDUM FIVE TO LEASE AGREEMENT FOR A GAMMA KNIFE UNIT (this “Addendum Five”) is dated effective as of May 18, 2012, and is entered into between (i) GK FINANCING, LLC, a California limited liability company (“GKF”), and (ii) SUNRISE HOSPITAL AND MEDICAL CENTER, LLC, a Delaware limited liability company that is qualified to do business in the State of Nevada, d/b/a/ Sunrise Hospital and Medical Center (“Medical Center”), with reference to the following recitals:

 

Recitals:

 

A. Medical Center owns and operates an acute care hospital facility located at 3186 South Maryland Parkway, Las Vegas, NV 89109.

 

B. On June 3, 1999, GKF and Medical Center executed a Lease Agreement for a Gamma Knife Unit, which Lease Agreement was amended by (i) a certain Addendum dated effective December 1, 1998, (ii) a certain Addendum Two (“Addendum Two”) dated effective January 17, 2007, (iii) a certain Addendum Three (“Addendum Three”) dated effective June 20, 2007, and (iv) a certain Addendum Four (“Addendum Four”) dated effective February 8, 2010 (collectively, and as amended, the “Lease”).

 

C. The parties desire to further amend the terms and provisions of the Lease as set forth herein.

 

NOW THEREFORE, in consideration of the mutual covenants and agreements set forth herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

 

Agreement:

 

1. Defined Terms. Unless otherwise defined herein, the capitalized terms used herein shall have the same meanings set forth in the Lease.

 

2. Extension of Lease Term. It is acknowledged that the Commencement Date of the Lease was January 8, 2001. Pursuant to Addendum Four, the Term of the Lease was extended to January 8, 2013. Pursuant to this Addendum Five, the Term of the Lease is hereby further extended for an additional six (6) years, which extended Term shall expire on January 8, 2019; provided that, the Term of the Lease shall be further extended for the period of time that the Equipment is unavailable to perform procedures due to the Reload (which is estimated to take approximately three (3) weeks for the Reload). All references in the Lease to the “Term” shall be deemed to refer to the Term, as extended hereby.

 

-1-
 

 

Exhibit 10.66

 

3. Cobalt Reload of the Equipment. The Equipment shall be reloaded with new Cobalt-60 that meets the manufacturer’s radioactivity level specifications (the “Reload”), subject to the following terms and conditions:

 

a.Scheduling and Process for the Reload. The Reload shall be performed at the Site and shall include any required installation and rigging. Subject to scheduling availability, GKF shall use its commercially reasonable efforts to perform the Reload in the first quarter of 2013; provided that the Reload shall be performed only after all necessary and appropriate licenses, permits, approvals, consents and authorizations, including, without limitation, the proper handling of the Cobalt-60 (collectively, the “Permits”), have been obtained by Medical Center at Medical Center’s sole cost and expense. The timing and procedure for such Reload shall be as mutually agreed upon between the parties. Notwithstanding anything to the contrary contained in this Addendum, GKF makes no representation or warranty to Medical Center concerning the Reload, and GKF shall have no obligation or liability to pay any damages to Medical Center resulting therefrom, including, without limitation, any lost revenues or profits during the period of time that the Equipment is unavailable to perform procedures due to the Reload process.

 

b.Medical Center Personnel and Services. Upon request and as required by GKF, Medical Center, at Medical Center’s cost and expense, shall provide GKF with Medical Center personnel (including Medical Center’s physicists) and services in connection with the Reload, among other things, to oversee, supervise and assist with construction and compliance with local, state and federal regulatory requirements and with nuclear regulatory compliance issues and the calibration of the Equipment.

 

c.Cost of Reload. Subject to Sections 3.a and 3.b above, the actual costs of the Reload paid or payable to third parties shall be the sole responsibility of GKF. Medical Center shall not be entitled to reimbursement for its personnel costs, internal costs or overhead in performing its duties under Section 3b above.

 

d.No Additional Responsibilities. It is understood by the parties that GKF is not responsible for any upgrades, hardware, cobalt reloading, software changes and/or other modifications to the Equipment, except as expressly set forth herein or otherwise agreed upon in writing by Medical Center and GKF.

 

4. Per Procedure Payments. In consideration of the Reload and notwithstanding anything to the contrary set forth in the Lease, commencing from and after January 8, 2013, Medical Center shall pay to GKF a per procedure payment as stipulated in Exhibit “A” attached hereto. The term “procedure” shall mean each individual treatment session (fraction) that involves stereotactic, external, single fraction, conformal radiation, commonly called radiosurgery, that may include one or more isocenters during the patient treatment session, delivered to any site(s) superior to the foramen magnum, whether performed on an inpatient or outpatient basis, using the Equipment and/or any other equipment or devices that are used in lieu of, or as an alternative to, the Equipment. The parties acknowledge that the per procedure payments represent fair market value for the use of the Equipment as described in the Agreement. Nothing set forth herein shall amend or otherwise affect (i) the per procedure payments set forth in Addendum Four which shall remain in effect until January 8, 2013, and (ii) the per case reimbursement rates for medical radiation physicist services payable to GKF pursuant to Addendum Two.

 

-2-
 

 

Exhibit 10.66

 

5. Transfer of Equipment Ownership. If, on the expiration of the Term (as extended), no Event of Default by Medical Center (and no event or condition which with the giving of notice and/or the lapse of time would constitute such an Event of Default) then exists and is continuing under the Lease, then, GKF shall quitclaim to Medical Center all of GKF’s right, title and interest in and to the Equipment on an “as is, where is” basis, without representation or warranty.

 

6. Captions. The captions and paragraph headings used herein are for convenience only and shall not be used in construing or interpreting this Addendum.

 

7. Full Force and Effect. Except as amended by this Addendum Five, all of the terms and provisions of the Lease shall remain in full force and effect.

 

IN WITNESS WHEREOF, the parties have executed this Addendum Five effective as of the date first written above.

 

GK FINANCING, LLC   SUNRISE HOSPITAL AND MEDICAL  
    CENTER, LLC  
       
By: /s/ Ernest A. Bates, MD   By: /s/ Chris A. Mowan  
  Ernest A. Bates, M.D.   Name:   Chris A. Mowan  
  Policy Committee Member   Title:     Chief Operating Officer  

 

 

 

-3-
 

 

Exhibit 10.66

 

Exhibit “A”

 

PER PROCEDURE PAYMENTS

 

 

 

Annual Procedures Performed Per Procedure Payment
* * per Procedure
* * per Procedure

 

 

 

Notwithstanding anything to the contrary set forth herein, for purposes of determining the per procedure payments pursuant to this Exhibit "A," (a) only those "procedures" (as defined in Section 4 of this Addendum Five) performed on or after January 8, 2013 shall be counted; (b) the number of annual procedures performed shall be reset to zero (0) on January 8, 2014 and on each anniversary date thereafter; and (c) there shall be no retroactive adjustment of the per procedure payments irrespective of whether the number of procedures performed during any annual measuring period reaches a lower per procedure payment level. For example, if during an annual measuring period, * procedures are performed, then, Medical Center would pay * for each of the first * procedures, and * for each of the next * procedures (i.e., for procedures * through*). There are no minimum volume requirements.

 

-4-

EX-31.1 3 v359320_ex31-1.htm EXHIBIT 31.1
Exhibit 31.1
 
CERTIFICATION
 
I, Ernest A. Bates, M.D., as chief executive officer of American Shared Hospital Services, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of American Shared Hospital Services;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
 
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (or the fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
 
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):
 
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.
 
November 14, 2013
 
/s/ Ernest A. Bates, M.D.
 
Ernest A. Bates, M.D.
 
Chief Executive Officer
 
 
 
 
 
EX-31.2 4 v359320_ex31-2.htm EXHIBIT 31.2
Exhibit 31.2
 
CERTIFICATION
 
I, Craig K. Tagawa., as chief financial officer of American Shared Hospital Services, certify that:
 
1. I have reviewed this quarterly report on Form 10-Q of American Shared Hospital Services;
 
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
 
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
 
4. The registrant's other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
 
a) designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
 
b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; and
 
c) evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
 
d) disclosed in this report any changes in the registrant’s internal control over financial reporting that occurred during registrant’s most recent fiscal quarter (or the fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;
 
5. The registrant's other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent function):
 
a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and
 
b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal controls over financial reporting.
 
November 14, 2013
 
/s/ Craig K. Tagawa
 
Craig K. Tagawa
 
Chief Financial Officer
 
 
 
 
 
EX-32.1 5 v359320_ex32-1.htm EXHIBIT 32.1
Exhibit 32.1
 
CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
 
The certification set forth below is being submitted in connection with the Quarterly Report on Form 10-Q of American Shared Hospital Services for the quarterly period ended September 30, 2013 (the “Report”) for the purpose of complying with Rule 13a-14(b) or Rule 15d-14(b) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Section 1350 of Chapter 63 of Title 18 of the United States Code.
 
Ernest A. Bates, M.D., the Chief Executive Officer and Craig K. Tagawa, the Chief Financial Officer of American Shared Hospital Services, each certifies that, to the best of his knowledge:
 
1.          the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
 
2.         the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of American Shared Hospital Services.
 
November 14, 2013
 
 
/s/ Ernest A. Bates, M.D.
 
Ernest A. Bates, M.D.
 
Chief Executive Officer
 
 
 
/s/ Craig K. Tagawa
 
Craig K. Tagawa
 
Chief Financial Officer
 
 
 
EX-101.INS 6 ams-20130930.xml XBRL INSTANCE DOCUMENT 0000744825 2011-01-01 2011-12-31 0000744825 2012-01-01 2012-09-30 0000744825 2012-01-01 2012-12-31 0000744825 2013-01-01 2013-06-30 0000744825 2013-01-01 2013-09-30 0000744825 2012-07-01 2012-09-30 0000744825 2013-07-01 2013-09-30 0000744825 2013-09-30 0000744825 2013-11-01 0000744825 2008-12-31 0000744825 2012-12-31 0000744825 2010-12-31 0000744825 2011-12-31 0000744825 2012-09-30 0000744825 us-gaap:CommonStockMember 2013-09-30 0000744825 us-gaap:CommonStockMember 2012-12-31 0000744825 us-gaap:PreferredStockMember 2013-09-30 0000744825 us-gaap:PreferredStockMember 2012-12-31 0000744825 us-gaap:CommonStockMember 2010-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2010-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-12-31 0000744825 us-gaap:RetainedEarningsMember 2010-12-31 0000744825 us-gaap:ParentMember 2010-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2010-12-31 0000744825 us-gaap:CommonStockMember 2011-01-01 2011-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2011-01-01 2011-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-01-01 2011-12-31 0000744825 us-gaap:RetainedEarningsMember 2011-01-01 2011-12-31 0000744825 us-gaap:ParentMember 2011-01-01 2011-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2011-01-01 2011-12-31 0000744825 us-gaap:CommonStockMember 2012-01-01 2012-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2012-01-01 2012-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-01-01 2012-12-31 0000744825 us-gaap:RetainedEarningsMember 2012-01-01 2012-12-31 0000744825 us-gaap:ParentMember 2012-01-01 2012-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2012-01-01 2012-12-31 0000744825 us-gaap:CommonStockMember 2013-01-01 2013-09-30 0000744825 us-gaap:AdditionalPaidInCapitalMember 2013-01-01 2013-09-30 0000744825 us-gaap:RetainedEarningsMember 2013-01-01 2013-09-30 0000744825 us-gaap:ParentMember 2013-01-01 2013-09-30 0000744825 us-gaap:NoncontrollingInterestMember 2013-01-01 2013-09-30 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-01-01 2013-09-30 0000744825 us-gaap:CommonStockMember 2011-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2011-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-12-31 0000744825 us-gaap:RetainedEarningsMember 2011-12-31 0000744825 us-gaap:ParentMember 2011-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2011-12-31 0000744825 us-gaap:CommonStockMember 2012-12-31 0000744825 us-gaap:AdditionalPaidInCapitalMember 2012-12-31 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2012-12-31 0000744825 us-gaap:RetainedEarningsMember 2012-12-31 0000744825 us-gaap:ParentMember 2012-12-31 0000744825 us-gaap:NoncontrollingInterestMember 2012-12-31 0000744825 us-gaap:CommonStockMember 2013-09-30 0000744825 us-gaap:AdditionalPaidInCapitalMember 2013-09-30 0000744825 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2013-09-30 0000744825 us-gaap:RetainedEarningsMember 2013-09-30 0000744825 us-gaap:ParentMember 2013-09-30 0000744825 us-gaap:NoncontrollingInterestMember 2013-09-30 0000744825 ams:IncentiveCompensationPlanMember 2010-06-01 2010-06-30 0000744825 ams:IncentiveCompensationPlanMember us-gaap:MinimumMember 2010-06-30 0000744825 ams:IncentiveCompensationPlanMember us-gaap:MaximumMember 2010-06-30 0000744825 us-gaap:RestrictedStockUnitsRSUMember 2013-01-01 2013-09-30 0000744825 ams:NonEmployeeDirectorsMember 2013-01-01 2013-09-30 0000744825 ams:NonEmployeeDirectorsMember 2013-09-30 0000744825 ams:MevionS250Member 2013-06-30 0000744825 us-gaap:FairValueInputsLevel3Member 2013-09-30 0000744825 us-gaap:FairValueInputsLevel3Member 2012-12-31 0000744825 us-gaap:FairValueInputsLevel1Member 2013-09-30 0000744825 us-gaap:FairValueInputsLevel1Member 2012-12-31 0000744825 us-gaap:FairValueInputsLevel2Member 2013-09-30 0000744825 us-gaap:FairValueInputsLevel2Member 2012-12-31 0000744825 ams:ShareRepurchaseProgramMember 2012-01-01 2012-12-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure 10-Q false 2013-09-30 2013 Q3 AMS 4608870 AMERICAN SHARED HOSPITAL SERVICES 0000744825 --12-31 Smaller Reporting Company 100000 100000 4609000 4609000 4606000 4606000 2701000 0 1955000 1564000 50000 50000 9000000 9000000 4715000 3706000 298000 401000 615000 925000 316000 310000 16949000 15956000 85489000 84453000 738000 694000 7560000 9754000 93787000 94901000 42265000 41224000 51522000 53677000 0 2687000 982000 1003000 72154000 73323000 867000 263000 217000 168000 722000 747000 1591000 801000 4379000 3932000 3843000 3742000 11619000 9653000 11187000 13837000 12884000 13173000 8740000 8550000 3280000 3280000 8578000 8578000 4971000 4902000 -424000 -357000 6508000 6806000 19633000 19929000 4811000 4901000 24444000 24830000 72154000 73323000 4396000 4236000 13647000 12923000 470000 383000 1317000 1102000 1615000 1532000 4658000 4481000 730000 626000 2080000 1935000 2815000 2541000 8055000 7518000 1581000 1695000 5592000 5405000 887000 960000 3275000 3093000 532000 525000 1459000 1638000 162000 210000 858000 674000 306000 0 840000 0 11000 10000 19000 25000 -133000 220000 37000 699000 0 28000 40000 52000 -133000 192000 -3000 647000 1000 183000 227000 614000 -134000 9000 -230000 33000 -0.03 0 -0.05 0.01 -0.03 0 -0.05 0.01 -51000 -120000 -185000 -111000 -22000 -52000 -163000 -59000 -111000 -120000 -341000 -87000 -44000 -52000 -297000 -35000 23044000 8606000 4703000 0 6262000 19571000 3473000 4597000 125000 74000 69000 0 125000 0 0 125000 0 0 74000 0 0 74000 0 0 69000 0 69000 0 14000 4000 3000 28000 28000 0 0 0 28000 0 9000 1509000 217000 139000 0 0 0 0 0 1509000 0 0 0 0 0 217000 0 0 0 -68000 -68000 207000 996000 780000 480000 0 0 0 0 0 996000 0 0 0 0 0 780000 0 0 0 0 0 480000 1489000 813000 0 0 0 506000 506000 983000 0 0 0 38000 38000 775000 0 0 0 -230000 -230000 227000 25171000 8606000 4828000 0 6768000 20202000 4969000 8578000 4902000 -357000 6806000 19929000 4901000 8578000 4971000 -424000 6508000 19633000 4811000 4611000 4606000 4609000 -637000 0 0 -67000 0 -67000 -44000 0 0 -357000 0 -357000 -280000 -45000 -120000 4746000 4563000 -6000 0 840000 0 69000 62000 0 -3000 966000 372000 -193000 542000 -25000 263000 1437000 -228000 6285000 4396000 3293000 4103000 0 29000 14000 31000 -3168000 -3994000 2584000 2946000 2916000 2796000 3109000 3925000 269000 950000 79000 600000 480000 679000 -2681000 -2146000 391000 -1864000 2580000 716000 1522000 1782000 42000 147000 2625000 264000 139000 169000 <div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WIDTH: 0in; WORD-WRAP: break-word"> <div><strong>&#160;</strong></div> </td> <td style="TEXT-ALIGN: justify; WIDTH: auto; WORD-WRAP: break-word" valign="top"> <div><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font> <div><strong>Note 1. Basis of Presentation</strong></div> </div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly American Shared Hospital Services&#8217; consolidated financial position as of September 30, 2013 and the results of its operations for the three and nine month periods ended September 30, 2013 and 2012, which results are not necessarily indicative of results on an annualized basis.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Consolidated balance sheet amounts as of December 31, 2012 have been derived from audited financial statements.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">These unaudited consolidated financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2012 included in the Company&#8217;s 10-K filed with the Securities and Exchange Commission.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">These financial statements include the accounts of American Shared Hospital Services (the &#8220;Company&#8221;) and its wholly-owned subsidiaries:<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> OR21, Inc. (&#8220;OR21&#8221;); MedLeader.com, Inc. (&#8220;MedLeader&#8221;); and American Shared Radiosurgery Services (&#8220;ASRS&#8221;); ASRS&#8217; majority-owned subsidiary, GK Financing, LLC (&#8220;GKF&#8221;); GKF&#8217;s wholly-owned subsidiaries, GK Financing U.K., Limited (&#8220;GKUK&#8221;) and Instituto de Gamma Knife del Pacifico S.A.C. (&#8220;GKPeru&#8221;); ASHS&#8217; majority owned subsidiary, Long Beach Equipment, LLC (&#8220;LBE&#8221;), GKF&#8217;s majority owned subsidiaries, Albuquerque GK Equipment, LLC (&#8220;AGKE&#8221;), Jacksonville GK Equipment, LLC (&#8220;JGKE&#8221;) and EWRS, LLC (&#8220;EWRS&#8221;), and EWRS&#8217; wholly owned subsidiary, EWRS Tibbi Cihazlar Ticaret Ltd Sti (&#8220;EWRS Turkey&#8221;).</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to nineteen medical centers as of September 30, 2013 in the states of Arkansas, California, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas and Wisconsin, and in Turkey.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">GKF also provides radiation therapy equipment to the radiation therapy department at the Gamma Knife site in Turkey.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (&#8220;IMRT&#8221;), Image Guided Radiation Therapy (&#8220;IGRT&#8221;) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company formed the subsidiaries GKUK, GKPeru, EWRS and EWRS Turkey for the purposes of expanding its business internationally into the United Kingdom, Peru and Turkey; LBE to provide proton beam therapy services in Long Beach, California; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> AGKE and EWRS Turkey began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> GKPeru is expected to begin operation in the latter part of 2014.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> GKUK is inactive and LBE is not expected to begin operations in 2013.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></div> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> &#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">During 2012 and 2013, the Company&#8217;s partner in its Turkey operation,&#160;its partners in the Jacksonville Gamma Knife <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> operation and the Albuquerque Gamma Knife</font> operation&#160;have made investments in EWRS,&#160;JGKE, and AGKE&#160;respectively. These investments are included in the line item &#8220;Non-controlling interests in subsidiaries&#8221; in the Company&#8217;s financial statements.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Based on guidance provided in accordance with ASC 830, Foreign Currency Matters (&#8220;ASC 830&#8221;), the Company analyzes its operations outside the United States to determine the functional currency of each operation.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Management has determined that these operations are initially accounted for in U.S. Dollars since the primary transactions incurred are in U.S. Dollars and the Company provides significant funding towards the startup of the operation.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> When Management determines that an operation has become self-sufficient, the Company may change its accounting for the operation to the local currency from the U.S. Dollar, depending on the facts and circumstances. The Company determined that effective in the third quarter 2012, the functional currency for its Turkish operation, EWRS Turkey, was the Turkish Lira.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Therefore, in accordance with ASC 830, EWRS Turkey&#8217;s balance sheet accounts were translated at rates in accordance with guidance provided under ASC 830, and accumulated gains and losses and translation differences were recorded in accumulated other comprehensive income (loss), which is a separate component of equity.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">As of September 30, 2013 and December 31, 2012, EWRS Turkey&#8217;s balance sheet accounts were translated at rates in effect as of those dates, respectively, and income and expense accounts were translated at the weighted average rates of exchange during those respective periods. Translation adjustments resulting from this process were also recognized under accumulated other comprehensive income (loss).<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Gains and losses from foreign currency transactions are listed in the Company&#8217;s Consolidated Statements of Operations.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The Company recorded a net foreign currency loss of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">306,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">840,000</font> for the three and nine month periods ended September 30, 2013, respectively, and a net foreign currency gain of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">133,000</font> for the year ended December 31, 2012.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Based on guidance provided in accordance with 280 Segment Reporting (&#8220;ASC 280&#8221;), the Company has analyzed the factors that define an operating segment and determined that there is only one operating segment.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The nineteen locations are aggregated into one reportable segment because, in the Company&#8217;s judgment, these operating segments have similar historical economic characteristics and are expected to have similar economic characteristics in the future. Furthermore, each operating segment utilizes the same business model and technologies, servicing the same end users (radiation therapy patients).<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> All significant intercompany accounts and transactions have been eliminated in consolidation.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 133000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt">Note 2.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font> Per Share Amounts</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> For the three and nine months ended September 30, 2013 basic earnings per share was computed using <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,609,000</font></font> common shares, and diluted earnings per share was computed using <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,612,000</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,613,000</font> common shares and equivalents, respectively.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> For the three and nine months ended September 30, 2012 basic earnings per share was computed using <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,606,000</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,610,000</font> common shares respectively and diluted earnings per share was computed using <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,630,000</font> and <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 4,635,000</font> common shares and equivalents, respectively.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The computation for <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> the</font> three and nine month periods ended September 30, 2013 excluded approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 580,000</font></font> of the Company&#8217;s stock options because the exercise price of the options was higher than the average market price during those periods.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The computation for the three and nine month periods ended September 30, 2012 excluded approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 310,000</font></font> of the Company&#8217;s stock options because the exercise price of the options was higher than the average market price during the periods.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 4609000 4606000 4610000 4609000 4612000 4613000 4630000 4635000 580000 310000 580000 310000 21500 11000 69000 3000 62000 3500 880000 750000 1630000 115000 609000 576000 0 0 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WIDTH: 0in; WORD-WRAP: break-word"></td> <td style="WIDTH: 0.75in; WORD-WRAP: break-word" valign="top"> <div><strong><font style="FONT-SIZE: 10pt">Note 3.</font></strong></div> </td> <td style="WIDTH: auto; WORD-WRAP: break-word" valign="top"> <div><strong><font style="FONT-SIZE: 10pt">Stock-based Compensation</font></strong></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">On June 2, 2010, the Company&#8217;s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the &#8220;2006 Plan&#8221;). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the &#8220;Plan&#8221;) and increased the number of shares of the Company&#8217;s common stock reserved for issuance under the Plan by an additional <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 880,000</font> shares from <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 750,000</font> shares to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,630,000</font> shares.&#160; The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors.&#160; The Plan serves as successor to the Company&#8217;s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans.&#160; The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans.&#160; Under the Plan, there have been <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 115,000</font> restricted stock units granted, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, and there are <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 609,000</font> options granted, of which <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 576,000</font> options are vested as of September 30, 2013.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">Compensation expense associated with the Company&#8217;s stock-based awards to employees is calculated using the Black-Scholes valuation model.&#160; The Company&#8217;s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates.&#160; The estimated fair value of the Company&#8217;s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award.&#160; The estimated fair value of the Company&#8217;s options is amortized over the period during which an employee is required to provide service in exchange for the award, usually the vesting period.&#160; Accordingly, stock-based compensation cost before income tax effect in the amount of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">11,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">69,000</font> is reflected in net income for the three and nine month periods ended September 30, 2013, compared to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,000</font> and $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">62,000</font> in the same periods in the prior year, respectively.&#160; There were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3,500</font> options issued and no options exercised during&#160;the three month period ended September 30, 2013.&#160;There were <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 21,500</font> options issued and no options <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> exercised</font> during the nine month period ended September 30, 2013. There were no excess income tax benefits to report.</font></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 55000000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WIDTH: 0in; WORD-WRAP: break-word"></td> <td style="WIDTH: 0.75in; WORD-WRAP: break-word" valign="top"> <div><b><font style="FONT-SIZE: 10pt">Note 4.</font></b></div> </td> <td style="WIDTH: auto; WORD-WRAP: break-word" valign="top"> <div><b><font style="FONT-SIZE: 10pt">Common Stock Investment</font></b></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></b> <font style="FONT-SIZE: 10pt">As of September 30, 2013 the Company has a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,701,000</font> investment in the common stock of Mevion Medical Systems, Inc. (&#8220;Mevion&#8221;), formerly Still River Systems, Inc., representing an approximate <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 0.77</font>% interest in Mevion. At&#160;December 31, 2012 the investment was $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2,687,000</font> which represented a <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1.0</font>% interest in the convertible preferred stock of Mevion.&#160;The <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> Company&#8217;s</font> investment was converted to common stock in April 2013 when it declined to participate in a new <font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> financing</font> round.&#160;Therefore the Company&#8217;s investment was converted from preferred stock to common stock in April 2013.&#160; The Company accounts for this investment under the cost method.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In June 2013 Mevion announced that it had secured a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">55</font> million round of financing which will be used to accelerate the manufacturing and deployment of the Mevion S250.&#160; The funds were raised from existing equity investors, as well as from debt financing. The Company invested an additional $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">14,000</font> in this round.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company reviews its investment for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may not be recoverable.&#160; The Company evaluated this investment for impairment at December 31, 2012 and reviewed it at September 30, 2013 in light of both current market conditions and the ongoing needs of Mevion to raise cash to continue its development of the first compact, single room PBRT system.&#160; Based on its analysis, the Company estimates that there is currently an unrealized loss (impairment) of approximately $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">2.4</font> million.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">In assessing whether the impairment is other than temporary, we evaluated the length of time and extent to which market value has been below cost, the financial condition and near term prospects of Mevion and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value.&#160; Although the investment is not without risk, and the manufacture of the first unit has taken longer than originally anticipated, the Company believes that the current market value is a temporary situation brought on solely due to the delays in treating the first clinical patient.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">During the second quarter of 2012, Mevion announced that it had received FDA 510(k) clearance for its MEVION S250 system, which enables users of the system to treat patients immediately upon completion of system installation.&#160; Mevion had previously announced that it had received the CE Mark certification which enables Mevion to market, sell and install these systems through the European Union and any country that recognizes the CE Mark.&#160; Based on the continuing progress being made by Mevion toward the manufacture and installation of the first single room PBRT system, the Company believes that our investment in Mevion is not other than temporarily impaired, and the fair value will increase so that the carrying value will be recovered.</font></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 0.0077 0.010 14000 2400000 the Bank&#8217;s prime rate minus 0.5 percentage point, or alternately, at the Company&#8217;s discretion, the LIBOR rate plus 1.0 percentage point 9000000 2015-08-01 0.0144 8740000 8550000 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WORD-WRAP: break-word; WIDTH: 0in"></td> <td style="WORD-WRAP: break-word; TEXT-ALIGN: justify; WIDTH: 0.75in" valign="top"> <div><b><font style="FONT-SIZE: 10pt">Note 5. <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font></font></b></div> </td> <td style="WORD-WRAP: break-word; TEXT-ALIGN: justify; WIDTH: auto" valign="top"> <div><b><font style="FONT-SIZE: 10pt">Line of Credit</font></b></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt">The Company has a $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">9,000,000</font> renewable line of credit with a bank that has been in place since June 2004 and has a maturity date of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">August 1, 2015</font>.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The line of credit is drawn on from time to time as needed for equipment purchases and working capital.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Amounts drawn against the line of credit are at an interest rate per year equal to <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>the Bank&#8217;s prime rate minus 0.5 percentage point, or alternately, at the Company&#8217;s discretion, the LIBOR rate plus 1.0 percentage point<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>, and are secured by the Company&#8217;s cash invested with the Bank.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The Company is in compliance with all debt covenants under the agreement.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> The weighted average interest rate during the first nine months of 2013 was <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1.44</font>%.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> At September 30, 2013, $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,740,000</font> was borrowed against the line of credit, compared to $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">8,550,000</font> at December 31, 2012.</font></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The estimated fair value of the Company&#8217;s assets and liabilities as of September 30, 2013 and December 31, 2012 were as follows (in thousands):</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level 1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level 2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level 3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Carrying&#160;Value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="36%"> <div>September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Receivables</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Common stock investment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,701</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,318</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>18,719</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Accounts payable and other accrued liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Advances on line of credit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,870</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,870</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>32,293</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>31,870</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>44,007</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>44,430</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="36%"> <div>December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Receivables</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Preferred stock investment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,687</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>14,721</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>1,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,021</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>17,408</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Accounts payable and other accrued liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Advances on line of credit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,577</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,577</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,684</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>10,529</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>34,577</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>45,106</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>45,213</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WIDTH: 0.75in; WORD-WRAP: break-word"> <div><strong><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font>Note 6.</font></strong></div> </td> <td style="TEXT-ALIGN: justify; WIDTH: auto; WORD-WRAP: break-word" valign="top"> <div><strong><font style="FONT-SIZE: 10pt">Fair Value of Financial Instruments</font></strong></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><strong><font style="FONT-SIZE: 10pt"> &#160;</font></strong></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The Company&#8217;s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company&#8217;s own assumptions about the assumptions that market participants would use in pricing the asset or liability.</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> </font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font>The estimated fair value of the Company&#8217;s assets and liabilities as of September 30, 2013 and December 31, 2012 were as follows (in thousands):</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify">&#160;</div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; FONT-SIZE: 10pt"> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-ALIGN:Left; TEXT-INDENT: 0in; WIDTH: 100%"> <table style="BORDER-BOTTOM: #9eb6ce 0px solid; BORDER-LEFT: #9eb6ce 0px solid; MARGIN: 0in; WIDTH: 100%; BORDER-COLLAPSE: collapse; OVERFLOW: visible; BORDER-TOP: #9eb6ce 0px solid; BORDER-RIGHT: #9eb6ce 0px solid" cellspacing="0" cellpadding="0" align="left"> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level 1</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level 2</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Level 3</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: center; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="11%" colspan="2"> <div>Carrying&#160;Value</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="36%"> <div>September 30, 2013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>11,005</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Receivables</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>5,013</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Common stock investment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,701</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,018</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,318</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>18,719</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Accounts payable and other accrued liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>3,397</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Advances on line of credit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,740</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,870</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>31,870</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>32,293</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>12,137</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>31,870</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>44,007</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>44,430</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 700; TEXT-DECORATION: underline" width="36%"> <div>December 31, 2012</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Assets:</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Cash, cash equivalents, restricted cash</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>10,614</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Receivables</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>4,107</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Preferred stock investment</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>2,687</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>14,721</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; COLOR: #000000; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>1,300</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>16,021</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>17,408</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 3px double; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Accounts payable and other accrued liabilities</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>1,979</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Advances on line of credit</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>8,550</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Debt obligations</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,577</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,577</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 1px solid; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="10%"> <div>34,684</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ffffff; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> <tr style="HEIGHT: 10px"> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; PADDING-LEFT: 10px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="36%"> <div>Total</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>10,529</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>-</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>34,577</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>45,106</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="1%"> <div>$</div> </td> <td style="BORDER-BOTTOM: #000000 3px double; TEXT-ALIGN: right; FONT-STYLE: normal; PADDING-RIGHT: 5px; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: bottom; BORDER-TOP: #000000 1px solid; FONT-WEIGHT: 400" width="10%"> <div>45,213</div> </td> <td style="TEXT-ALIGN: left; FONT-STYLE: normal; FONT-FAMILY: Times New Roman; BACKGROUND: #ccffcc; FONT-SIZE: 10pt; VERTICAL-ALIGN: middle; FONT-WEIGHT: 400" width="1%"> <div>&#160;</div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> </div> </div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> 300000 1300000 11005000 10614000 5013000 4107000 18719000 17408000 3397000 1979000 32293000 34684000 44430000 45213000 11005000 10614000 11005000 10614000 5013000 4107000 5013000 4107000 16318000 16021000 16018000 0 300000 14721000 0 1300000 3397000 1979000 3397000 1979000 8740000 8550000 8740000 8550000 31870000 34577000 31870000 34577000 44007000 45106000 12137000 0 31870000 10529000 0 34577000 300000 1300000 1000000 72000 9000 3.26 <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WORD-WRAP: break-word; WIDTH: 0.75in"> <div><strong><font style="FONT-SIZE: 10pt">Note 7.</font></strong></div> </td> <td style="WORD-WRAP: break-word; TEXT-ALIGN: justify; WIDTH: auto" valign="top"> <div><b><font style="FONT-SIZE: 10pt">Repurchase of Common Stock</font></b></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt; TEXT-INDENT: 0.5in" align="justify"><font style="FONT-SIZE: 10pt">In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 1,000,000</font> shares of its own stock on the open market, which the Board reaffirmed in 2008.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> There were no shares repurchased in the first nine months of 2013.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> In 2012, the Company repurchased <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 9,000</font> shares at an average price of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.26</font> per share.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> There are approximately <font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> 72,000</font> shares remaining under this repurchase authorization.</font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WIDTH: 0in; WORD-WRAP: break-word"> <div>&#160;</div> </td> <td style="TEXT-ALIGN: justify; WIDTH: 0.75in; WORD-WRAP: break-word" valign="top"> <div><strong><font style="FONT-SIZE: 8pt"><font style="FONT-SIZE: 10pt">Note 8.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"></font></font></font></strong></div> </td> <td style="TEXT-ALIGN: justify; WIDTH: auto; WORD-WRAP: break-word" valign="top"> <div><strong><font style="FONT-SIZE: 10pt">Income Taxes</font></strong></div> </td> </tr> </table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">&#160;</font></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 8pt"><font style="FONT-SIZE: 10pt">We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annual effective income tax rate expected to be applicable for the full fiscal year.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> However, when a reliable estimate of the annual effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the year-to-date period.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Our effective income tax rate is highly influenced by the amount of the nondeductible stock-based compensation associated with grants of our common stock options.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> A small change in estimated annual pretax income (loss) can produce a significant variance in the annual effective income tax rate given the expected amount of these items.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> Because of this variability, a reliable estimate of the annual effective income tax rate for 2013 cannot be made.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font> As a result, we have computed our provision (benefit) for income taxes for the three and nine month periods ended September 30, 2013 by applying the actual effective tax rate to income (loss) for the period.<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">&#160;</font></font></font></div> </div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <table style="FONT-FAMILY: Times New Roman; TABLE-LAYOUT: fixed; FONT-SIZE: 10pt; dtth: tableHanging" cellspacing="0" cellpadding="0" width="100%"> <tr style="PADDING-BOTTOM: 0pt; PADDING-TOP: 0in" valign="top"> <td style="WIDTH: 0in; WORD-WRAP: break-word"></td> <td style="TEXT-ALIGN: justify; WIDTH: 0.75in; WORD-WRAP: break-word" valign="top"> <div><b><font style="FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt">Note 9.</font></b></div> </td> <td style="TEXT-ALIGN: justify; WIDTH: auto; WORD-WRAP: break-word" valign="top"> <div><b><font style="FONT-FAMILY: Times New Roman, serif; FONT-SIZE: 10pt"> Reclassification</font></b></div> </td> </tr> </table> </div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-JUSTIFY: inter-ideograph; LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> &#160;</font></b></div> <div style="clear:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-JUSTIFY: inter-ideograph; LINE-HEIGHT: normal; TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> </font></b><font style="LINE-HEIGHT: 115%; FONT-FAMILY: Times New Roman,serif; FONT-SIZE: 10pt"> Certain comparative amounts in the consolidated financial statements have been reclassified to conform to the current quarter&#8217;s presentation.</font></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> EX-101.SCH 7 ams-20130930.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME link:presentationLink link:definitionLink link:calculationLink 106 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 107 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 108 - Disclosure - Basis of Presentation link:presentationLink link:definitionLink link:calculationLink 109 - Disclosure - Per Share Amounts link:presentationLink link:definitionLink link:calculationLink 110 - Disclosure - Stock-based Compensation link:presentationLink link:definitionLink link:calculationLink 111 - Disclosure - Common Stock Investment link:presentationLink link:definitionLink link:calculationLink 112 - Disclosure - Line of Credit link:presentationLink link:definitionLink link:calculationLink 113 - Disclosure - Fair Value of Financial Instruments link:presentationLink link:definitionLink link:calculationLink 114 - Disclosure - Repurchase of Common Stock link:presentationLink link:definitionLink link:calculationLink 115 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 116 - Disclosure - Reclassification link:presentationLink link:definitionLink link:calculationLink 117 - Disclosure - Fair Value of Financial Instruments (Tables) link:presentationLink link:definitionLink link:calculationLink 118 - Disclosure - Basis of Presentation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 119 - Disclosure - Per Share Amounts (Details Textual) link:presentationLink link:definitionLink link:calculationLink 120 - Disclosure - Stock-based Compensation (Details Textual) link:presentationLink link:definitionLink link:calculationLink 121 - Disclosure - Common Stock Investment (Details Textual) link:presentationLink link:definitionLink link:calculationLink 122 - Disclosure - Line of Credit (Details Textual) link:presentationLink link:definitionLink link:calculationLink 123 - Disclosure - Fair Value of Financial Instruments (Details) link:presentationLink link:definitionLink link:calculationLink 124 - Disclosure - Repurchase of Common Stock (Details Textual) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 ams-20130930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 ams-20130930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ams-20130930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 11 ams-20130930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R17.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2013
Fair Value Disclosures [Abstract]  
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]
The estimated fair value of the Company’s assets and liabilities as of September 30, 2013 and December 31, 2012 were as follows (in thousands):
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
Carrying Value
 
September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
11,005
 
 
 
 
 
 
 
 
 
 
$
11,005
 
$
11,005
 
Receivables
 
 
5,013
 
 
 
 
 
 
 
 
 
 
$
5,013
 
 
5,013
 
Common stock investment
 
 
 
 
 
 
 
 
 
 
300
 
 
$
300
 
 
2,701
 
Total
 
$
16,018
 
 
$
-
 
 
$
300
 
 
$
16,318
 
$
18,719
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and other accrued liabilities
 
$
3,397
 
 
 
 
 
 
 
 
 
 
$
3,397
 
$
3,397
 
Advances on line of credit
 
$
8,740
 
 
 
 
 
 
 
 
 
 
$
8,740
 
$
8,740
 
Debt obligations
 
 
 
 
 
 
 
 
 
 
31,870
 
 
$
31,870
 
 
32,293
 
Total
 
$
12,137
 
 
$
-
 
 
$
31,870
 
 
$
44,007
 
$
44,430
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
10,614
 
 
 
 
 
 
 
 
 
 
$
10,614
 
$
10,614
 
Receivables
 
 
4,107
 
 
 
 
 
 
 
 
 
 
$
4,107
 
 
4,107
 
Preferred stock investment
 
 
 
 
 
 
 
 
 
 
1,300
 
 
$
1,300
 
 
2,687
 
Total
 
$
14,721
 
 
$
-
 
 
$
1,300
 
 
$
16,021
 
$
17,408
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and other accrued liabilities
 
$
1,979
 
 
 
 
 
 
 
 
 
 
$
1,979
 
$
1,979
 
Advances on line of credit
 
$
8,550
 
 
 
 
 
 
 
 
 
 
$
8,550
 
$
8,550
 
Debt obligations
 
 
 
 
 
 
 
 
 
 
34,577
 
 
$
34,577
 
 
34,684
 
Total
 
$
10,529
 
 
$
-
 
 
$
34,577
 
 
$
45,106
 
$
45,213
 
EXCEL 13 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0`!@`(````(0#ZP-;3N@$``-<0```3``@"6T-O;G1E;G1?5'EP97-= M+GAM;""B!`(HH``"```````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M``````````````````````````````````````#,F%U/@S`4AN]-_`^DMP9* M4>#T;*N M@@486RJ9$A;%)`"9*5'*:4H^)B]AGP36<2EXI22D9`66C(:7%X/)2H,-?+6T M*2FFYL[?FBG5/)OQ*=`DCGLT4]*!=*%K>I#AX`ER M/J]<\+STC]2KA1B'QEN\86I;97'H/0 M3H5FYG>!3=V;WQI3"@C&W+A77GL,NJSHES*S3Z5FT>$F'90JS\L,A,KFM=^! MR&H#7-@"P-55U(Y1S4NYY3Z@WRZVM!W8F4&:]VL;G\B1(.&X1L)Q@X3C%@E' M#PG''1*./A*.>R0<+,8"@L51&19+95@\E6$Q58;%51D66V58?)5A,5:&Q5D3 M+,Z:8''6!(NS)EB<-?DO9W4^-@)MKW__.MHV1W*+=:L*[)G_-=9-CRD7W(!X M=\8'[+,#_.Q]B,/'S[%1VOH@;N#T7=@F[:8ZU+X1&%?"+FMW9=:=H@_QIPON MA69HC@D$B`YMVAY+#+\!``#__P,`4$L#!!0`!@`(````(0"U53`C]0```$P" M```+``@"7W)E;',O+G)E;',@H@0"**```@`````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````````````C)+/ M3L,P#,;O2+Q#Y/OJ;D@(H:6[3$B[(50>P"3N'[6-HR1`]_:$`X)*8]O1]N?/ M/UO>[N9I5!\<8B].P[HH0;$S8GO7:GBMGU8/H&(B9VD4QQJ.'&%7W=YL7WBD ME)MBU_NHLHN+&KJ4_"-B-!U/%`OQ['*ED3!1RF%HT9,9J&74"T\ MU<%J"`=[!ZH^^CSYLK$SO+=N5#9@NIS]NHFD++28,5 M\YS3$$ MX4UD^&'!Q0]47P```/__`P!02P,$%``&``@````A`$ MM^X'F$1-0E,[V-Y'__U,UZ4M=-HEZ!*P0^271Z\4>;'ZVC?)!SI?6Y,)&*0B M09/;HC9E)MXVSP\SD?B@3:$;:S`3!_1BM;R_6[Q@HT/\R%=UZY,8Q?A,5"&T MCU+ZO,*]]@/;HHEOMM;M=8A+5\I6YSM=HE1I.I'N,H987L5,UD4FW+J(YV\. M;3SY_]AVNZUS?++Y^QY-N'&$_+1NYRO$$(-J5V+(1+?EY?'-;!`5"WE;#`R9 MU<"0E,,-!T@Z:M(G'1\.331;EZB?-86#.SED;A3T":-SZ9E'MW4RK@**S919 MS902`XI9#2A2#C<<(.FH<9]T0FS%>';-<2F/3](OW!FB$]1K8^D*YTREVSK5 M$DPHOZCXDV3])ZF4DL/=:$C?<&>*3!2PHR'9J!&W;T:4;WIM,UT%_5U48TH, M<*L!4H[BGB44.4P`=\?D-``#__P,`4$L#!!0`!@`(````(0"\ M%-JUT0(``$$(```/````>&PO=V]R:V)O;VLN>&ULE%7;3N,P$'U?:?\ARON2 M&]>*%I6V:"M!0;0+CY9)IL0BL2/;H>7O=Y+2=)IHV?*43)(Y.7/FS/CR:IUG MSCMH(Y3LN\&1[SH@8Y4(^=IW_RQN?IV[CK%<)CQ3$OKN!QCW:O#SQ^5*Z;<7 MI=X^?>CD7 MTMT@]/0A&&JY%#&,55SF(.T&1$/&+=(WJ2B,.[A-A4YO"AF/$?>Z\QU M,F[L)!$6DKY[@J%:P=X#71;7I$WM M]B'">P2_5A#_4U\=69>W580-9<(FT@K[P:9RH[Y0V,)*]2E6%KB.[@F\T=,D MJ(A3E-'];#R9S2=CAG?S^]OI>+C`X'IX.YR-)@0E)"CA]U"00$,F(C"UW@>0 MF2^0TQTETEO-V]@-H-D^Y!C;,52FMH9F4_D4[9= MT+R.)V^XT.R)9V6=?2,DE['@&7(P5I<$)\(IW?V_8\I'*$H=IRA!S8*40S'V MAJQCR2GNUQS8@J]QE^XZ'M&A"CH.?(08]Y<1N/_:HD=TCH*.Z;ZNG8Y`1$^V1-A)7 M=G%"VE@,6CC[YMPKJN1X_C3#'=)68]#"^;IA=-F$M/,8M(#^[=:*'"$4T;$/ M:\=Z-5L\9F*>Q7C^59?J`*G5\[:G_^`O````__\#`%!+`P04``8`"````"$` MX\OI_HP%``#!%@``&````'AL+W=OC,#LGN1LLMGLQS6#K9(1,<",<_[]5E/H='6C@S?. MB`\O]795=Q>]^/91'HQW7C=%=5R:;&J;!C_FU:8X[I;F/W\_3T+3:-KLN,D. MU9$OS9^\,;^M?OUE<:[JUV;/>6N`PK%9FONV/FU,A\C5V;UZ]MIDE?E"21>BD/1_NQ$3:/,Y]]WQZK.7@[@^X-Y67[1 M[KYH\F61UU53;=LIR%D8J.XYLB(+E%:+30$.Q+`;-=\NS2??>;';MY!N'QP)8_/-SX0W.8PHR$P=7RCEU0$"@$^C+$1IP(AD']W? M<[%I]TO3#:;^S'89X,8+;]KG0DB:1O[6M%7Y'T*LET(1IQ>!.WH1YDR=T&=^ M\+6*A1%U!I.LS5:+NCH;4#7PS.:4B1ID0OK'88T[Y'U`.)3)+X@8@"%;'*Y\"G+Z"WIA1#9`T=76S!8LJWA M1%VB%["(_O+<-5X`[:L=ASXWUHE90)%$1Q215"\1@P*&*20;#&GX M:T3@\SH&:K%]221?$ND]@MB#F36^'`6LY"]2["'B8_[$P*OIDP$W)...4TL& MF,L&DD<(9L.6\_D08BYXQ)R`J;GP4[8+;8T(FF,!\^4'=T1,"-\EH:$]F?`" M/]0T4D)X(9,)8@]6M?&Y$[!B3UFRUHB@O9G(C.(_EH'`&9AY,N#8PILBD&7?,G4R$MD^"[XA4)F8^ M(]DE]J)'[`E8L>&#`8W M<6U]D8Q[Q.OV2,TN-^:DPT`..-8;M`C*E]"T,&C3%]<8PIH,>= M4&"H,.5'T.*FYD0#,-XFZ^(R82Z9];A\$L01A:OD)2&$JR]0 M*0&"B(P`-2A:@/$&L6&0#49*;&N&S&#-Q?V/F%J'+`>=]X0`@R4I]RP^F=74 MF-C^QQO#9H$84WL6)C<4-S(G(VQ@6TNHB)[\E`#*"P4U*!H`R:!X:W5AY[K? MOC!L&XA1M7_IF7YA&9I_@96 MNYOO@%\CR==(>A>A)I5F9ES=.GI3$ZE-3<]$W6XWL:>VDNVX!S#;2I(2[6Y% M/B4`J'^N#]0?%-SCQ0HG=VKC':D=3<_<\8'0&'GU)D[]7!CUZ]7KB>13=R"I7%^S.1QSP4&3^A4?9TQELHC4>0>*7MCIUQW@O50M'A]V_>S@JYG"`9D\! MWE95>_DBCLFNA\^K_P$``/__`P!02P,$%``&``@````A`'WO::+>`@``E`<` M`!D```!X;"]W;W)K&ULC)5=;YLP%(;O)^T_6+XO M7PGD0R%5DZY;I4V:IGU<.\:`5<#(=IKVW^_83BB0-FTO:(#7KY_S^N1D=?U4 M5^B12<5%D^+0"S!B#149;XH4__E]=S7'2&G29*02#4OQ,U/X>OWYT^H@Y(,J M&=,('!J5XE+K=NG[BI:L)LH3+6O@32YD3338IOPN5VAOWURN;SE[.#ZGU&JA2'KY)GWWG#(&PX)G,`.R$>C/0^,X]@ ML7^V^LX>P$^),I:3?:5_B<,WQHM2PVG'4)"I:YD]WS)%(5"P\:+8.%%1`0!< M4))X\2R8A"!'.Z;T'3>6&-&]TJ+^YT3AT-(_#.'G?Q7=$ML!;HLEZ)<4!0=/`GJHEI@7#)3B_7A&48K0W1ISB M&48`J^`4'M=1,EWYCQ`=/6HV3@/73A,.%=N3PB0.%!T*I/-Q%",V*"9LP[9Q M#_K[1J-]7U',.LF`!(+HDYCCGD#37`['++)'W!4>)7'G[R"=9FZC6P3V;ZC8 M.L6T%]^+QX`1)'W&RVQ&/&9+ACMOG":Q;-,H"E^RL>Q;]QZN77UOD$%+]\E, M>LF[Z9E%8\(1P<9I^@11,A]6L3W7O$&9#"DOYV?$8[K%<.>-T\03&V#H3:=? MKL8=Z"3]`MZ`@Z]8/\++<$8\A(O'9^LDKN_FLZEIO"$]3$]CS/Y0BB[>]H-Y9O(SM7N!0S%EA3L!Y$%;Q2J6`Y+`V\& MIR;=6'4W6K1V-.V$AG%H/Y;PZ\?@BQYX(,Z%T*<;,T:ZW]/U?P```/__`P!0 M2P,$%``&``@````A`/''M&ULE%9=;]HP%'V?M/\0Y;WY@H0/$:I"UJW2)DW3/IY-8HC5)(YL M4]I_OWOC$##00'D(!!^?G'/NQ=S9_6M96"]42,:KV/8=S[9HE?*,59O8_O/[ M\6YL6U*1*B,%KVALOU%IW\\_?YKMN'B6.:7*`H9*QG:N5#UU79GFM"32X36M M8&7-14D4W(J-*VM!2=9L*@LW\+S(+0FK;,TP%;=P\/6:I33AZ;:DE=(D@A9$ M@7Z9LUKNVFM(;:M,IT^;B@NR*L#WJS\DZ9Z[ MN3FC+UDJN.1KY0"=JX6>>YZX$Q>8YK.,@0.,W1)T'=L/_C3Q?=N=SYJ`_C*Z MDT>?+9GSW5?!LN^LHI`VU`DKL.+\&:%/&7X%F]VSW8]-!7X**Z-KLBW4+[[[ M1MDF5U#N$!RAL6GVEE"90J)`XP0A,J6\``%PM4J&K0&)D-?F?<Y;H M9A97^VIB2H@B\YG@.PMZ#Y3+FF`G^U-@WN>CW72)O1<8)(4D#\@2VR/;@BPD M5/EE'H31S'V!RJ0M9J$Q<#W"C$S,\ASCFXCD'!$,P@[C@JO.&L1^;.URR?<. M$(P.L`70TD)_8TPA[RT#8T(!TWA1L[(,U[!E[N!29D8&SS'.Q3)L`3//+;4;P7! M)U8BSWSN0F/&C4Y_""K-]:5>A^M[5I,^A*$=?MVW:T?PJ?9#)KJ?-*9'VU(C M0OWS07>G_I(^#D-]]!'U"#;51Z<]I"%]XJ\BDCZ$(1Z.D=NC1[`I/H@"LRT6 M&M.G7B/:Z$>>?Q[]G@//MD/;&;IQ9C@Z2OO;'<&F[NAP,.B.T9`^V5<121_" M$#_YB'@$F^+/0]>8/O5[A!EIXSW1:VU!HC$>25U1#=T^G)&WI]Z@3Y6?G&Z+ M%M0G_3HDZ868%O`_[>;&@6GI>O@M2)^488A'R5&`^M1O,3TV<3+#9UV&:`]Z M\M(C14G%ABYI44@KY5NMF8%EQ!:-6\S&'T9K"W[7G`'C-N=K?X%#8#>OS_P```/__ M`P!02P,$%``&``@````A`'Y/FPO8!```-18``!D```!X;"]W;W)K&ULG)C;CJ,X$(;O5]IW0-Q/..2,DHR:<-:NM%KMX9H0)T$- M.`+2Z7[[*>/`Q"9-I:M6IX\(Y?'Y>OE_"VA^1DD=FF6UA^-J*KDB14> M"UK&NPS&_6Y,XJ35;BYZ\GF:E+2BAWH$6@1VEKPP-]RP$C;5> M:Z_)P%^ELB>'^)+5?]-K0-+CJ89T3V%$;_L,A50*.@LS(G#*EA&;0`?A4 M\I1-#7`D?F_^7]-]?5JKX]EH.M?'!N#*CE2UES))54DN54WS_SEDW*2XB'D3 M@18W$<,MX MLRKI58$)#,.OSC%['`S+`.769>Y)Y_MGMH/?3.6%R:Q5Z"(X6L%<>=N8$W.E MO4%^DQMC]YGY5$2V+<*RR72=-O!3UQ";N"W1-O'D@"\'`AZ`S[O.CD794&X4 MW04T\*XS$&:(8.#CZ=GZQ&CF4]M;NPW<]47LR;9/S&$!,I,Z&3S#1,"/X/Y;\9Q-X#!-Y.`^LE9`'.;"5`XX<<.6`QP." M@Y.)Y.$C1GH*@D?,7-0)GV"B849P<2*Y..P>HP7WY,!6#CARP)4#'@_PY9<] M^[X<".1`V`;N'I[)0C0J>L0L.T8P`=9BX5%F4VD"P6$S6*NU"C/VYVHRU;L? M:)8QFS/0E8Z1"CAHT3`">[W8B&XV4R_$)6(A@@A([#% M]S(R0Y=;UDK.B+1%V9P9R@A*."CAHH2'$CXG;O/;8--7G-X!*A&B1#1$"!EA MYQWY#0Y?M5@K.2/2.Y#-F:&,H(2#$BY*>)S@?L_T9<]O'Y4(4")$B6B($#*R M?)`1_!EAK>2,2&\/-F>&,H(2#DJX*.%Q@F=D.I_U,X)*!"@1HD0T1`@982<; MX2$9WM(;7,R%8%LG1;7?S MT_=CIT-8;4%J[W8W/VWOX8B/(P&.A#C"JF;J21;DF65 MDM`+JWBQ-:>+=M6XEPDK*TAQV["@JM*/.X8%A9%^/&15O0=QV[3L1_I;TX+# M7E_',2TX\_7CKFG!T0_B6M=1*-J=XR/Y,RZ/:5$I&3G`$/41*XV5O.S'+VIZ M;NI5.UI#N:[Y>H+R+(&SHCX"^$!IW5ZP'^@*OIL?````__\#`%!+`P04``8` M"````"$`!AQ*DNX"``#N!P``&0```'AL+W=OV``:N`D>TT[;_?,0Y) M#%U7[2:)3Y[S^KP^YK"Z?:XK]$2%9+R)L>]X&-$FY1EKBAC__'%_,\=(*M)D MI.(-C?$+E?AV_?'#ZLC%HRPI50@4&AGC4JEVZ;HR+6E-I,-;VL`_.1U*T):[!16(KW:/`\9RE->'JH::.,B*`545"_+%DK>[4Z M?8]<3<3CH;U)>=V"Q)Y53+UTHAC5Z?*A:+@@^PI\/_L3DO;:W6(D7[-4<,ES MY8"<:PH=>UZX"Q>4UJN,@0-][$C0/,9W_G(787>]ZL[G%Z-'>?4;R9(?/PF6 M?6$-A<.&-ND&[#E_U.A#ID.0[(ZR[[L&?!,HHSDY5.H[/WZFK"@5=#L"0]K7 M,GM)J$SA0$'&";HR4EY!`?"):J9O!AP(>>Z^CRQ398S#J1/-O-`''.VI5/=, M2V*4'J3B]6\#^;JHLTAP$H&,DX@?.,$\\J/IOU5<4U%G,"&*K%>"'Q%<&MA3 MMD1?07\)RKTS4\?9Z]^L0GE:Y$ZKQ'B&$;B0T)ZG=1#.5^X3G&EZ8C9C9A;9 MR+9'M&VMF_2!BZYOI^QZ0KG3AKXG%STNYNT,4SOTX?Y.2"V-A%: M-9K;:!.^1NRSVME$&%T3ED]XU*ZOI^[G!&)O]U,G#7T.GH>-88S/:#XVL;T& M0KL3QN4U\)H"#%I=AMEBH&`\FCEJQDQ-14&WM*HD2OE!S\@0[MHY>A[?=X%^ M^@;QC;^$F3".)S#NN[A[3H!QVY*"?B6B8(U$% M*QBTW<\2WJL4IHWG`)QSKOJ%GBGG-_7Z#P```/__`P!02P,$%``&``@````A M`!Y9%G6D!@``UR$``!D```!X;"]W;W)K&ULG)K; M;MLX$(;O%]AW$'1?6]3)4A"GJ%UTM\`NL%CLX5J1Y5B(91F2TK1OOT,.;6M& M-&WN31K7GT8_AS/\*2J/'[\W>^];U?5U>UCZ8A;X7G4HVTU]>%GZ?__UY4/F M>_U0'#;%OCU42_]'U?L?GW[^Z?&][5[[754-'D0X]$M_-PS'A_F\+W=54_2S M]E@=X)MMVS7%`!^[EWE_[*IBHRYJ]O,P"-)Y4]0''R,\=/?$:+?;NJP^M^5; M4QT&#-)5^V(`_?VN/O:G:$UY3[BFZ%[?CA_*MCE"B.=Z7P\_5%#?:\J'KR^' MMBN>]S#N[R(NRE-L]6$2OJG+KNW;[3"#<',4.AUS/L_G$.GI<5/#"&3:O:[: M+OU/XF$=Y_[\Z5$EZ)^Z>N]'OWO]KGW_I:LWO]6'"K(-\R1GX+EM7R7Z=2/_ M"RZ>3Z[^HF;@C\[;5-OB;3_\V;[_6M4ONP&F.X$1R8$];'Y\KOH2,@IA9F$B M(Y7M'@3`3Z^I96E`1HKOZM_W>C/LEGZ4SI)%$`G`O>>J'[[4,J3OE6_]T#;_ M(B1T*`P2ZB`1J-??A[,P2T22WHXR1T5J@)^+H7AZ[-IW#ZH&[MD?"UF#X@$B MRY%%D!_SR&!(\II/\B)U*=`]3,>WIW`1/,Z_00I+S:P,#"76!F)Q1N:@[RP2 MACX6:1$R! MQ#5>U@;L86108P93.)Y!U$B(1/;/I8&(QIQJM'>'A+FVC.4/&9V_,,P-[4&0 M.,VN]ZZ`]7B<0KL\17-].=.G(108Q['4=\D-9H\R24A[G.1/,!>YH1`7?EB\ MSAT09NSN*Q5RZ=O:Q(I0?7(U=RY"@1Y`5NF,.XF&,)-7EFG*6-=I(9?TD=(; MF40#H`JYCZB02Q\5FI=J@EC7:B%7]?OUH0=0?=Q)5,B3/E6(K!;6FC#7`IUH M)R^16SC>RADW$PV9;ZX[A;@)&P+5Y^0F`HV`IH^9Q4I#N@#32!`KTP(QT(D) M0MA.7)),%3)/N5&`:`.TE;F9"(2L&;0A5-__\A-A,)2,&XJ&,$MFUR.(U?:$ MDZ(L\C+G-/E3'WL+M;:'"-?-(2"%DS9T.H/B?7"/$9 M@LSL9".M(:L^C&-&B#YY-#1NV?N>.-55K'4G&VD-X0Q?V4A3QKJ1CIS<0]%< M(=](:P@5FC?2!+%NI",G[U`TU\?=34,Z@VE@V@E2)EY8=H*17,COWNHKFAU] M9'PGJ"%SH6$76Q%:BQ!FK._.6I17\4QR&XX0PDR:=X($L>X$(R" M&D)]YIT@16P[P*9@KS M22^?S.)R!L$&L=9QS,5**]')52)T`_NJK2'SS76GW.TJD9.K*)KE+V/)66G( MO-&Z\B7)6,1UID#S/)F8;,.;OR)=7DY!FQ MI-D\YOSP14/6G&$<,T+U.3E&+&D^IY=]FRKRE8;,-\<^L")4'X09.\:-FI,T MRU\VR1]"VBGD`R\;P3I&`GZ>3SLOS43E.1E%C(\+M.3XX96&S#?7Z<,X>AVV M'5[%3D:A:)Z^R\CU](Z-@MU;RQL3Z@AZE&&:/B>7B-$`Z"K,]RL:LJ;/9B14 MGY-+Q+BZT^GE3Y4:TM5G/G&AC/7$!5ZAN_0'/C50A9,)1@C?8L+9I.E,2-UV MZ6O&K!!?S>.;ZV/Q4OU>="_UH??VU1;:*I@MH(H[?#&/'X;VJ-Y0/[<#O%!7 MO^[@#R@J>'T=S`#>MNUP^B!?_9__)./I/P```/__`P!02P,$%``&``@````A M`+=!H+GO`@``10@``!D```!X;"]W;W)K&ULG%9= M;YLP%'V?M/]@^;U\)20%A50-J-ND39JF?3P[8,`J8&0[3?OO=XT##21-NN6! M!'/N\3GGVB:KN^>Z0D]42,:;"+N6@Q%M4IZQIHCPKY\/-[<8246:C%2\H1%^ MH1+?K3]^6.VY>)0EI0H!0R,C7"K5AK8MTY+61%J\I0T\R;FHB8);4=BR%91D M75%=V9[C+.R:L`8;AE"\AX/G.4MIPM-=31ME2`2MB`+]LF2M[-GJ]#UT-1&/ MN_8FY74+%%M6,?72D6)4I^&7HN&";"OP_>S.2=IS=S?`#FQ@6J\R!@YT[$C0/,+W;I@LL+U>=?G\9G0OCWXC6?+])\&RKZRA$#:T M23=@R_FCAG[)]!`4VR?5#UT#O@N4T9SL*O6#[S]35I0*NNV#(>TKS%X2*E,( M%&@LS]=,*:]``%Q1S?3*@$#(<_>]9YDJ(SQ;6/[2F;D`1ULJU0/3E!BE.ZEX M_<>`W`.5(?$.)#-0?WCN6=ZM[_J+?V"9'UC@NY=R58)M['3I)$21]4KP/8(5 M!X)E2_3Z=4,@[&,Q)H:@WLH)`M(D]YHEPDN,(`()O7U:>\%\93]!0](#9G,& M,T;$9Q"!/\8D!@/7UYF6`\0&4X,S"/O8V?E&]P8T6!O0C=>.-M.!>#J0F(&1 MDF!Q7@KT^UB*#GD&*_BR)%T489CEU6GP:M6H-!CHVX"9Y!4;A-_UQ'6ZSZ"Q MXT@N<8P"A6FF+N9O[J`^6%TT=7$[5K`Q&*-Q"<>B,WX>F^=P?=/]8(YG$ M+7HZ'KLA[%08MX<".,5;4M!O1!2LD:BB.4SE6$M(6YCW@+E1O.V.PRU7<'YW M/TMX75,X#1P+P#GGJK_1$PQ_`-9_`0``__\#`%!+`P04``8`"````"$`^V*E M;90&``"G&P``$P```'AL+W1H96UE+W1H96UE,2YX;6SL64]OVS84OP_8=R!T M;VTGMAL'=8K8L9NM31O$;H<>:9F66%.B0-))?1O:XX`!P[IAEP&[[3!L*]`" MNW2?)EN'K0/Z%?9(2K(8RTO2!AO6U8=$(G]\_]_C(W7UVH.(H4,B).5QVZM= MKGJ(Q#X?TSAH>W>&_4L;'I(*QV/,>$S:WIQ([]K6^^]=Q9LJ)!%!L#Z6F[CM MA4HEFY6*]&$8R\L\(3',3;B(L()7$53&`A\!W8A5UJK59B7"-/90C",@>WLR MH3Y!0TW2V\J(]QB\QDKJ`9^)@29-G!4&.Y[6-$+.99<)=(A9VP,^8WXT)`^4 MAQB6"B;:7M7\O,K6U0K>3!`6#?!TVM+$6:]?Y&K9/1+(#LXS+M;K51K;OX`OWU)9E; MG4ZGT4IEL40-R#[6E_`;U69]>\W!&Y#%-Y;P]?O/R M\1?E>%G$__K#)[_\_'DY$#)H(=&++Y_\]NS)BZ\^_?V[QR7P;8%'1?B01D2B M6^0('?`(=#.&<24G(W&^%<,04V<%#H%V">F>"AW@K3EF9;@.<8UW5T#Q*`-> MG]UW9!V$8J9H"><;8>0`]SAG'2Y*#7!#\RI8>#B+@W+F8E;$'6!\6,:[BV/' MM;U9`E4S"TK']MV0.&+N,QPK')"8**3G^)20$NWN4>K8=8_Z@DL^4>@>11U, M2TTRI",GD!:+=FD$?IF7Z0RN=FRS=Q=U."O3>H<],9&R;,UM`?H6G'X#0[TJ=?L> MFT1.[P:3?$45*&'=`X+&(_D%,(48SVN2J#[W$W0_0[^`'' M*]U]EQ+'W:<7@CLT<$1:!(B>F8D27UXGW(G?P9Q-,#%5!DJZ4ZDC&O]=V684 MZK;E\*YLM[UMV,3*DF?W1+%>A?L/EN@=/(OW"63%\A;UKD*_J]#>6U^A5^7R MQ=?E12F&*JT;$MMKF\X[6MEX3RAC`S5GY*8TO;>$#6C\S210*:D`XD2+N&\:(9+:6L\]/[*GC8; M^AQB*X?$:H^/[?"Z'LZ.&SD9(U5@SK09HW5-X*S,UJ^D1$&WUV%6TT*=F5O- MB&:*HL,M5UF;V)S+P>2Y:C"86Q,Z&P3]$%BY"<=^S1K..YB1L;:[]5'F%N.% MBW21#/&8I#[2>B_[J&:+T5';:S76&A[R<=+V)G!4ALZ%8JNU'N_*J8E+\@58IA_#]31>\G<`6Q/M8>\.%V6&"D,Z7M M<:%"#E4H":G?%]`XF-H!T0)7O#`-005WU.:_((?ZO\TY2\.D-9PDU0$-D*"P M'ZE0$+(/994FRE)")J(*X,K%BC\@A84-=`YMZ;_=0"*%NJDE: M!@SN9/RY[VD&C0+=Y!3SS:ED^=YK<^"?[GQL,H-2;ATV#4UF_US$O#U8[*IV MO5F>[;U%1?3$HLVJ9UD!S`I;02M-^]<4X9Q;K:U82QJO-3+AP(O+&L-@WA`E M<)&$]!_8_ZCPF?W@H3?4(3^`VHK@^X4F!F$#47W)-AY(%T@[.(+&R0[:8-*D MK&G3UDE;+=NL+[C3S?F>,+:6["S^/J>Q\^;,9>?DXD4:.[6P8VL[MM+4X-F3 M*0I#D^P@8QQCOI05/V;QT7UP]`Y\-I@Q)4TPP:```8````>&PO=V]R:W-H M965T&ULG%G;;MM&$'TOT'\@^&Y)>^'-L!Q$"M(&:(&BZ.69 MEBB+B"0*)!TG?]_9G96T,Z1ILGEP+.OL\.R9G3F[W(1G^_=?GNS0,FC8_;?-#=2J6X8^B"3\\_OS3PVM5?VWV1=$& M$.'4+,-]VY[OY_-FLR^.>3.KSL4)OME5]3%OX6/]/&_.=9%O[:#C82X7BWA^ MS,M3B!'NZS$QJMVNW!2?JLW+L3BU&*0N#GD+_)M]>6XNT8Z;,>&.>?WUY7RW MJ8YG"/%4'LKVAPT:!L?-_9?G4U7G3P>8]W>A\\TEMOW0"7\L-W755+MV!N'F M2+0[YVR>S2'2X\.VA!D8V8.ZV"W#C^)^K74X?WRP`OU3%J^-]WO0[*O77^IR M^UMY*D!MR)/)P%-5?370+UOS)Q@\[XS^;#/P1QULBUW^FK8[_(DBX4!A$NB`*V+OOY4RFD8CB]Z/,D9&=X*>\ MS1\?ZNHU@%4#SVS.N5F#XAXBFYDIT*=_9C`E,^:C&62'`KJ!='Q[E/'#_!LH MN'&050^$(M8]B.0*F0.]*T>8N<]QF)L!PQS"X,8MO8:U]%<(T1XDHHCU$()0 M@^>,IV;`RQ!BWZAE],$KA*164Y%%T6*QH(@U042Q]A&$&LQO/#4#IM04>_`* M(9&E9GBQ[]=O?T]HP8(?3\N`&2U!]5@A!&EEAE:'V!""4(LI-5,+&@8/KS"(<0$M%M?NF%F%LVH=7JOB;@,D9N(,VWJ@NJZ=G$<)LHB,@-*D'G$ M.P2QKT.;NG8Y=>OKV(`%8J!C7#%,WO4@A-(SS=I;>N_0P];N-V'%_4$@!K5) M(YWVZ4:=[CZ6&K)_2X7YA]V[4X,I6DB:\-EB[%0/F\ MW?=$CVF,V$!U74-SU["1+U5\IZ6,27-S3'WGN--"R@$M)YF'Z+J'YN[A,+@. M82,JX5S2R;7O()&*$Z(W+11F(N]43;!"4SDG%[>3N*;I@U-Q2'&>K7@Q"293G)3BR: M^IWF=N(PKE_'9(&AB@0AXP$-35L?W6^D03-RW$P]8JZ=DC$(C*%)&7BO>_7$1V723B+N(P**)*-5GZ3D3? M0U2B!VA.4J80 M!>^2O>5*5636,KRI5EU+B;FE.`S2@T-)7Y)]2X$=S=LO%Q2SE)$J=JTEYM9B M(U\,6F2Q(MW.+4;?6D2626(_5,=)WJ+P6.&WG)A[B\.XU9B*OM7HGTX&SZ&* M.XZ2LP=Q4:\Z"B(?IHYRKA$VU&L7+BS.`SJ MF/0?HRAF\!BE)WF+13."W%L<9JAY#T*HCI.\1:.WD'7(O<5AM'VS?\L>9MA] MB>+*F.Y_*#'F*L,K4'?=).9NXC"#NF&8?@BE9_QA],D.;A/YR2[NZ(88O*R1 M"3U]./5\R$U:)(;7C7@;=\Z?B]_S^KD\-<&AV,%&8#%+P&!JO&S$#VUUMK=N M3U4+EX3VUSU<"A=P);>8`7A75>WE@[G.O%XS/_X'``#__P,`4$L#!!0`!@`( M````(0"\'.B\20(``*,%```8````>&PO=V]R:W-H965T&UL ME%3;CMHP%'ROU'^P_+YQPIV(L%I`M"MUI:KJY=DX#K&(X\@VM[_OL0V4F^@N M#R$F=D]+R3%=IP;82J,YQ$,4:\9BH7]3+#OW[.GP88&4OKG%:JYAG> M])*;1G.:^ M2%:D%<<](JFH<6!(]7LX5%$(QF>*K26O;2#1O*(6])M2-.;()ME[Z"35JW7S MQ)1L@&(A*F'WGA0CR=+79:TT753@>Y=T*#MR^\,-O11,*Z,*&P$="4)O/0_) MD`#3>)0+<.!B1YH7&7Y)TFD'D_'(Y_-;\*TYNT>F5-LO6N3?1,TA;&B3:\!" MJ96#ON;N)R@F-]5SWX#O&N6\H.O*_E#;KUPL2PO=[H(AYRO-]S-N&`0*-%&K MZYB8JD``7)$4;C(@$+KSWUN1VS+#[5[4[)$5L;J^2?`$H. M5(&D=2!I@_K#\U;4&G23;N__+"0H\@9GU-+Q2*LM@J&!_S0-=2.8I,#LG+4A MG_O.P)*K>7%%OA30!KJQ&??C$=E`@NP`F=Q"6I>(Z1U$_P0A(.^D$9Q_7*,K MRC!<_VE,3O3>QB1`!MY`$KO/)6#Z`'`A$(([%_@X/`>^$G85S21`NEY8IQW+2"8!\DC:%>*.M+!G80P;NN1O5"]%;5#%"VA6 M'/5A*738LG"PJO'CME`6ML/?EO`RY#"+<03@0BE[/+@]/KU>QW\!``#__P,` M4$L#!!0`!@`(````(0`_77[R8"8``!5W```4````>&POMN',?9Y[\OL/=0$/3"$D!2I,YV;+T8\6`SHD2&0]D(C/W0G&F2 M;SO_U3U8;JGAY23Q6YB&^1,'9YZSJ5W]]Z?'6R^O.>*,DJGT2Q+X^_NW<3% MO?]^]3__Q[=%43KFIL5W]Z[*\OJ;1X^*R54\CXJM[#I.^>8BR^=1R:_YY:/B M.H^C:7$5Q^5\]NCQ]O;S1_,H2>^Y2;9(R^_NO=QY<<\MTN1OBWC7?_)D>_O> MJV^+Y-6WY:N];+*8QVGI1NG4[:=E4MZXP]2O#]C?/BI???M(0_WPK]W;+"VO M"H9.XVGWVW%\O>6>;&^XQ]L[3[I?OLL^;KGMG=5?UF"T]G8_'R5I[`[+>%[\ MK^YJ7W4_"+"?QI=)4>81)WH7S>/NJ*]&;_=/#W='[]SXA]'I_I[[X7A\S;J;@:5!/&3S>9:Z<9E-/FRX\564 MQX4[7I3&QZS87:HF[-G-=?^P.]N;?^G.&,&.4V/)@UG46^^KBVA6]!:J=SF) M\R03(Z_&;CTND"(,/T`(BBX<7_VEQ\+=Z4;)U9-72<#N\;N]_7=CN(Z?QL=' MAWNC,WYY/3H:O=O=AR/W]\_&[L'[\9Z[_[`+SEX\0;:\^#SN?CD:CYG:_70W M*JXRDSR^CI*IBS^C.`M85>C(;-8D2&54%'$? M)97,3N.+&.F=NC+Z[%8//):'/Y-%X=OXREHGC4C M;/Q%-$EF29G$O>,=7T"6N!G>76_/D\H?>Y*ED'DQ*='KPO)UGETBO;U%*U@W MW,E,>E0@[U<@;[CO\ZP_!^(OYHL9'#(5?T"1)+)]-#F:2QG]:A]T(7P'@P#( M"N1T1WI:KR/!ZN^.#D>O#X\.SP[WQV[T;L\K_A^.C_;V3\=?N?V_O#\\^VMW MKYJ7KZ,;,7+W^_WY]2R[B6-L[%R,U9SU/$[CBV05/Q5E-H=9@_04CVK.RN./ M<;KH[1'..YGD"Y`Z2Z+S`2:H6-54/J1%F/`G+C?+.)^SW7E/4E=,R,YGR:6= MHL!7F`+G)+I.Q->S.$)NN@A8YODUP!TM0;+!Y5L)WAE\U@BWC^IF;BK;`9.BJ],TLJ;GMQB9645 M(?'D@WOP=./Y]M>FRPIO'Z/2X1KAQYR#V,H_,KG2T.>=H6CZ,#)H^YXM&$TY M#5(,>:3=-A'F@*DN*MMR&=0>')O'5S!M\C%&#=C)'\R0Z=XVIW&)(PGSX;"D MV/8!+I`Z*V\VL=O8D`C?0(>>NA^RPG/0.,X_HJ5ZL]]EZ28ZJ[GMT:0GA-Z MF'X$7FGR[MZ!(=9/OZ,_<`(Z\;GC4J;AX9!_,+K%Q#X`JU,P'>5]0K?9=\,% MIDV*`L4S<##C]'IH-NS_#9QQ?(;K\W;_'?[.\8$[/MD_'9T=XA0-G>[)G>.. MGH]0V=0BL*$;T+>[65&B-"ZJ[WM"_A9A*./4W!B9M6)Q?3U;890QNG>W?U[+ M3Q-FX"EA!E'"R,)$P/1QCW``X.EJ@V&&V;V-\LND%[>-8R]C9HZG\R2U(*F4 M"@BN47>SPTH:![X_KF'U.J0[_PB-(A6,PQ_))_+9NM6(\PHA]XUK# MHA+_^7Q1RE=P9>;2`=76.W!K#;^5ZR[UY6JU"[V#4EZH>RR]'Q1[.*>-Q""8 M+9,6=YON/"J2B6MICV:Y'N+NL!P^V@+VNW339+8P#_%N2]])C^P>OSTYW?^! M&.OPQWUW^([?]X*>> MZ)B/-#R^QR,8AT&6ZRZ.KA\Z<6_=+^:]VZ@D96^)EX[_/40D0UWW!"WOYR1X M/[O!61TRU&TWR!-^&0V5.I'2>CAH[FM_J.;SH?V\R1Y<",^G[?C46F]HN=<1 M@9A<6AS)=AY@NXN:>J"$RMOQA[=.\DX*%,68?,N@(W' MM.3E847=^0* M?%KHT0H-NM@8'KD.A[L^TI;M-EO:TT#=;>I3=([;"A MU==FC6_3*.8_[H[&/[B#H^.?!OW'QEN1Y_'1DBD]!2]C'*RP-_]=1(X:)2]^ MPV=#D,G(6IHK>`RR_JQC*;>+/)NWG+HU6Z\(1;N;WTIV"V_,:>I.-5_LP27^ MZT.Y9`590+'FZGS)[E647B*/:)#&'_5#;8=60-7#X&F=^NN)[,EP)FXU'-T< MC&T>W9X.$1778[^+'J^4Y)2LH=!)=&-):24PV_)]M^15>S:(N*-^6-:6,!O% MI#*1CXD)#Q&J16+=$RWC(+$P=?E\W1D'B0*;Y3$]\I[D,'ER;6D'PX9/LBRE M>+H+KYZSG-CISE$"R-7I*W=1PP;S?A&^[Y($^L-69!G)#9`-$W7/M7]Q86$> M":E&R*H`*?[L/W2$@(@?1Q47=Y>P36VR!-3X7+&2_;`FP[\[5`J0=W!.S2Q5 M@D=*@6"!"DIWV[7SJ=<,SQPK2HXE.K"-@7E!+0#WOYB0=%KD<8_+*G>H"T-P MTE:&=V/JH].%5VL6?.F\+;X'PKL0:#0AET5M0QX]N*@3]>Y34EX!?2LEVJS7 MA?,U$1/TNW"HO$+GUG+=0J[6"?(+#,0L: M/@OW\^A6WZMIY'X^BS^7[O6,_&9OKW<9=:&=+7>G.$4K,40R[2:$&NTSQ3TM*4<.2C5LCBET!5\$(% MLL(+(Y2Y5-FI'9BY!YJ*O`=6S]*9?$Y*Z3.'+2=!X?4?&7>*C`^QX_C< M-$E5D[)4$7Q80P3T^B<%57'<.Y> MGMM=1?BTYW%,IA(M]%'DE0=5L<`J6F]U!>OL"CHM\TT0+2WG+6_$02?G:SF7U2G:#.VA//?0,K')\^IH2!WMYR#YBO7__U M]W\^_),C)WL$KN-\"UEOC:@_]\.T21>\4QH79#P;W?>K/%,LG< M=)4.^_V;]V^TEF'JD,IK4BY0(]/8?1_-YY%[DR87,;_.W`GE7O][620.9XG*K"2W@Z&1C\YS#8L_!/I^,&V_O\ MY@$3H?UO_P@H[X+&(37`G27GYXG;3:ZB7REE\.L$G56ZHQ(]5R9&1#]ND7^( M$:U_/EPE(Y7H27UFBTM7Y,)+YM`M)8Q50%?:C?4JIK M'FKX$ZP%-<-A)1^T@-DM,P2C_(-2X]!@%Z6*AD^3R'P##!'%GT6YX0YF,/24 M3P^5S\\2QKXE?(+P"[H82OTJS<`_U]?)!BGJCY%&OXL_N3\#3,Q9]//;^#,, MYW_^:Y;3R7,6IRG&+J9GX_C#++K*YDP[ODH8A.G'4(E$/^$0R(*F&U[^4W=F M:.ZA&$;#^!:RFH8SFD(06^_=H$SRZ/JFY5R!/6F8_A!JY5%N]36YJ1K31CU^ MFG+^%0SHF[-&J?KM?5T%([8&#ATLCTFB0-G:X=M@82EK.03R1SDTS1MO,WQ, M&R@MY(_#GG8` M^]K\$=CBW"AZP7G^?,TP@28).5_`-LIK)Y**U'"'>R;W(APV`/J&&5,9!6UG MN/$\]B>'&O..F+&42%KB0YW'T5PP&Q'J&A]LT>C$MCS]R9:4!K,?I)W:BRYA ML2H8LEA+*;8ER*_14H*UA,H3JG=I:20%6Y`M9%:`O]("RB5-W=\6,#SE&IRS MG0;`@3D7V2+'VVO/T;:>4HX81`E%G;6?Y$Q$8]^G?HWW;[0" M_A*J!Z],%!L^WAS<`.!HO'OO^$5"],@:G:S)36$"]J>*;^ZZ_U9;PJR.9=K-=0+89NV MI1'U(LSH'&VDK?+X>O@G0$.^X;E+])*5L6N3QI**NW+_L7F@H_&N>ZEFE8-0 M]]JM*KAOC6>*X'39**_U6E!!X&AV\ZORB%"K1BT_TBN`5K03+.DFB>$4$YI3 M'O1?7P0?/*JZZZ@>2['(S:E7%+>^K4-(0HBB647T]H8#>M0SL&5&#CQKTT`Z M.,XPJ%%0!2;>;XVWW)[OE7"HK8D'YSI/YA8,M@K8HJK00I.;K;D\M^*X0*G& M"A54Q*VC4@$E_582BY(.R7R*+P%I\0GRJE>T3USC35$Z[ MI%V$CG-4"]U-13R[V"P6ZAA,<$V6!`_?YR;DI(Q>`24"2SA9@D%TT@?D`MJ$ ML4A-G[>PMP$I*"?9\6`[?4LO(_P@Q$R2G)Y!3JK*E@E-Q=$]`L:6-Y,:"JQ? M7B7YDK(DDK755W",$94]I4@2LD(U,BN/TEP8(F%0I36J<4=)'@G?9]@6ZR^0 M3S`L)2T=;S[VN:_959&OYS$""A:KRS9BFS+D^U:LW1=36`7-6$NFT`BIZLY+ M9?@]"_CF>J`Z7F4. ML`<1K(4ZQB^R\B%7&>!JR:GUA?6TT,B\@X&D1"]H7B+2'T6LYY_@B9=7>"B. M5)N"G;;BKIQ:DQ9A+M0_C>8HB)7$$\=\HL'E2OJ#]$4NOR]D<.4#A9SNU)L^ MOW>S:96I@?U;5&KU$@A`,D`FB$J%P/C8OCR#@`$<<[-%1C2*\C">1=I<<2LM MS>!W6,&?HRLBM;;7WPMWKK_)+1-BD[W7S[UK>.5KOI#2;%5S#``A>1,4$37D.(S M5J'$[M/!_N2)M7)68*Q+!O7$XLN,\^.7VR0_+JTB114Y7/90#"+EP+=]@RQ3 M$(RR]X.DBC,"5+,:="/+[#;&`]5?A`V$X]K*-#95!@]B*(F*S%=ZM9D7E&<3 M&$;&M*=\NB_VRF!H*3/DW M)KX!H?`IQ8*\C+(%"`\G5ANE@\_2;$YG$P*J##KY1N*HB5>9`J_MX9H[6"TR M.!.>$(`7BY*JQI8[D'..-X,(;2SY+`UXCMX%94^#T8^PTG6<-,^4&S(%'D^N MTFR675IZQH=*0 MC9JS3=M.3I.7C6>@DNC-B[R2`779HL?1!'"^%Y@9J6K):"%P()>3`^6_P='I6(5U8_S=Z M@PEUBYWG.-\-AX/3_LHL:+BR8WZS[@I">5'R8$W^?TWB'PCA>9+4UL_=M/*9 M]U.?0['ZI6O:V-M`831-'ZA]C\/>>2F*#;K=H[DL3."GWY86MN_D-(0C+ROD M/WSHQZ&%\O?1@P\-=76Q]"!@!K^"#UK91\>Z>++IU<\NVJAJX>N.:U5T.4E[I#L-*5!K@P\W.\.*H7EE7;WYWUWX M-DW>3R8=I^[/"UP&(C_R2*0I>@PIA1VNB'A/305%.`R3&2Z82G(1Y:IP7+&F M[E#[&Z[D?I7&5^2INW!U) MK(JLFTV7*+0$0;6Y:1^2$)0N97N$A,;.F,TR?[F+'`3&+)!=6`(%I#J9+9VA M:Q^6&_*!A";:QK1G"G?-S:.701>$32Q>>/',ZX?P&5[=SL;SH.K\9U+C9W)< M1!WO"*[>7AZAW6[$K5F6NHV`:>H[+@X7\4"XVCZJ7PETB23DW7IK%4T_)@6_ M5;O;B>S0@%!0MYPHH)))];D-X;VJS%YS7R3)%OAHGS)_PRN(1;T9R*PESEW# M%8'\.U]__*@PKSA5FX8EH7*H2(@H81*H6:(E MN<)?.+D.8HFIM)1[WMS/J35TM0E*Q4/<9"9"9UG`A7#EL9AF.+?FU+I+W$/% MWX[RVA43&920V^=^-O[NQXRPANJAO* MWM#XNIN!$4\WP$'=V.'3=.I<`#>^08':/9TFG:"J%7-`ERH+1>[3YS3$Z))QHA>.%-#E>8Z5JFY4 MXWK/WCX5B-,M5"SFP>G0Y4/%XGG(Z_IN.TU3TXZ=AV"),$^#:NFK/D#]-:,$ M#?/:9_5@50P$"IN)'H-M4*1)ZPB26BXAX,=,23CN<5.#G=*"3#?3U-TD\0SV M-4.4%!\V+]3-8U$9JUL>*?"2>$W*_%U?9=4@=WQ5!JQSGE5'JA!N4&$2JL0 MU!=>)04*,?QN.L'(J@]\-@,];?Z=M`5`U^)0+JQL]91P:=>%_%X(P#D5V3HQ MU/V=G=K+OO_<7\FU`US,?%V,&53M@9I=_-L$@NX/N? M^\@G0&<1>_#CA"YMB,J"7Y0NZL<\9Z9P3#D_V7A&S%1I$QEJ:1*V0#%7GU;. M-AF;A:IMO__6G*C='*:D`;-7:*#??VMM2?_.E^]I9^JUHPWOZ%/L/B'-46`@ M7R@VHNC&7KBHAPE6T[U21*OTI!R:L3DTAW71KNL`-]]@HY4-.08].6Y>4^4; M3D'(-=ZLQ_^C>*S<:L%5&YEUO=BP9$KG[CS=>\,2/?\:C0FG% MY9"S\3F1SK?RJRAEA7Z9\0V6<0Y9<']]$Y0?X#.9B#SWRX%ZC`Z=N5,L0,[K M-:TI$AV#&G\=U2)GM4G/NNVM%R_^"TBP#M*L")Y?'>>]_/VW7MG!SM94<"T] MPN&>OWQAAZNZ)L-^$D,Z8+>7-Y#@X9<`Z,J>?2FH`(.)W)*QZ6P=EF$?)&`) MCQQDA/J8*0AZ@JV@-IB49&LG*B_;<'02C@]=^]1G&*V4]J>J$1(\T?^43M'` M)O2F6`5W(*LE\@=A,>L-"H*_Z!VSM0!6MJKBFE!GK-I9T.<1@)A8T'(@> MH8P.6CR%*V>6[*KA$GACWE<2*H4EY&FA++II6M/$U#MY&,32\BRG,0&<\>-G MV]7I5?$-U9L\(C&"YR$_J&[E\86S@`H?PV@X;(_;:$/UJD<#['+QU&-09UP* MU^[O/`UR"5@R@D;WKGZ$"RK:(TX?D_B3+^"WR"*SGF#I$@129E8L%5I0$$\E M&)%AQ@"K[JG[*&&IV`O>J9=QOJD:BX5*7Z3'*%Q/HW.GQ^5YQ`CB"39DKC&/+7TF]&36S@;T>8_$B%@0"U M3DQ!XBRSYX(T1PM=)#DJ##6`JJ:.KV0M[9=Y!@^=O#X]S9+:ODJFL#E6`9-/YP4U9_SW%G%I0HC32Y`O MQ&#G3`2YJ""^!(]>A@-!/$OY?@B4Y#E(_00.B]`(T330U)2SU5*<,G\5Z9IW MC]3DTR:=>(4F+.??YO&I8-D8OS^-J1%\H@$='HR"YTOFH>K'$,#XQP`E)I7L MP@1>;2M)96TNN:1:J2ZJL3I$%T".@*8I%-Y)IHL68>`HFTL=!)#!Z M5MT+1:\>\^UY3:T96()VPQT]5[+:?$`'GC9#+QSLC=RSG>T''QZZ M"2\DD0V9^/A!@O9V_T?>,G%2^4$6JVX)LG[H*YY8PK652\QB@P4+*Y1M!+Y&>_`\"/P>C$'%20P>==%'XL7P@%D[;#-EKHR(5YE M#NOS"([=?3T>\L%-Y+`09MJ*08@JP,/B$,.S(-K'[!(L%>`0.=!E'CCQ@%'3 MB+2_T$-?]AC_2,5]>&87YV?50UBX$ZT4_G`( MM"?'HSUR.'&O%TS[T<0[719[MN76.1[6J>#N6[QN/@O9\OB3=058TR3G\`]Z M^>Q7A-.1?O#(J?4[!""OB5!"2_[K2P7;VT\-SWX#LD"H`]JZIW)"6'2TN%Q@ M6'>LHO!,/'<&JW6VA)[3//J$!/*VC:6O9'BDGOOKT00HFAHA0$G;+L%JK5Y]?QJ=/ MGQB0WK@T"0W3W#[>PLG=V7KZ]+^,A*LA/XDU3K/LSS//G'`81IW M4DDO-YZ%L@K4Z/FK/5$_4!;SQ\J!/JAOO!W:ZX_RV7MW\UM3&ME>5^X;FC"L M#5Z9X#_O02L)ZW*7OQ=61D1(&T=-^CM?V('D,?KJI^Q*.Y%[E1`C\!K' M33!DEFJC\[=JNDE2LLB66!([>M]2QJE4TXW>3#9CC0'!XE%B(WALKP[+2"LK M:3N3GVY)Y2/]Y';@4%M:`KM(?4\?9/_;`@TXK5PAP"'9)6;&E5=6VYM5'Q`K M18P/B#3+8S8/?NDA2'9>ED_OM'&.RA\%.H6L],R%@>$,%KE)[8EO/;R/V_`& MT%M&*X`=X)6X`7-U4H-#Y\S.E30R32W])Y0:Z-(KU;L1:)68Z:BK^G8.WRH8 MQ'Q1K6I`>M(&:9&V%@_PF:?L4=/:P-JDI&_(3"C/:V"T>8S[`X^L_OA)]^/=X)[\_IOIH>[7 M(R-9;^M=[NRC^G1S7X83692NLHQX5?O3E]W5[G<_@-1-GK$)AKK#-KL?'`T_ ML:KJQ$*T#^_!FA?AI0/YNNV!5G.:6B^L=C<^Z:30AF&FU;/U=$@XJ.6\NVO: MA_4#F?O@$T?GG9RO8>=N>$YC%6Y_">!%C^D/4T?Y]VM#FDKAWF]XGF M4FY741!^GZF4ED=!$9*H;*BL316FZ6,/'@$9`;K=BT-N`/YE?;#U^+G?+0]$` M9V[B-;%1W9[\PI>A:FCU1P*$T\I%PH0VN]=8]V%EE[M(T:M@=K;JP=SFNZ5` M8?"IBH'QM[D2+WML]E/L+@D4N2[_PI?GV,%K'@N=+)E&GD"?X<_8 M'P50\4_4^P'?$"*+$V'+")+(;I+>^^+]J8:G/E6JD-AR9P"H1E5#":Q!3XQ< M'5E1@J103#6'IY(UY;81IV'T559>X&^6V::%4KZZJ=,<+PB"6I=WJDT\[N$X M=?Z1G:"MEH2O9>M#8-`4<85L.C*(J1:X2$*%B6]H;]"1ZOX(+.927T35I7)A M)V9H8Q="O51`CERA/YM0WW]J:*W\A!ZX0-Y(Y7VNL!3>"%.[`5@$+*B[U%;] M,:(%06%GT`-AE6%,7,)`7F747+.$`/D:*HX)W->^(=[S(2BTS>QM<,5K_P;# MB)86U2QSCJ%(N3J4,E=1C)%\DX?G)I\!;=BI?E:USU@5M_RA`KL>")0068'` M)+#+G+50(W&!H0.IJHUKSNPJM%,*9G!/G?;J?M\R@,=Z@'=Y]!J;>MO$V]3< MUSTUMTMZ3FEE<;YN74GW>&;Q:5'$A>Q8Z,LGTF@"IKK1,5R+L.9UG.YP&G^[!F51:_QWJ]BM.S3H4 MZIOPI^6DD6&S@`P&3$62\'X/-0^DXF?;PJU!KQ\'C"^BW@5$`T69$N]RV=O(15Z#6 M33[!&1C;9851R"GUSM3=[Z?J`MLH^!?OZJL*MM+27WC9L(>>)O_F&GO^_D!W ME1$!;WT7HO7^S7[5CVXIMUW3/#X_#0'WJ^L,]=%A&3M[=WGS<(/ET"*UY>BA M:.A%VIVU5.<:M]NO_C9$X]<.O>MZBE''DU,^P""SQQH(T4Z+Q9IG:,EEUH]L M]EZ`Q9N"EZ43ELZGALO!YVC?1CB)B_GP]SB*Z[XW'EF%U5%.8<2_[27MW1Y7 M/8@X4GJ>)Q6Z##<*7G__!?KV*DMGO/MN@:D/?0<5NA3&6?'HW7]@IV/?FLCS M&6""^+'>2Z](E++AR/H%^1`22[VTW/_=_5?^'9?_Y)8_PMUPMM(2^ZV'*/0Q M3\LT+W@);F'7A`/ZX:PNUN$YVM50UMJ M>PF3UG:P8I63AUF6@!(F,587L3TX8(!V#]%Z&[M9LSOH?5/-ER5R#V12J..G MKIG38T8UOV%QB<6GZX:%JI?5/H?4WG(QZNX([LP[\'\6":^W4F!>Z;=YJWOT MP27@4.[[FW7>(R_:G6P]A79W=H[PA?EC/L+M<%;_BO&MTVLYM]O&U\C8@;B[369'!Y&J:N M-?6.?\=L;GN-[IF7J-=LU1T6=&1AK;])K;C7K=QHT2^9%3`S#,D2>S3#>KCY M4M9HENJ>?1U;#,_JL\3PV,8DW,8XS1I2CZI]\=1?J(4-F8+A.8\'W='A.4\& MYYPVF6)\KB6K>F?7G]I*]1<8MU]V"6&.$U%HG9`^45L*3Y,-G=S[&?T)E3@\U#R][RA^0]1G?-6QEQP,P_70;;!AWON\S_LRXYG! MOO[NQ7.5+W88.8$_4P?O^ZIB^U:PZ:^VI'Z MWW#)^L@],P8#L/' M7K0);7,582//[6G]_F7/,QU?321<>9:($,\,G[>;"ROP-F;L+!W7B5^9+%7Q MK*N/CWX0FDL7H+X,=-/*9+.#DGC/L<(@"M;Q>Q#7"]9KQ[++**>]:0\DW5S[ M6\_PXDBQ@JT?SU0M/Z4DGWQ_>'=N_Z_ MOOGV'S_8JW_^^/OR9S]^H_8R-40F^*!>YOM^K5CX.)'<2RVXN5X'/C%$`YJ0 MK:MG/_CJ&_@9!`.8AU^[N8Y^5KZ8+IP9(#PK<(-0B<'+8!\[XYN>G7QC8;K. M,G3P:VO3<]S7Y+2&)UA@I-_S''`3GNPE&DZK9XEH,ILF"(.S:8AGJ$T>F&3B MR7J;S)_VV,3I&C7K.H0_3A>SHMZNSG25XZ+$X2&Z'CY/ID+O..(W](0("KR$E^.N=9FY"'6N7S&5@0T.JZ;#PV' M(QP\P9F;:QBEQG;H&W"@I.\?7CJ;*\2!)*\2A!(\BH;X_94@D.35<<<5>"S=JP2! M)*\2!)*\RF:F.LQ5F$:4G*L$@22O$@22O-K9X#.MP%/I7B4()'F5(#BU5[/+ MJD4VL"Z/S#H;'Z>Z M01DW/9%PDZ@XEH:\ZNEX-:&/]?Y8'VF7R05;1ZH]>^5LO;)UN>Z]<0DT(K?- MAA,._5Q)&@[%%%D/O9"Z3[`%8VE#B[*=#0WV6-G00M1&/FXR[W+"\ZD++,][D.SP MS7W];3!`4=(PP[-3!-/ZA+.WR9J!<+G;;VZC>&(U2&C770G;0)1D;7:H[=KN M1O$$4FN[2TYLU/:V8!'FBA@CW*8.4CI4@9&/9;ON9QR+_'V=#W]@1O'F^F5- M-EO`#ACH5^X$F8CT/TPYS;7G\`+U+U0W`)Z^\R'G"#4AK4X`(:U'5XND0`,RL9`G"" M#`2XH2KE`,)3!@*X8LT00(`6"`!.350HP3TD`@R*J0 M)!HT62628I!5(PM7:+)*)($@JT)23\@JD12#K!I)7"&K1!((P(B4"DD](:M$ M4@RR:F3ABJ&L$DD@R*J0Q!/#(Y?('ITV3291R?SI2'_3_*GRLFZ<2(65Z7SV M8-?56?/DZBFY<@1?L&LI826F0C_,>ZM*&^6=\W,`EL.):+0< MYU4:Y^7SN-IW6=T8((T8V,2";!#(=8JA\Q#H*$4PURE7=-.\T_W'/3N;(X_.ZI,X^Y8;/-TM4(:F2>` MR_:DO3VE3N/\-V08Z?-P!CA/L-V)+S[!ZJ+A%*ET9'2'.OO(\)+JWJ&SZZOI MP<[^1=!)^R(%?^&:=!:PX:Q7FHD@E\0MDN9(O9(HNP2T!I5:,-,E@ZXJ3T>. MV/+XZ:TA40]4,KM5(7'6H*M"@BNZN--!O,N2,8`Y-5S1,D'HK2X3)Z!7%"^) MX>I:7,;;/O/>%"2B5A#6.2NX3,1]*^<1U%6D-\`]7]*Y4&^PHFX\=-0@(:RW MP7N^K'.ASA=$L/4\0KTJ,T\-5[225`4)C[?4/?Y"@N1<4[,B2N#TDDV.X*)K MN1/B*\F;:H?P5!I!R!4//B[@Z,AI)QK'57CY"("],6>"5RSO2OR>6=Y56='` M^IE9@9FVEK`.RK9LP"8-\I,W_@=O^98.!>\,"'7(RW2!1)RL?*&KH."(+XJ^M+)"0I)B&6["(+)@N M;"LK#_\A6$MDP:\!6\O*4Q_N^/?*SBOB\17%16X4<^5H>"L4IE%7[D8Q5-;HNK\"-()7SI M\$%;684?^3JA"]8):F/A1Y[[D2#WNQ65CWA-,.(3*87OX!WA")=T1#A*I!1> MXZ-\*!CEB93"7WQ\ZX+QG4@I/`7RB$4Z?"!N4>ZC(<^N+LCNW%QE59^MK0O/(@CP209L7R,N!!*#[D*0GVWI6%O`S]5P0GP_8C8H(NGO9 MN*9OQD'XJN!>QEP<[_21H+@_!D'.$2]!@T,10'^"YS[`(R44X"7MQ#F"XY-1V"TP\NL!(&IEK\VM M&S_D'\[4XOV?V8VM()C2;WWO?`EB)F*F%N\_X1W#((MAF1+*S:<([D(%?Y5M MZ,S4_]S-Q]/;.T.[F/3GDPM]:(\NIJ/Y[<5(7\QO;XUI7^LO_@N4X6-DKN`Y M)`<\IH4]3@;V:P_TJ\B%A[F$J;$I^,_%N9E*#A+X[#9!`!N66C,C>E'^F)N; M_P$``/__`P!02P,$%``&``@````A`.8I)&V)`P``%`P``!@```!X;"]W;W)K M>8]42$9+R*$1P'R:)'P ME!6'"/W^]7"S0)Y4I$A)Q@L:H1WFXX?UF8M'>:14>1"AD!$Z*E6N?%\F M1YH3.>(E+>`_>RYRHN"C./BR%)2DU4-YYH=!,/-SP@ID(JS$D!A\OV<)O>?) M*:>%,D$$S8@"?WEDI;Q$RY,AX7(B'D_E3<+S$D+L6,;42Q44>7FR^G(HN""[ M#-;]C"39C11-(6=0Y[>D1WGC_K1 M+_!5`$ED!>@D\M\ES5VHL_A-FN[[2\J':MN^"R^E>W+*U`]^_DS9X:@@TQ3* MH*NQ2E_NJ4Q@&R#7*)SJJ`G/(`2\>CG3_01E),\1"L&.I>H8H?%L-)T'8PRX MMZ-2/3`=$GG)22J>_S40KD.9(.,Z"/RM@^!P:!#?"%5KO2>*;-:"GSWH-$@I M2Z+[%J\@\.L+@I5H]D[#$9I#R2,DH:I/FV#M/T'=DIK8&@)>&P+;1'PA=.G! MH1&!T@P7T;`6T9769EOS13=OZ.3M$^.&L$2@"L-%-`R;V5GOI(EJS`PQZ1!3 MFXC?(BPS"-(UTTTXAOY_>\_T0U7C-3LRL_-O#=$UG-M$W"?:-5B&T,Q=P[?- M-&R;+>R\6T-TS98V$?>)*V:S]YAIV#;#;J,;I*N&W4[O(U?G MU;<&L=S:7J^Z,NXC5]STS][@^T'#CIM['`QBN;69C5L?:0FKVY:VV[#SH!]R M'-T#89"N8RM@%`TQK:[`R2Q8+.9M?UB*&,[G\/I5M"/GG,5MS73ML'-NXE>8 M=@6VG[Z.!^\O-I90W(J#C2F62:]A)_T#(5A:YIOFZ&P MGM::?\!X59(#_4;$@172R^@>'@U&<_A%$&9`,Q\4+ZLI9\<5#%;5VR-,WQ2F MAF`$\)YS=?F@9Y)FGM_\!P``__\#`%!+`P04``8`"````"$`Q?HN'^8"``#, M!P``&0```'AL+W=O;6KM1*5=7+LP,F6`L8VS?#2"I2I:3@%8WQ&Y7X8?'QP_S(Q;/, M*54(&"H9XURI.K)MF>2T)-+B-:W@2\9%212\BKTM:T%)VB25A>TY3F"7A%78 M,$3B%@Z>92RA:YX<2EHI0R)H0134+W-6RY:M3&ZA*XEX/M1W"2]KH-BQ@JFW MAA2C,HF>]A479%>`[E=W0I*6NWD9T9S!M_?C%ZE+UG)'-^_"18^H55%,R&-ND&[#A_UM"G5(<@ MV1YE;YL&?!,HI1DY%.H[/WZF;)\KZ/84!&E=4?JVIC(!0X'&\J::*>$%%`!7 M5#*],\`0\MK8S]P)J&CN\"'.VH5%NF*3%*#E+Q\K;NM/@/UB"$PO<6Y;`FGC3<'9#+;;1U=BT)HHLYH(?$6P]J%S61&]D M-P+FUA^CIG/L;X:!4YKD4;/$.,0(O)#0Y)>%YT_F]@MT)CEAEF-,.!U"5BU$ M]T'SKMO`F=<=IFQ:1)NR-0&X]DHYKV.#[$X[]*6O_?T]T4K48"VQ76AI`H.% MAK6MQH@P&$+68X@W1&S&B$N2[1CBA1W+0+$_5*R[[<.9^K=RG11C6*3GZ(6. MI<%,>IBSYTTK5U<1ZZN(S57$UB!FS19T?=]QG/>-@$K[K;_-")UT:<39Z$;F MTF!,`;X3]`LP/O0!Y^+,=N]_FTT@]P*PZ0,NOL$4U=7!M6O3N05F$Y@I:8Y_ M2<6>KFA12)3P@YZ`/IC61;OA_.CI'7\17[H1G-5Q?.U&<"`A;G<),$QKLJ=? MB=BS2J*"9K"48X4P"X49Q^9%\;H91CNN8(PVCSG\-2E,`<<"<,:Y:E_T`MU_ M>/$'``#__P,`4$L#!!0`!@`(````(0`TUKG-*@,``#X)```9````>&PO=V]R M:W-H965TT\8'HD*U["+ZE4!3/PJ@Z>KA1GB4TJ@N'3%,1 M\TC&QX*7IB91/&<&].M,5+IE*^*WT!5,/1ZKFU@6%5#L12[,BR6EI(C#+X=2 M*K;/H>YG?\KBEMN^G-$7(E92R]2,@,ZKA9[7?.?=><"T7B8"*D#;B>+IBF[\ M,%I0;[VT_OP6_*1[WXG.Y.F3$LE747(P&]J$#=A+^8BA7Q*$(-D[RWZP#?BN M2,)3=LS-#WGZS,4A,]#M&12$=87)2\1U#(8"S2B8(5,L^!!.]ER;!X&4E,1';63QIP[R&ZJ:)&A(X-F08/*5A$F3 M`,\FP9^_KGHE<=HDPO."W/-$KR[7NAH&%Q$[,]C_'=B%T;@=U!VJ@'>*"W M$PW^_@?1R(*BV^6V+="K8J"PC6A3HA[@*(2&#A5.8*8O3V/K(B;!W#DN+EP% MVSK&AU9U5L_.PMOW*,1@ M5V&#V!.S5GB&1'W$61LV8M\=W-3!;`3JW]E8Y'%E-0BLW+-IN(^[H-;OJ(\X M2O'V[1T_U_N(P:Z<&IG:F\$>$/7]4)]P!5<'ON-YKDDLCWCV+^!HZM#N6MH$ MF#_`MW!=V<-]B`7_9K!_Q0.)^P8 MAR*5TK0ON$#WSV?]%P``__\#`%!+`P04``8`"````"$`1BF=<.\$``"H$P`` M&````'AL+W=O)&*?%L>-__=?C]\6OE?5<;&/,U'PC?_.*__[]N>? MUA=1/E M!>%X'`5YG!9^DV%5WI)#'`YIPA]$\I+SHFZ2E#R+:^"O3NFY:K/ER2WI\KA\ M?CE_2T1^1HJG-$OK=YG4]_)D]>-8B#)^RK#N-S:-DS:W?.BES].D%)4XU".D M"QJ@_34O@V6`3-OU/L4*B':OY(>-?\=6NS#R@^U:$O1/RB^5]K]7G<3EES+= M_Y86'&RC3E2!)R&>R?7'GDP(#GK1C[("?Y3>GA_BEZS^4UQ^Y>GQ5*/<,ZR( M%K;:OS_P*@&C2#,*9Y0I$1D`X*^7I]0:8"1^D[^7=%^?-OXD&LWFXPF#N_?$ MJ_HQI92^E[Q4M-_XL*GF-#-==IV+#0I!-BAJY(&5I"SH!01> M2QF-30SWRNDSF)V+#1.9=9CN?=9R1LX235VXS\O`#F;DRN+QH%N,3A8FC,1!]'D*Q10(A.%LI@43+JB-\7IG&P*&%X3 MMW,@O2R1R: MR;ZR/_J2*5/W>L(ZI>VN7C81X2#1E-YF3[0FC0C#9/1$Z!#-R1@M-+`C9!X+ MAU,QK:/8K@WL;]UPD&)*;PN`+H_-JZKU M[NK5:XI!HAGV1;,UZ4WQH6C2E4J7)2F:2T8WL\%]H;1/>X'([/8&F5]/DJI2 M*M!1*1*XFU\@N-3:HJE,4WJW-INAN;8V%[:^XUE6>8EXH2LI_+?KSMS< ME^_#$!?FD%+T1B88F3A'IAB1T_9B9AB1'-DC+%KM\'YQS,/F&)'WK%[,`B,+ M9\P2(TO72#@&`GF'M[.%]&E`7@3L$888G,=^JX1\-85&8:9 M2S(VC^+5JZYZC?O^PX_RY'W/ZZ:HSFM?S!>^EY^S:E><#VO_G[\_SU:^U[3I M>9>>JG.^]G_FC?_AX==?[I^K^EMSS//6@PCG9NT?V_9R%P1-=LS+M)E7E_P, M5_957:8M?*P/07.I\W1G;BI/@5PLXJ!,B[./$>[J*3&J_;[(\D]5]E3FYQ:# MU/DI;8%_MS*:$*]/ZV]-EEE7E!4(\%J>B_6F"^EZ9W7TYG*LZ?3Q! MWC]$F&9=;//A)GQ99'755/MV#N$")'J;7$XME#N"#+2B=WM?G[*FPP4A3!S&>E(674"`O"O M5Q9Z:8`BZ0_S_W.Q:X]K7\7S:+E0`N#>8]ZTGPL=TO>RIZ:MRO\0)&PH#")M M$`7L[74YEZM(1/'K40)D9!+\E+;IPWU=/7NP:N"9S275:U#<0>0N,^31Y_I2 MJI"C#O)11UG[2]^#+!JHS_<'R.P^^`Z:9A:S&(I9Q#R%,0*'I3#08*NT\6,AK7"2'F-#!,-FV M8PC"#8),YZ;!:Q\2[T41BA+8(`9H]$EP\<80A&-,.8YSTV`JWHIILT%(9+0+EV'LBF/4 MW1)$%!-]"37H*E>^<6H:3*D)F3#9$(/<9@/,\'IHN%_S(IRTL;&I\7I)]4V, MF[K&QS6'&.2V"D$U!M@B8)1<0LF-"Z;!C)1@\V&#&"05)[>^J-D[,H!DS)5@I+8C+@2O,7D3>+Z\OH MTP[/5^3#H4XFG%)8>[B+<(L M8&-!5L-0$9^R--$FND3DRLV$KL$W^82X-0JA^`[`@O#A,>SGW(=;?L0K5$*6 M*>7W)K,0..EA"?4&*A3?!5@05+(',8FWHQ#*[UW&(8:<@V\&+,@64DHRI2YR,05.60G-UWM^H50`X8B"():#F$IF:5,8VGNXGW#N]N"AJW% M7NPZAJ1`";[+7"2^";C31X175S5=L;$@RP&N.[Z+?4,12K@(RE(/^6'49!1*(]\CH.*#GF,*^4>#YA.1&[0%67XR7I%YC`09 M1HSTLWJ7LYB[.%-N?1;4*3FP(Z,(H7?=5ZVID'K&.X-Q6E,K=`:W:41T?8(1 M:V-!2%,E0W)B&)N(6,4O&XQB!C.1)WH(YA`; M\]M1".7'O&9\3*H!CXFX&UH0UE!$DKR*VC*['B.6*P*A_-[D,>K68T3$Q-E8 M$/*C+\J6G>LQ8N0'3<4\9N(:1).@1>9>8T*O_=$B8YQA"!7Q768#!RDW6Y^( MFXT%X8_#$@X@W`%HY<0X'81T/=+$\Q8\CBCS^I!O\].I\;+J29^E2/@!LO^V M/^?Y*/4O^^S[#9S_F,.2H+\`QR^7])!_3>M#<6Z\4[Z'D(OY$CJMQ@,<_-!6 M%W,(\EBU+.8#W5=5V'_2Y1']T]_`_````__\#`%!+`P04 M``8`"````"$`4,^^@88'``#1)P``&````'AL+W=O/_TX'D;?JTM;-Z>G,9MZXU%UVC3;^O3Z M-/[[KVRR&H_:KCQMRT-SJI[&/ZMV_.GYUU\>WYK+UW9?5=T((IS:I_&^Z\X/ MLUF[V5?'LITVY^H$EEUS.98=_'IYG;7G2U5N>Z?C8>9[7C@[EO5IC!$>+D-B M-+M=O:F29O/M6)TZ#'*I#F4'XV_W];F]1CMNAH0[EI>OW\Z337,\0XB7^E!W M/_N@X]%Q\_#E]=1FNEGT?MOGG++_7VM_I4@=IP MG_@=>&F:KQS]LN7_!`CUZJ MMLMJ'G(\VGQKN^;X+T),A,(@O@@"GR((8W<'F8L@\"F"^,&4!5YXQT`"$0,^ MK[.!'P?.`N;;2P&?5^?[I0A%$/B\SF(Y>`1`]B.`3^',[A\!K.P^"'Q>IP'W MQ:[!#+.B3[*D[,KGQTOS-H*5"_>]/9=\'V`/$)!G5W`SNR"MN,]G[M2[`MW" MDOC^S+SYX^P[I/%&,&L3$U`FUIDPHDBB(\Q;4"8U,2%E,A.SI$QN8E:4*4S, MQYAGH.J[M'!39&G-"_8J*8>?QO#OAZ3,H]=>([/J!??G7A!XGH+$,K(*O5`C M$ID(8!O0B%0FE/B9;`O]$,X"A-=92678B06O<;!(EIJHT^<,5(GD3F)W$D4-H*H"-,=KB*'515]145D M4",X132)8@2"7D0E/Q*7G$G52]E2ULC@R.81)%^)L1(F/6R MV%*++;/8M6`H9":*0W'B2<0R.@N$IU].JADK)N1:0[6`0 M".HZC:^F;NK6`K*F(<82\ M9*'T,1)WC-2-9&XD=R.%%:&B\E):$M5^E#`LO*F8:HDL(%1JJ9=SL0",69:X MO%.;=V8SYJ[0Q0UO*A@OI27!!F8A]U(W1+509@A9LQ`1L2%J^WGB#I&ZD"WY^8,>I9U+;9Z9 MS9C;C(4P&H=,9>/UM22;8^UB-4[D\I4IK9E:K31N3BW<_Z-L? M+<]D9K7H[RM]HI60,$%DZ!)2@DS,"U>^$#0C>J>=DR@LBGR]B"H(`X,A!3\1 MU+^K(>EIY?SUU<)%0+;S5R#B_#4_9.8#@V\2I&)=V2!2]X4R-Y*[D<**4#GO M:DA\4T.BR8D0:D5;2US5(HIQ;2;">-,[???^:(H4G;-WQ'!ZYZX+%#>\J6RP M1.5E/>P4\;F7DHU,K08%9,FC6""HD;YM)NX0J1O)W$CN1@HK0C556I*!FII: M$[4:]!%"P=A)`P^:WQ. M*\FHU84"0N$FS/`@)A:(49S$9DQI\)!,K-\I,IM[[G0O*$&_.Z3*_:]&A'^' MKRJH%84"$@H&IJ)0(#<4M'4B-L_,9LQMQD(8S6.FPO&Z?WC*89<@ES=:4>@C M(ZZM;VZQ`&ZH9>M#;)X9O2Y\U:P5[[D;*0CB^R2EJ7!*&V*OIGU#^^%K!P=" MXKOR`/YH4XA%(&3,=2%!@LCPB#LER"3P]0ME!`D7GJ'()@B+PKE^LPO"!"NZ M_U!!>3

IVXD"?^ MO9B7IH-7J?H?]_#J7`4OS7A3@'=-TUU_X2]]O;^,]_P?````__\#`%!+`P04 M``8`"````"$`Z$;PIVD#``")"@``&````'AL+W=O*`M4DV:)GPE)6'R/[U\VDTMRVI M2)F2G)92RA,4].!2V5$1$T)PKRET=6 MR4:M2-XC5Q#Q?*I&"2\JD-BSG*FW6M2VBF3YY5!R0?8Y^'[U)B1IM.N'@7S! M$L$ES]08Y!R3Z-#SPEDXH+1>I0P@M=W/;6:_J^OQF]"P[ORUY MY.=/@J5?64FAV-`FW8`]Y\\:_9+J(0AV!M%/=0.^"RNE&3GEZ@<_?Z;L<%30 M[1`,:5_+]"VF,H&"@LS8#[52PG-(`#ZM@NF5`04AK_7WF:7J&-G!=!S.W,`# MW-I3J9Z8EK2MY"05+_X8R+M(&1'_(@(1%Q'/'_OST`NG]U4" MGRU8-#"GK(A>@MX2E+6S`.IC\FB]_L\J>-0BCUHELF>V!>$2VO.R7LQ6S@N4 M-+D@FR$R"S&R;1!=0"T;-P/_9#T=VQ MD1=,7-?%Q+9++`9_Q]V_1WX`0$]@UR4"#;03((<3[/"V,PW#.NTZF[>R]=+9 M&`0^6_/]U7:7B.\2NUL$L@>O5G<]OJ^!.JC7P$7/ID%"T\#0ZY:WKL,6`1X< M&YT&F)<,$]Y08X<)K(%<3K'+VTW4,'8'4_?L&>9BSYN'@^RWF+B2?8R(8'+% M'R+FL^XDR![L;_TF3J`VMVWJH+[-WBZV,6WGEPWZ,.ZGOL;78;PS1;S13M!&:I(B*\LMD@P%^@1M42<`?0B5PF M"=!R,2[-$6].P(**`]W2/)=6PD_Z^`[@/6I'VYO%HZ]/AM[XQEO">34.>=I MJ[_4W3+Z\,>?]W='/]=/N\WVX>.Q=](Y/EH_W&QO-P]?/QZ72_\_Y\='N_WJ MX79UMWU8?SS^:[T[_N/JW__Z\&O[]'WW;;W>'RG#P^[C\;?]_O'R]'1W\VU] MO]J=;!_7#^K_?-D^W:_VZM>GKZ>[QZ?UZK9*NK\[[78Z9Z?WJ\W#<6VX?'J+ M8_OER^9F/=[>_+A?/^QKR=/Z;K57GW_W;?.X@^W^YBVZ^]73]Q^/_[G9WC\J MQ>?-W6;_5R4]/KJ_N0R_/FR?5I_OU'7_Z?57-W!7OPC]_>;F:;O;?MF?*-UI M_4'E-5^<7IPJT]6'VXVZ`EWM1T_K+Q^//WF796]P?'KUH:J@_V[6OW:-?Q_M MOFU_39\VM_'F8:UJ6[63;H'/V^UW'1K>:J223T6V7[5`]G1TN_ZR^G&WS[>_ M@O7FZ[>]:NZ!NB)]89>W?XW7NQM5HTISTJT^QLWV3GT`]=^C^XWN&JI&5G]^ M/.ZJ@C>W^V\?CWMG)X-AI^>I\*//Z]W>WVCE\='-C]U^>_^_.LC3'^H@Z1N) M^FDDWLGY8-`_.Q^^7:(BJT^B?AK)X&3H=2YZ[W"H7ETYU$]JKBJ2/V/W[]XKP>-^L=O7[YW!HOZQ]_X,$-HU#]^ M_\.@3KUW5VI7#8.Z5^KQ4/>XBQ.OWWFA&4_K3EV-D?%JO[KZ\+3]=:0F'M5M M=X\K/8UYEUWU"T9'W:"'\?+2<%%=7%L^:=7M=3^<_E3C M\L;$7,L8SXX8(4*/'*T=NV#B`M\%4Q<$+@A=,'-!Y(+8!8D+YBY(79"Y8.&" MW`6%"Y8N*!O@5+7HH5G54/LGFE5K=+.B0:X!&NWLM"$BD#)VP<0%O@NF+@A< M$+I@YH+(!;$+$A?,79"Z('/!P@6Y"PH7+%U0-H#5AFJ>^R?:4&O4/:LQ-+V+ M"[O1KNL83]V=#N-W8(>,#B&'AA5D(H@OR%200)!0D)D@D2"Q((D@00UL+,A'$ M%V0J2"!(*,A,D$B06)!$D+D@J2"9(`M!XI[H3=/^V^;F^_56#22U MD'IF(/;44K9>X&J)W8J&7+`5!1G7I*\V6XVQVK^_2]0=_Y M+",3T#VTZ=B0WH%,#.D?B&](?2ZAMT13X0F$)Q2>F?!$PA,+3R(\<^%)A2<3 MGH7PY,)3B*RER"J;65;KJ?WS.UI/1]NM5Y-N8T869"S(Q!!NCWQ#S@\-.!59 M@2"A\,R$)Q)9L2")\,R%)Q59F2`+XG,82!.#L$$H5`G`UF0'1% M0'3%$B5`=,V!Z$J!Z,J(6FIA8:)Z+]9"#@]+*X#4,HLMXU;P$NIN=1]\IH)+ M>"JUW7OT0<@[>D]];F+UGAKUU#[[\!D]=P,\TN?0:OY7

ZW5BBB4&]?G4E M@X[G;+%\Y+#W3H%H#B0*@3BD9D!T14!TQ1(E0'3-@>A*@>C*B%A57;4;9,\TGCB1 MKA.MF:9&/0Z["5P\34QB MW\S,9QW/6=+X4'/`38$XX`)X6DL+$:7FP\-TV?690\RR4B"6E;VIK`6B4)<]MRYSJ%E:@:36RU@B2A\/_+SRSH>>LT(I M+;7=3?6QDNBFZD&NVT_;=Z#ZD-?MFS5JS%4C$]5`8X/ZW&1.@%@//A(Y6J=` MG!D")-(5`M$U0R)=$1!=,1+I2H#HFB.1KA2(K@R)="V`Z,J12%>!*"8N@9A8 M6HEVX^I#J&;COM*(YLR*[FO]@+I>G#3'I+/V&#$*,^=8H@D0%P<^$$N<`G&` M!1*%0'3-@.B*@.B*)4J`Z)H#T94"T95)M`"B*P>BJP"B:PG$Q!*H2K3;59\; M-=M5KT*Z9_H+(\\=&S9.BKSZQ$EU&;34M4'.RL,Y!!N9*&OHFM.KUB7X!/IZ M"=[K73@G43[,[/=3((ZA0*(0B,N<&1!=$1!=L40)$%US(+I2(+HRHN8`<58V M"Q/5>ZD2KC+JOKU,A:?@RI#P\X\!6)A@40A$`?;#(BN"(BN6*($B*XY M$%TI$%T944LE+$S4BY600\/""B![(>74WA+F>A$IC+;/4:I154XRZQ-`B> M;O?"6024EL?J+OK;87^_NU06^]C5(&O^$<]O1B:JN?TQZ)7M#Z+,NKKK]=Q[ M%]0\Z0*BVUW3G=0V)W+L-&O?WN MJ!ZUN1L@@QK3U$BBL4'-#1`0Z\%'(@?I%(A30H!$[A="(+IF2*0K`J(K1B)= M"1!=TV];>][W:&[,D8$!\18H@D0EPD^$*]D"D17(%$(1-<,B*X(B*Y8H@2( MKCD072D079E$"R"Z.]JT/@BTVK1&UL`4:-P5 M:`+$98`/Q$X[!>(`""0*@>B:`=$5`=$52Y0`T34'HBL%HBN3:`%$5PY$5P%$ MUQ*(B250E6@WHGLZ^LK`E$>?W1KI?L+;9<.P2F/#?49AIIP[2U`QSG0')FHQA`>$S4ZA#C2AMX'I15`[0<2 MKZI+>"JUW7OT:>,[>H\.=W8$-;)W!.*1J^HVU4V=O7PLT<0@L_7N>^YZU4<. MQ\\4B.9`HA"(0VH&1%<$1%8"JV?.\M*R*%A8040 M"UL:]&)=ELBI-':G>.ZPTVL\H7C3P[.N//@TR)YI//?XRD2IS\<[2.UJ'C;` MQ?'J(Y$C:`I$5X!$HA"(B3,D$D5`3(R12)08-##3G7SF"@W-*1`U&>BJGIB+.>:9 M4\]G3AWDL:=QO7;J4"?BH6M_V'4>.OO&H^91U-D4B$,N>%-I(:*L991XZ`H] M2XR`6&(,5^MF/3%1`_.='-%+YC"SL!2(A65O*FR!*#QU[;B5F4/-T@HDM5[' M$E%&K8ZGG<5G::GM?JI/Y9HWNM\\=*@/]ZR]38T:T]6H*]#8(.O0H8[JLQY\ M)'*X3H$X-P32%0+1-4,B71$073$2N=]/@.B:(Y&N%(BN#(ET+8#HRI%(5X$H M)BZ!F%A:B5;CZAN*U;CM>YLJW%[%&&3O;=QO?(T8A6E@+-$$B.L#'XA7,P7B M``LD"H'HF@'1%0'1%4N4`-$U!Z(K!:(KDV@!1%<.1%NJJUMGN3<0@71JWK^Y>9&2B&J-Y3-1,=,X[)]";R>EBZ&R@?&C8[Z=` M'$.!1"$05SHS(+HB(+IBB1(@NN9`=*5`=&5$+96P,%'J1_6]&%$).30LK`!2 MR]Y&NSC5NWS-7$)3F>U>I`\4FU/_*[-#??[8G.+54V3=FZP]CGCJ:H+4%,+) MHN)LJ:BVI7TCT2.LBD0AW2`1*(0B*X9$NF*@)@8 M(Y$H`3+?/>T/ALZN8@X/U2D0/1D\K?/#`E$OEI9#S=(*)+&T)1`\9^?.:55I M>>SNXAZQ_EYWD2>O:E2(^4?N?TR4-0'5B:_L?TPB]C^=05?^PSFP6(DIM71NCUOW2*?0<[A$0YY88KM82$T35=Z7>UUD_2JF^C4S]^NGK^O1^NYN=W2S_:%?LZ2^P7WUX8#K=T!=]R_5'\RK M&Z?+!Y?JS["?X6>7ZN]])1\/+]6?TTH>#"_5W\)*'@\OU1^R2IX-+Q?/\6)X MJ?ZH5,:K=UA]JOJE^_G5NZVJ%T&YO'NI7OLA/=<]]2ZL9_BG_N6G^AU9IP>3 M>D?5X^KK.ED]?=T\[([NUE]4Y7:J[Q$_U6^YJG_9F^^]?][NU=NI5/VKE_RH MMY&MU1^3=O27X[]LMWO\HC[1Z>']9E?_!P``__\#`%!+`P04``8`"````"$` M5NC*I\$"``"T!P``&````'AL+W=O MJ^',SBZY6ET]R08]:TZ!?) MAL1AN""2BA9[ADR?PZ'*4C!^H]A.\M9Z$LT;:B%_4XO.O+!)=@Z=I/IAUUTP M)3N@V(I&V.>>%"/)LKNJ59IN&_#]%,TH>^'N7T[HI6!:&57:`.B(3_34\Y(L M"3"M5X4`!Z[L2/,RQYLHNXY"3-:KOD"_!-^;HV=D:K7_K$7Q5;0%"\%B.Z8F&H@`;@B*=S6@(K0I_Z^%X6M*!!.X#2;((YFF81*#Y'Q+B$^K]W5!+URNM]@@V#4B:CKHM&&5`_+HA M<.*P&P?.<8H1Y&J@"X_K*(U7Y!$JQP;,M-04SMW/R+82J,T7$V;V*W M_N_X+-OXF4W&+S`S.UKQ>ZHKT1K4\!(XP[Y,VD]=_V)5!WG"T%,6IF7_6,/? MD<-D"-T6*96R+R^@3,;_[?H/````__\#`%!+`P04``8`"````"$`CMD5`#4$ M``#-#@``&0```'AL+W=OWFFP4E0`T:8=+K_?JM\(3:PFCGY[SFFJU,/T)7 M)LW+I?Z2LK(&BN>\R-MW0>HZ91I]/U6L29X+6/<;"9-4&;L!4._9PA!LC_(?A([\%OC9/287(KV=W;]A>:GU3CI2NDUYXR\J_91!15))DHDC@5Y&0A1=.9HNE8+F3.569\*LS)QX)@SG. M?BE=I%3(+ZLUR4^X"KHGO`OIA)N()1SF,H7? M]Q6#A3[-NU>(:"VBU`X*@8HSUK"PUQ"/!MWJW%(X?T0A!ML*%2(ZIU0X0&(3 ML>:&%]%T1[S4)/06H/_!K44F6YA"X/PTC%K:1AVZ(.UX;"*65CR(C09T?R]UY!EUBKHF76+THFQ M!=EJL2L;:N_7%)$]W-*D(-.N`13K1!%E"\"&:PCXSW:IQFW:I2#;+M*WJXNZ MV65"MEKLLH;:G]BE>K*I24&F70,HQC,+WY,1N["O&@*$79.%]WB[PC.H]RYJ MR#:L?[#?HFZ&*:X1OQTE%.);(+="WF_ES:RDS8D>:%%P)V47 MO+N"9]MU!\N+]9X$<+,6)]A@!._1(UIVH713M91;^(]:!V5.H_@M!Q9]B*"DVD$ M7T9P:HS@JRA>(>YW$\/'1)V&ULK%;; MCILP$'VOU'^P_+X0"+FA)*LD:-M*K515O3P[8(*U@)'M;';_OF,#+D[2:%?: MEQ`F9PYGS@R>+.^?JQ(]42$9KU94&I0L!0RQ4NE&IBWY=I02LB/=[0&G[)N:B(@EMQ\&4C M*,E,4E7ZX6@T]2O":MPRQ.(U'#S/64H3GAXK6JN61-"2*-`O"];(GJU*7T-7 M$?%X;.Y27C5`L6UKSP%SXPK9<9@PJT[4C0?(4W09S,L;]>&G]^,WJ2@^](%OST2;#L*ZLI MF`UMT@W8<_ZHH5\R'8)D_R+[P33@NT`9S%D]D\T(^_D1EU MF7#M94^L[,L\OZW:F)@01=9+P4\(!A,*DPW18Q[$P-6[US)8/_]G)_BH23:: M985G&(%5$D;@:1V&X=)_@KZE'69[B0ET2?D@P"CD)HZ#LHU"PPCXZM8U?2ML4$T#OK_<2%["S$RAY& M'-U`\PZZ-0L,%$RPU12&D:MJVX%N";<0*WP8<83#LX;"K[_]_;AJL-'7\VZ[ MB#EJS.SMN@@T>%##F;/)5="_P7<43M^B4(-=A5UD:L=U=Q%)AA'GV?!F#MTQ M;SD<42#_C2^Z)G)U=1%X],"GJ=OKG07UAB?#B"-5K^7!@72[D1KLRFDCD7:I MI6T71WOF550G,33V"O\L!A=UG38!]EI##O0;$0=62U32'$H< M>7H)B78SMC>*-^`:K#>N8*69KP7\@:%PYH[T4.2\[5];0/3;ILPB$"G'0F:AGCO!M$&V[NMR<\?1L]R M\(YDSL]?!$N^L8I"LJ%,N@!'SA\T]#[1)G"V9]YWI@`_!$IH2DZ%^LG/7RG+ M<@757D)`.JX@>;ZE,H:$`HWE+353S`L0`+^H9+HS("'DR3S/+%%YB!_FU`;DO5D'@M"3Q;DLV%XQ6_1>L'SV[SA>7ZSDKO M/?>S&^TF%;=$D=U6\#."]@)ULB:Z6=T`N+H<-`Q]5OZ7%,B&)MEKEA"O,8)X M)13R<>>YZZW]"-F/6\QACG''B*A#Z**!O%XCY.8#-&H6K5$74HL^=(:!Z(F@ M#C$5!(GZ`$&:!7IFE+3-6,&AP;C^`+0<0Z(>,E4)3A^@4K-`PA4YG`/)3Y\NGK&DV#C9J^BJT%>N>BSW/&^J(6!/6\@`8-.NJVU7OT M:/!83VM9]7T6#2VCG>"\#",W9\_UK36H?>?YTTQC&:T%]KY$[$T/7`^:UD3? M<(.I\'I--'B\>6/Q=0J:@)L9W`R>DHJ,1K0H)(KY2<_7#4R,WMJ/_KVG_2?V M`UP)9H!.[5X0O8A?!'!`YCQ[/]B;JV7*XP>1T3VUKP*HXYSGL`XB,U+LW@&N MB)ID]#L1&:LD*F@*(3JFJJ*Y9)J%XC5D#2X*KN!R,*\Y?`M0&$V.!2V0&ULK%;);MLP%+P7Z#\(ND>;=\%V8%M( M6Z`%BJ++F98HFX@D"B0=)W_?][2PI*VD2=%+9$WF#8?#1Y'+V\>RA5$57[A.5[NWZ_;OEF8M[>:14.:!0 MR95[5*J.?5^F1UH2Z?&:5O"?G(N2*'@5!U_6@I*L*2H+/PJ"J5\25KFM0BQ> MH\'SG*4TX>FII)5J100MB`+_\LAJV:N5Z6OD2B+N3_5-RLL:)/:L8.JI$76= M,HT_'2HNR+Z`>3^&8Y+VVLW+E7S)4L$ESY4'J.H:3KI">I>/FK)86=5"L2=2+P M[$3"F1?-)^%DBBHO5(ZZ2GCVE9$7CH._U8V[.G@.V+X>T&^GW:28$$762\'/ M#K0F3$S6!!L]C$&LCZ]5T($^ER<$B2(;5%FY,]>!J"0TP<,ZG,V7_@,L7-IQ MM@,E MP_&S7=FGB$70?U:*"]O!MN6$L%0ZZHE-V6F*=FDBEDV0N;2)F^>-JX\JT#]0 MJ#V%\\!VM>U(+QG7%&W<1"SC,)9I?'BW][DBN?'7ZVX[I/FT-*VVZQ#H.&,. MH3V'9(AD]+GEZHT4AG92?\*@$ M_GJI87V.;R(4N,"W>+X/X5$,'\D'/.5?^"`^B[Y?HW````__\#`%!+`P04``8` M"````"$`28BYQO(0``#E5```&0```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`5S%\0N2%R0NF#A@LP%N0N6+BA M#N2-,>J*]=YD'VM!9H+X@@2"A()$@LP%B05)!$D%60B2"9(+LA2D$&0E2"E( MU296K%5TK%@?7NCCPJJMZY`B%#>&J,S?"K)G!WEBC%1JV1NU+\C6`:GEUA$' MI*WM`S+D:G^5F`@R%60FB"](($@H2"3(7)!8D$205)"%()D@N2!+00I!5H*4 M@E1M8H5++;*L<.D56W]TIB)^Y)I-"]F1-$0UO1\U_9Y[@=\;841.!9D)X@L2 M"!(*$@DR%R06)!$D%60A2"9(+LA2D$*0E2"E(%6;6,%5>Q`KN-W)05O;$33D M@G-1D*D@,T%\00)!0D$B0>:"Q((D@J2"+`3)!,D%60I2"+(2I!2D:A,K7&K; M=T2XM+4=+D/L"3=P:#_A!)D)X@L2"!(*$@DR%R06)!$D%60A2"9(+LA2 MD$*0E2"E(%6;6!'4198C0EB;VS$$:LTYB:82S23R)0HD"B6*))I+%$N42)1* MM)`HDRB7:"E1(=%*HE*BRD)V$/4V6%8QSG3UZWFXVZH"FC`^ETH*H5 MIH;1;*;5\AD3[<8SJ*[_UE83B:88::%TWA_8TGM$*\KY!J@0$%$CYD(YM M>6=_%M$*6G,I'TOYA(YM^0O[Z%-:07XAY3,IG].1\E[/Z9PEK2!?2/D5K:C5 M[UW:AUK2"EJ5I64/';W[;@^=`T-$E<#W8Z39K%MCI$&J>*;+7D-O-'0.:*)K ML"KQ]_O[,$^!!GLT`QKND0_$$1D`42L$HE8$1*TY$+5B(&HE0-1*@:BU`*)6 M!D2M'(A:2R!J%4#46@'1L02B8P54.]HQU?OL(V)JMN4\@AM=^M81:^=T@:;2 M:@;$DID/Q/U1`$3Y4*((B%IS(&K%0-1*)$J!J+4`HE8&1*UF)+GJYDU.@&:QX(?"!V&(` MQ$D02A0!46L.1*T8B%J)1"D0M19`U,J`J)5+M`2B5@%$K140M4H@.E9`M:,= M5UV:."*NII+!([C1]2T5L8%:N;4NMTY)=4$"&C:V`V%@)&;W6^OV3[,L*/K6,/2AT.:4]*)J; MF,6VLU5E:F,8Z<=C-H<;[Z<.0,"H#H&,*1*`*BXQR. M1#$0'1,X$J5`5W6_#]S;!0NH4#@#HDH.%35']K/JP%`QW7)YN*T"PFQK16$L MYDN@ZUJE?]ES`E)9,O9(T96<_W^DF'I0>Z0TR,XJ[BYGHG]BX&:5!@VMBYD[ MQV;&<6BR\47/7GK,J MJ2QI>VCJ$E77T"PW+[^J8;0WJ*;2Q6._T3].T:..TW4BT=2@(7=8,R!J^7#D M#`V`*!_"D5H1$+7F<*16#$2M!([42H&HM8`CM3(@:N5PI-82B%H%'*FU@A4= M2R`Z5I:C%5S](Q\KN-U5AMK<7K889&]FW/7&A%;(EE.)9D!<$/A`/)L`B),Y ME"@"HM81K@^V4_\;V:$I)ZI-$B;YC4X+*L5;RX^14\*=&"/U`;\I M44>GS:#>;'.N+H?.EMF'#(\H`&)CH401$"?;'(A:,1"U$HE2(&HM@*B5`5$K M)^KHA*6Q,ML2#F]5T*YV?E(Y0HRM;(]3,G!FK`:>T#T?.L@"(CB$UMW^0)XMQD#,+0FT.EM,8=670 MZ6QM":NFM>&PY]Y!*R#-MP'22R]U M*;1&9X-::6IBK%IH:E![`P3$?O#AR$D:`#$EA'#D?B$"HM8B5@Q$K42B%(A:"R!J94#4RB5:`E&K M`*+6"HA:)1`=*Z#:T0ZBKJP=$<2F$&<%T=3FK$5NSZE/3OI[*X1Z*M$,B.// M!^+`#8`X<$.)(B!JS8&H%0-1*Y$H!:+6`HA:&1"U0L!&:0-V78WH7GY',? M.ASM`1!'>RA1!,0),`>B5@Q$K42B%(A:"R!J94#4RHDZ>F%IK'";5?9"`1VV MM@)2%[?6`M7IX/)-Z0HZM;0U>G30C\@*M;F]YC+(WA&(VZS&2FUP]UE!HAFT MFOK#T'/7JSY\.'\"("J'$D5`G%)S(&K%0-1*)$J!J+4`HE8&1*VW?*5L6IG M&CARVLV`.%]].'(&!4!T#.%(%`'1<0Y'HAB(C@DX($/E#(@R M.97;7>5,_26LFCNDLK$"RFQL!1\V5@*9&ZWJ:7S[EY:5)6./%5V0;"\KW,W< MNWZ1J\JT8JPTR,XKXD:K<;3R2N/X1J7!..)&Z_"R[]Q<]B'-:18`<9J%T+&' MM!.G"%;JT%H#WZTT0)XMQD!L,8%69XLIK$PEY<`P;+I)[>20D3/96`Z9SL:6 ML,*=UI[;F06DV=H*3IW2):R,M"I).PO.RI*VQZ:NQ'6-S?<5&O00=`H-!K52 MU$2BJ4'M0@,0^\&'(Z=H`,0I&L*1^_((B%IS.%(K!J)6`D=JI4#46L"16AD0 MM7(X4FL)1*T"CM1:P8J.)1`=*\O1#JXNE+6#V[WN59=3$413:K,GI5-DG1A' M*\/L'3%U9K#BFL`'XMD$0)S-H401$+7F0-2*@:B52)0"46L!1*T,B%JY1$L@ M:A5`U%H!4:L$HF,%5#O:<3U4'7S7G=:!+`@:Y"PXG/W'Q%BU9O.4J)VPG;0^ M@[Q)3M>7SJ;)APS'?0#$.11*%`%Q=3,'HE8,1*U$HA2(6@L@:F5`U,J).CIA M::S4$J'^+8SHA`(R;&P%U+VQ>4NY@DRM;(\B70\\(CLTY<-VM6/0()V`]I=L M<:?5&%G)H?%3B'Y]\3LOJ)L[K:.1,[1\*'-F!4"<6:%$$1`GVQR(6C$0M1*) M4B!J+8"HE0%1*R?JZ(2EL5*Y0(\<]1XHIQ,*R+"Q%5!G]Y9O*5>0J97MD>,6 M.__:@E;60-5M47T%Z?56%FYR#AR9LZ@Q2GMPY&S+`"B8PA'H@B(6G,X M4BL&HF,"1Z(4J-E(#(:C2VM%9!F:RLX ML;42"#H75\X5HK)T[.'BEE7_VG"1U=9!@ZS\(^^T&BLK`36.;^U_C)7)VKU1 M7UR[&HO6!B&0K84&=;<6P4J-Y%8\Q?Y'M!C+%A-H=>X;4E@UYW=P)(K6,ME: M#IW.UI:P:EH;CKR>4]0H(-U.928$G=*E*ZWNB;N;\_:)V(/3K0V[@_.=&R!9 M,U8O2M3)K%Z\-TTV[SUL7CGVM'[]MIZL'Q^W)W>;'_J=ANHW_9\^[''SPL6; MX5B]/$4MH5U^,58OQ3C`+\?J?0H'^-58/;A_@%^/U>/@![C7&^MGC.4WZ@'? ML7Y\5WZCGLT=ZR=OY3?JL=JQ?FA6?J.>B!WKYUWE-^KYUK%^>E5^\]D;?ZZO MHVZ?J)=3'K*_Z8_5:Z6DSLU`OO5U;[7YC65S7]VYG?)7S8[]79)%5/U$CGU.M&U>G];3[^5Y.MF ML\-_U!&=[U]0^NE_`@```/__`P!02P,$%``&``@````A`!CS]V&ULK%;;CILP$'VOU'^P_+[< M0DB"0E9)T+8KM5)5]?+L@`G6`D:VL]G]^X[-)9"DT:ZT+P$F9X[/G#$>EOJ9",5Q%V+0$4C_$HEOE]]_K0\$TK^"?CHB0*'L7>EK6@)#5)96%[CA/8)6$5 M;AA"\18.GF4LH3%/#B6M5$,B:$$4Z)#K4=PDO:Z#8L8*I M5T.*49F$C_N*"[(KH.X7UR=)QVT>+NA+E@@N>:8LH+,;H95^YB MLK2?H7-)B]E&<*.T27 M$@\"(X70SP]0J%DB#+\#6_VQI$V#<:%W/6@ZAFQ[2"][&!GI!IH/T*U98$/! MUN\UN8LS59L6=$MX#^F%#R,CX;#64/CU][_;KAIL]'6\FS9B#ANS][9M!!H\ MJ"$8.QM?!9TV_DAA\!Z%&CQ6V$:"?KMN+R+Q,#):&][,H3OF+7>@M'>^YIIF MK*J-P,(#EV9CE[8]J+,['D9&0O58'AQ'M]NHP6,Y3<37'C6TS>!H3KR2BCW= MTJ*0*.$'/13F<%3UT7Y>K3V=?Q;?P!PSA_YYW`OA$+B"GX3QY$I\[8=K,P_/ M>?PP-KK/XT$(;;W"/PO!15UGGP!SK29[^IV(/:LD*F@&)3J6'@BBF8S-@^(U MN`;#C2L8:.8VAP\8"B>N8P$XXUQU#WJ!_I-H]0\``/__`P!02P,$%``&``@` M```A`+VEU`B#`@``6P<``!``"`%D;V-0&UL(*($`2B@``$` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````G%5-3^,P$+VOM/\ARAW2 MEFJU0FY0:8M`XJ,B@3U:7F?26CAV9#M5V5^_DX26!%PD>K,];V:>9SS/Y&); MR&`#Q@JM)N'P=!`&H+C.A%I-PJ?TZN1W&%C'5,:D5C`)7\&&%_'/'V1I=`G& M";`!AE!V$JZ=*\^CR/(U%,R>HEFA)=>F8`ZW9A7I/!<`LB1#0'C;++K:[ M%N-X-&X0N.HCZP@M$S3T.:;"2;`/^9(9YZ,\[G)N6+2,6T*[+M*IRNA".:P7 MO5%MMX7N,M_?8?9P/U_<)XLYQ57R<'LSGZ:XN9S>3N]GBR-M M-&\NQZ09'4'MS.MSR:RP5.=T:<#BV#2/V(M<@J')FAF@TT)7JO]^]EU(G.8O M]6/,Z$P7.*3V<$0$%%K1Q@6[NP'KZLGU9K\5"FJ:,P.9\$.N<#CH,Y-5`[P2 MBBDNF,3(^.XK;]1'*"O#UTBWB=WAXX7?H'850%.VA=[T[&__"%PR:P4*T>%K M?\W3_QR\;:)S<$Q(2[UD/_5K#T]1%;TN!YKWYNAU.=##KUSZK>RQJA@*YKZ: MM8"U&UL M(*($`2B@``$````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M```````````````````````````````````````````````````````````` M````````````````````````````````````````````````````G)%!3\,@ M&(;O)OZ'AGM+:8T:TK)$S4XN,7%&XPWAVTHLE`#:[M_+NJ[.Z,DC>5\>GN^C M6@RZ33[!>=69&I$L1PD8T4EEMC5Z6B_3:Y3XP(WD;6>@1COP:,'.SRIAJ>@< M/+C.@@L*?!))QE-A:]2$8"G&7C2@N<]BP\1PTSG-0SRZ+;9%,3EI:A5V-LXT MZ9ZRI3B$&PO=V]R:W-H965T&UL4$L!`BT` M%``&``@````A`'WO::+>`@``E`<``!D`````````````````MA(``'AL+W=O MUR7T#``#Q M"P``&0````````````````#+%0``>&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A``8< M2I+N`@``[@<``!D`````````````````CAX``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`/MBI6V4!@``IQL``!,` M````````````````M"L``'AL+W1H96UE+W1H96UE,2YX;6Q02P$"+0`4``8` M"````"$`0^2<3)8&``"K'@``&`````````````````!Y,@``>&PO=V]R:W-H M965T&UL4$L!`BT`%``&``@````A`+P&UL4$L!`BT`%``&``@````A M`.8I)&V)`P``%`P``!@`````````````````Y6T``'AL+W=O&UL4$L!`BT`%``& M``@````A`#36N&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`#5\ M@"/1#P``)$T``!D`````````````````+(\``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@` M```A`([9%0`U!```S0X``!D`````````````````*Z(``'AL+W=O&PO=V]R:W-H965T&UL4$L!`BT`%``&``@````A`+VEU`B#`@``6P<``!`````````` M````````7<4``&1O8U!R;W!S+V%P<"YX;6Q02P$"+0`4``8`"````"$`D2+= M!#$!``!``@``$0`````````````````6R0``9&]C4')O<',O8V]R92YX;6Q0 52P4&`````"$`(0#9"```?LL````` ` end XML 14 R4.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Medical services revenue $ 4,396,000 $ 4,236,000 $ 13,647,000 $ 12,923,000
Costs of revenue:        
Maintenance and supplies 470,000 383,000 1,317,000 1,102,000
Depreciation and amortization 1,615,000 1,532,000 4,658,000 4,481,000
Other direct operating costs 730,000 626,000 2,080,000 1,935,000
Cost of Revenue 2,815,000 2,541,000 8,055,000 7,518,000
Gross Margin 1,581,000 1,695,000 5,592,000 5,405,000
Selling and administrative expense 887,000 960,000 3,275,000 3,093,000
Interest expense 532,000 525,000 1,459,000 1,638,000
Operating income 162,000 210,000 858,000 674,000
Loss on foreign currency transactions (306,000) 0 (840,000) 0
Interest and other income 11,000 10,000 19,000 25,000
Income (loss) before income taxes (133,000) 220,000 37,000 699,000
Income tax expense (benefit) 0 28,000 40,000 52,000
Net income (loss) (133,000) 192,000 (3,000) 647,000
Less: Net income attributable to non-controlling interests (1,000) (183,000) (227,000) (614,000)
Net income (loss) attributable to American Shared Hospital Services $ (134,000) $ 9,000 $ (230,000) $ 33,000
Net income (loss) per share:        
Earnings (loss) per common share - basic (in dollars per share) $ (0.03) $ 0 $ (0.05) $ 0.01
Earnings (loss) per common share - assuming dilution (in dollars per share) $ (0.03) $ 0 $ (0.05) $ 0.01

XML 15 R10.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-based Compensation
9 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
Note 3.
Stock-based Compensation
 
On June 2, 2010, the Company’s shareholders approved an amendment and restatement of the 2006 Stock Incentive Plan (the “2006 Plan”). Among other things, the amendment and restatement renamed the 2006 Plan to the Incentive Compensation Plan (the “Plan”) and increased the number of shares of the Company’s common stock reserved for issuance under the Plan by an additional 880,000 shares from 750,000 shares to 1,630,000 shares.  The shares are reserved for issuance to officers of the Company, other key employees, non-employee directors, and advisors.  The Plan serves as successor to the Company’s previous two stock-based employee compensation plans, the 1995 and 2001 Stock Option Plans.  The shares reserved under those two plans, including the shares of common stock subject to currently outstanding options under the plans, were transferred to the Plan, and no further grants or share issuances will be made under the 1995 and 2001 Plans.  Under the Plan, there have been 115,000 restricted stock units granted, consisting primarily of annual automatic grants and deferred compensation to non-employee directors, and there are 609,000 options granted, of which 576,000 options are vested as of September 30, 2013.
 
Compensation expense associated with the Company’s stock-based awards to employees is calculated using the Black-Scholes valuation model.  The Company’s stock-based awards have characteristics significantly different from those of traded options, and changes in the subjective input assumptions can materially affect the fair value estimates.  The estimated fair value of the Company’s option grants is estimated using assumptions for expected life, volatility, dividend yield, and risk-free interest rate which are specific to each award.  The estimated fair value of the Company’s options is amortized over the period during which an employee is required to provide service in exchange for the award, usually the vesting period.  Accordingly, stock-based compensation cost before income tax effect in the amount of $11,000 and $69,000 is reflected in net income for the three and nine month periods ended September 30, 2013, compared to $3,000 and $62,000 in the same periods in the prior year, respectively.  There were 3,500 options issued and no options exercised during the three month period ended September 30, 2013. There were 21,500 options issued and no options exercised during the nine month period ended September 30, 2013. There were no excess income tax benefits to report.
XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 17 R24.htm IDEA: XBRL DOCUMENT v2.4.0.8
Repurchase of Common Stock (Details Textual) (USD $)
12 Months Ended
Sep. 30, 2013
Dec. 31, 2008
Dec. 31, 2012
Share Repurchase Program [Member]
Stock Repurchase Program, Number of Shares Authorized to be Repurchased   1,000,000  
Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 72,000    
Repurchase of common stock (in shares)     9,000
Stock Repurchased During Period Shares Par Value     $ 3.26
XML 18 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Basis of Presentation (Details Textual) (USD $)
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Dec. 31, 2012
Foreign Currency Transaction Gain, before Tax         $ 133,000
Foreign Currency Transaction Loss, before Tax $ 306,000 $ 0 $ 840,000 $ 0  
XML 19 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (USD $)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Retained Earnings [Member]
Parent [Member]
Noncontrolling Interest [Member]
Balances at Dec. 31, 2010 $ 23,044,000 $ 8,606,000 $ 4,703,000 $ 0 $ 6,262,000 $ 19,571,000 $ 3,473,000
Balances (in shares) at Dec. 31, 2010   4,597,000          
Stock based compensation expense 125,000 0 125,000 0 0 125,000 0
Stock based compensation expense (in shares)   14,000          
Investment in subsidiaries by non-controlling interests 1,509,000 0 0 0 0 0 1,509,000
Cash distributions to non-controlling interests (996,000) 0 0 0 0 0 (996,000)
Net income (loss) 1,489,000 0 0 0 506,000 506,000 983,000
Balances at Dec. 31, 2011 25,171,000 8,606,000 4,828,000 0 6,768,000 20,202,000 4,969,000
Balances (in shares) at Dec. 31, 2011   4,611,000          
Repurchase of common stock (28,000) (28,000) 0 0 0 (28,000) 0
Repurchase of common stock (in shares)   (9,000)          
Stock based compensation expense 74,000 0 74,000 0 0 74,000 0
Stock based compensation expense (in shares)   4,000          
Investment in subsidiaries by non-controlling interests 217,000 0 0 0 0 0 217,000
Cumulative translation adjustment (637,000) 0 0 (357,000) 0 (357,000) (280,000)
Cash distributions to non-controlling interests (780,000) 0 0 0 0 0 (780,000)
Net income (loss) 813,000 0 0 0 38,000 38,000 775,000
Balances at Dec. 31, 2012 24,830,000 8,578,000 4,902,000 (357,000) 6,806,000 19,929,000 4,901,000
Balances (in shares) at Dec. 31, 2012   4,606,000          
Stock based compensation expense 69,000 0 69,000   0 69,000 0
Stock based compensation expense (in shares)   3,000          
Investment in subsidiaries by non-controlling interests 139,000 0 0 0 (68,000) (68,000) 207,000
Cumulative translation adjustment (111,000) 0 0 (67,000) 0 (67,000) (44,000)
Cash distributions to non-controlling interests (480,000) 0 0 0 0 0 (480,000)
Net income (loss) (3,000) 0 0 0 (230,000) (230,000) 227,000
Balances at Sep. 30, 2013 $ 24,444,000 $ 8,578,000 $ 4,971,000 $ (424,000) $ 6,508,000 $ 19,633,000 $ 4,811,000
Balances (in shares) at Sep. 30, 2013   4,609,000          
XML 20 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Basis of Presentation
9 Months Ended
Sep. 30, 2013
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]
 
Note 1. Basis of Presentation
 
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments (consisting of only normal recurring accruals) necessary to present fairly American Shared Hospital Services’ consolidated financial position as of September 30, 2013 and the results of its operations for the three and nine month periods ended September 30, 2013 and 2012, which results are not necessarily indicative of results on an annualized basis.  Consolidated balance sheet amounts as of December 31, 2012 have been derived from audited financial statements.
 
These unaudited consolidated financial statements should be read in conjunction with the audited financial statements for the year ended December 31, 2012 included in the Company’s 10-K filed with the Securities and Exchange Commission.
 
These financial statements include the accounts of American Shared Hospital Services (the “Company”) and its wholly-owned subsidiaries:  OR21, Inc. (“OR21”); MedLeader.com, Inc. (“MedLeader”); and American Shared Radiosurgery Services (“ASRS”); ASRS’ majority-owned subsidiary, GK Financing, LLC (“GKF”); GKF’s wholly-owned subsidiaries, GK Financing U.K., Limited (“GKUK”) and Instituto de Gamma Knife del Pacifico S.A.C. (“GKPeru”); ASHS’ majority owned subsidiary, Long Beach Equipment, LLC (“LBE”), GKF’s majority owned subsidiaries, Albuquerque GK Equipment, LLC (“AGKE”), Jacksonville GK Equipment, LLC (“JGKE”) and EWRS, LLC (“EWRS”), and EWRS’ wholly owned subsidiary, EWRS Tibbi Cihazlar Ticaret Ltd Sti (“EWRS Turkey”).
 
The Company through its majority-owned subsidiary, GKF, provided Gamma Knife units to nineteen medical centers as of September 30, 2013 in the states of Arkansas, California, Connecticut, Florida, Illinois, Massachusetts, Mississippi, Nevada, New Jersey, New Mexico, New York, Tennessee, Oklahoma, Ohio, Texas and Wisconsin, and in Turkey.
 
GKF also provides radiation therapy equipment to the radiation therapy department at the Gamma Knife site in Turkey.  The Company also directly provides radiation therapy and related equipment, including Intensity Modulated Radiation Therapy (“IMRT”), Image Guided Radiation Therapy (“IGRT”) and a CT Simulator to the radiation therapy department at an existing Gamma Knife site in the United States.
 
The Company formed the subsidiaries GKUK, GKPeru, EWRS and EWRS Turkey for the purposes of expanding its business internationally into the United Kingdom, Peru and Turkey; LBE to provide proton beam therapy services in Long Beach, California; and AGKE and JGKE to provide Gamma Knife services in Albuquerque, New Mexico and Jacksonville, Florida.  AGKE and EWRS Turkey began operation in the second quarter 2011 and JGKE began operation in the fourth quarter 2011.  GKPeru is expected to begin operation in the latter part of 2014.  GKUK is inactive and LBE is not expected to begin operations in 2013.
 
During 2012 and 2013, the Company’s partner in its Turkey operation, its partners in the Jacksonville Gamma Knife operation and the Albuquerque Gamma Knife operation have made investments in EWRS, JGKE, and AGKE respectively. These investments are included in the line item “Non-controlling interests in subsidiaries” in the Company’s financial statements.
 
Based on guidance provided in accordance with ASC 830, Foreign Currency Matters (“ASC 830”), the Company analyzes its operations outside the United States to determine the functional currency of each operation.  Management has determined that these operations are initially accounted for in U.S. Dollars since the primary transactions incurred are in U.S. Dollars and the Company provides significant funding towards the startup of the operation.  When Management determines that an operation has become self-sufficient, the Company may change its accounting for the operation to the local currency from the U.S. Dollar, depending on the facts and circumstances. The Company determined that effective in the third quarter 2012, the functional currency for its Turkish operation, EWRS Turkey, was the Turkish Lira.  Therefore, in accordance with ASC 830, EWRS Turkey’s balance sheet accounts were translated at rates in accordance with guidance provided under ASC 830, and accumulated gains and losses and translation differences were recorded in accumulated other comprehensive income (loss), which is a separate component of equity.
 
As of September 30, 2013 and December 31, 2012, EWRS Turkey’s balance sheet accounts were translated at rates in effect as of those dates, respectively, and income and expense accounts were translated at the weighted average rates of exchange during those respective periods. Translation adjustments resulting from this process were also recognized under accumulated other comprehensive income (loss).  Gains and losses from foreign currency transactions are listed in the Company’s Consolidated Statements of Operations.  The Company recorded a net foreign currency loss of $306,000 and $840,000 for the three and nine month periods ended September 30, 2013, respectively, and a net foreign currency gain of approximately $133,000 for the year ended December 31, 2012.
 
Based on guidance provided in accordance with 280 Segment Reporting (“ASC 280”), the Company has analyzed the factors that define an operating segment and determined that there is only one operating segment.  The nineteen locations are aggregated into one reportable segment because, in the Company’s judgment, these operating segments have similar historical economic characteristics and are expected to have similar economic characteristics in the future. Furthermore, each operating segment utilizes the same business model and technologies, servicing the same end users (radiation therapy patients).  All significant intercompany accounts and transactions have been eliminated in consolidation.
XML 21 R11.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock Investment
9 Months Ended
Sep. 30, 2013
Investments, All Other Investments [Abstract]  
Cost-method Investments, Description [Text Block]
Note 4.
Common Stock Investment
 
                As of September 30, 2013 the Company has a $2,701,000 investment in the common stock of Mevion Medical Systems, Inc. (“Mevion”), formerly Still River Systems, Inc., representing an approximate 0.77% interest in Mevion. At December 31, 2012 the investment was $2,687,000 which represented a 1.0% interest in the convertible preferred stock of Mevion. The Company’s investment was converted to common stock in April 2013 when it declined to participate in a new financing round. Therefore the Company’s investment was converted from preferred stock to common stock in April 2013.  The Company accounts for this investment under the cost method.
 
In June 2013 Mevion announced that it had secured a $55 million round of financing which will be used to accelerate the manufacturing and deployment of the Mevion S250.  The funds were raised from existing equity investors, as well as from debt financing. The Company invested an additional $14,000 in this round.
 
The Company reviews its investment for impairment on a quarterly basis, or as events or circumstances might indicate that the carrying value of the investment may not be recoverable.  The Company evaluated this investment for impairment at December 31, 2012 and reviewed it at September 30, 2013 in light of both current market conditions and the ongoing needs of Mevion to raise cash to continue its development of the first compact, single room PBRT system.  Based on its analysis, the Company estimates that there is currently an unrealized loss (impairment) of approximately $2.4 million.
 
In assessing whether the impairment is other than temporary, we evaluated the length of time and extent to which market value has been below cost, the financial condition and near term prospects of Mevion and our ability and intent to retain our investment for a period sufficient to allow for an anticipated recovery in the market value.  Although the investment is not without risk, and the manufacture of the first unit has taken longer than originally anticipated, the Company believes that the current market value is a temporary situation brought on solely due to the delays in treating the first clinical patient.
 
During the second quarter of 2012, Mevion announced that it had received FDA 510(k) clearance for its MEVION S250 system, which enables users of the system to treat patients immediately upon completion of system installation.  Mevion had previously announced that it had received the CE Mark certification which enables Mevion to market, sell and install these systems through the European Union and any country that recognizes the CE Mark.  Based on the continuing progress being made by Mevion toward the manufacture and installation of the first single room PBRT system, the Company believes that our investment in Mevion is not other than temporarily impaired, and the fair value will increase so that the carrying value will be recovered.
XML 22 R9.htm IDEA: XBRL DOCUMENT v2.4.0.8
Per Share Amounts
9 Months Ended
Sep. 30, 2013
Earnings Per Share [Abstract]  
Earnings Per Share [Text Block]
Note 2.                   Per Share Amounts
 
Per share information has been computed based on the weighted average number of common shares and dilutive common share equivalents outstanding.  For the three and nine months ended September 30, 2013 basic earnings per share was computed using 4,609,000 common shares, and diluted earnings per share was computed using 4,612,000 and 4,613,000 common shares and equivalents, respectively.  For the three and nine months ended September 30, 2012 basic earnings per share was computed using 4,606,000 and 4,610,000 common shares respectively and diluted earnings per share was computed using 4,630,000 and 4,635,000 common shares and equivalents, respectively.
 
The computation for the three and nine month periods ended September 30, 2013 excluded approximately 580,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during those periods.  The computation for the three and nine month periods ended September 30, 2012 excluded approximately 310,000 of the Company’s stock options because the exercise price of the options was higher than the average market price during the periods.
EXCEL 23 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%]E,C0R-#'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-/3D1%3E-%1%]#3TY33TQ)1$%4141?4U1!5$5- M13$\+W@Z3F%M93X-"B`@("`\>#I7;W)K#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!E#I%>&-E;%=O#I7;W)K#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DQI;F5?;V9?0W)E9&ET/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E M;%=O#I7;W)K#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I.86UE/D)A#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E!E M#I.86UE/@T*("`@(#QX M.E=O#I%>&-E;%=O M#I.86UE/E-T;V-K8F%S961?0V]M<&5N#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/D-O;6UO;E]3=&]C:U]);G9E#I.86UE/@T*("`@ M(#QX.E=O#I%>&-E M;%=O#I.86UE/DQI;F5?;V9?0W)E9&ET7T1E=&%I M;'-?5&5X='5A;#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D9A:7)?5F%L=65?;V9?1FEN86YC:6%L7TEN#I7;W)K#I7;W)K#I3='EL97-H965T($A2968],T0B5V]R:W-H965T3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,C0R-#'0O:'1M;#L@8VAA2!);F9O M'0^)SQS<&%N M/CPO'0^)T%-15))0T%.(%-(05)%1"!(3U-0251!3"!315)624-%4SQS<&%N M/CPO2!#96YT3PO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^)S`P,#`W-#0X,C4\2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)U-M86QL97(@4F5P;W)T:6YG($-O;7!A;GD\'0^)T%- M4SQS<&%N/CPO2!#;VUM;VX@4W1O8VLL(%-H87)E'0^)SQS<&%N/CPO'0^)S$P M+5$\'0^)V9A;'-E/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS<&%N/CPO'0^)S(P,3,\3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,C0R-#'0O:'1M;#L@8VAA'!E;G-E"!A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO65E(&-O;7!E;G-A=&EO;B!A;F0@8F5N969I=',\+W1D/@T* M("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO2U!;65R:6-A;B!3:&%R960@2&]S<&ET M86P@4V5R=FEC97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT M;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@ M("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$ M)W1E>'0O:'1M;#L@8VAA'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO2!T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E("AI;B!S M:&%R97,I/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XV.2PP M,#`\'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO6%B;&4@86YD(&%C M8W)U960@;&EA8FEL:71I97,\+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M)SQS<&%N/CPO6UE;G0@9F]R('!U2!N M;VXM8V]N=')O;&QI;F<@:6YT97)E6UE M;G1S(&]N(&QI;F4@;V8@8W)E9&ET/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@W.2PP,#`I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%]E,C0R-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG M(#QD:78@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U=)1%1(.B`P:6X[(%=/ M4D0M5U)!4#H@8G)E86LM=V]R9"<^(#QD:78^/'-T6QE/3-$)U1%6%0M04Q)1TXZ(&IU M6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)T9/ M3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@ M/&1I=B!S='EL93TS1"=C;&5A6EN9R!U;F%U9&ET960@8V]N9&5N2!T;R!P2!! M;65R:6-A;B!3:&%R960@2&]S<&ET86P@4V5R=FEC97,F(S@R,3<[(&-O;G-O M;&ED871E9"!F:6YA;F-I86P@<&]S:71I;VX@87,@;V8@4V5P=&5M8F5R(#,P M+"`R,#$S(&%N9"!T:&4@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G M/E1H97-E('5N875D:71E9"!C;VYS;VQI9&%T960@9FEN86YC:6%L('-T871E M;65N=',@6QE/3-$ M)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4 M+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T M:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F M;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%- M24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1% M3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1&IU28C.#(R,3LI(&%N9"!I=',@=VAO;&QY+6]W;F5D('-U8G-I9&EA2UO=VYE9"!S=6)S:61I87)I97,L($=+($9I;F%N8VEN M9R!5+DLN+"!,:6UI=&5D("@F(S@R,C`[1TM52R8C.#(R,3LI(&%N9"!);G-T M:71U=&\@9&4@1V%M;6$@2VYI9F4@9&5L(%!A8VEF:6-O(%,N02Y#+B`H)B,X M,C(P.T=+4&5R=28C.#(R,3LI.R!!4TA3)B,X,C$W.R!M86IO2!O=VYE M9"!S=6)S:61I87)Y+"!,;VYG($)E86-H($5Q=6EP;65N="P@3$Q#("@F(S@R M,C`[3$)%)B,X,C(Q.RDL($=+1B8C.#(Q-SMS(&UA:F]R:71Y(&]W;F5D('-U M8G-I9&EA3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0G/E1H92!#;VUP86YY('1H6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)' M24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1&IU2!E<75I<&UE;G0@=&\@=&AE(')A9&EA=&EO;B!T:&5R87!Y M(&1E<&%R=&UE;G0@870@=&AE($=A;6UA($MN:69E('-I=&4@:6X@5'5R:V5Y M+CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG2!P2!A;F0@2!D97!A6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P M="<@86QI9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T M)R!A;&EG;CTS1&IU2!F;W)M960@=&AE('-U8G-I9&EA3L@3$)% M('1O('!R;W9I9&4@<')O=&]N(&)E86T@=&AE2!S97)V:6-E2!B96=A;B!O<&5R871I;VX@:6X@=&AE('-E8V]N9"!Q=6%R=&5R M(#(P,3$@86YD($I'2T4@8F5G86X@;W!E6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O M;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM97,L M(%-E6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1&IU6QE/3-$)TQ)3D4M2$5)1TA4.B`Q,34E.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N+'-E3X\9F]N="!S='EL93TS M1"=&3TY4+5-)6D4Z(#$P<'0G/D)AF5S(&ET6QE/3-$)T9/3E0M1D%-24Q9.B`G M5&EM97,@3F5W(%)O;6%N)RPG2!A8V-O=6YT960@9F]R(&EN M(%4N4RX@1&]L;&%R2!T6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2 M;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI M9VX],T1J=7-T:69Y/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^ M)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG M;CTS1&IU28C.#(Q-SMS(&)A;&%N8V4@'!E;G-E M(&%C8V]U;G1S('=E&-H86YG92!D=7)I;F<@=&AO6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!L;W-S(&]F("0\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2P@86YD(&$@;F5T(&9O6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT M/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9 M.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z M(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A;&EG;CTS1&IU2!H87,@86YA;'EZ960@=&AE(&9A8W1O'!E8W1E9"!T;R!H M879E('-I;6EL87(@96-O;F]M:6,@8VAAF5S('1H92!S86UE(&)U3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%]E,C0R-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R#L@1D].5#H@,3!P="!4:6UE6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQS=')O;F<^ M/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G M/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!A;F0@9&EL=71E9"!E87)N:6YG6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/B8C M,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A&-L=61E9"!A M<'!R;WAI;6%T96QY(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG&-L=61E9"!A M<'!R;WAI;6%T96QY(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM M97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%]E,C0R-#'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@5&EM M97,L(%-E&5D.R!&3TY4+5-)6D4Z M(#$P<'0[(&1T=&@Z('1A8FQE2&%N9VEN9R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,"!W:61T:#TS1#$P,"4^(#QT6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3F]T92`S+CPO9F]N M=#X\+W-T6QE/3-$)U=)1%1(.B!A M=71O.R!73U)$+5=205`Z(&)R96%K+7=O6QE/3-$)T9/3E0M4TE:13H@,3!P="<^4W1O M8VLM8F%S960@0V]M<&5N28C M.#(Q-SMS('-H87)E:&]L9&5R2!A;B!A9&1I=&EO;F%L(#QF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG65E(&1I3X\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/D-O;7!E;G-A=&EO;B!E>'!E;G-E M(&%S28C.#(Q-SMS('-T;V-K+6)A M65E(&ES(')E<75I&-H86YG92!F;W(@=&AE(&%W87)D M+"!U6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)TQ)3D4M2$5)1TA4.B`Q,34E.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N+'-E&5R8VES960\+V9O;G0^(&1U3X-"CPO M:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,C0R-#'0O:'1M;#L@ M8VAA'0@0FQO8VM=/"]T9#X- M"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#XG(#QD:78@6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U!!1$1)3D6QE/3-$)U=)1%1(.B`P:6X[(%=/4D0M M5U)!4#H@8G)E86LM=V]R9"<^/"]T9#X@/'1D('-T>6QE/3-$)U=)1%1(.B`P M+C6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3F]T92`T M+CPO9F]N=#X\+V(^/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=724142#H@ M875T;SL@5T]21"U74D%0.B!B6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<@86QI9VX],T1J=7-T:69Y/CQB M/CQF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^("8C,38P.R8C,38P M.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C M,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.R8C,38P.SPO9F]N=#X\+V(^ M(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P="<^07,@;V8@4V5P=&5M M8F5R(#,P+"`R,#$S('1H92!#;VUP86YY(&AA7-T96US+"!) M;F,N("@F(S@R,C`[365V:6]N)B,X,C(Q.RDL(&9O6QE/3-$)TQ)3D4M2$5)1TA4.B`Q,34E.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N+'-E6QE M/3-$)TQ)3D4M2$5)1TA4.B`Q,34E.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N+'-E28C.#(Q-SMS M(&EN=F5S=&UE;G0@=V%S(&-O;G9E6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[34%21TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/ M3E0M4TE:13H@,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE M/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM& M3TY4+5-)6D4Z(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I M;B`P:6X@,'!T)R!A;&EG;CTS1&IU6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG2!I;G9E M2!B87-I2!E6QE/3-$)V-L96%R.F)O=&@[($9/ M3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%2 M1TE..B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@ M,3!P="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R M.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z M(#$P<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T M)R!A;&EG;CTS1&IU2P@=V4@979A;'5A=&5D('1H92!L96YG=&@@ M;V8@=&EM92!A;F0@97AT96YT('1O('=H:6-H(&UA2!I;B!T:&4@;6%R:V5T('9A;'5E+B8C,38P.R!!;'1H;W5G:"!T M:&4@:6YV97-T;65N="!I2!B96QI M979E2!S:71U871I;VX@8G)O=6=H="!O;B!S;VQE;'D@9'5E('1O('1H92!D M96QA>7,@:6X@=')E871I;F<@=&AE(&9I6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[34%21TE. M.B`P:6X@,&EN(#!P="<^(#QF;VYT('-T>6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1&IU7-T96TL('=H:6-H(&5N86)L M97,@=7-E2!U<&]N(&-O;7!L971I;VX@;V8@7-T96US('1H2!T:&%T(')E8V]G;FEZ97,@=&AE($-%($UA7-T96TL M('1H92!#;VUP86YY(&)E;&EE=F5S('1H870@;W5R(&EN=F5S=&UE;G0@:6X@ M365V:6]N(&ES(&YO="!O=&AE6EN9R!V86QU92!W:6QL(&)E(')E8V]V97)E9"X\+V9O;G0^/"]D M:78^(#QT86)L92!B;W)D97(],T0P("!S='EL93TS1"=W:61T:#HQ,#`E.R!T M86)L92UL87EO=70Z9FEX960[)R!C96QL3X- M"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E,C0R-#'0O:'1M M;#L@8VAA#L@1D].5#H@,3!P="!4:6UE&5D.R!D='1H.B!T86)L94AA;F=I;F6QE/3-$)T9/3E0M1D%- M24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE M/3-$)U=/4D0M5U)!4#H@8G)E86LM=V]R9#L@5$585"U!3$E'3CH@:G5S=&EF M>3L@5TE$5$@Z(&%U=&\G('9A;&EG;CTS1'1O<#X@/&1I=CX\8CX\9F]N="!S M='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/DQI;F4@;V8@0W)E9&ET/"]F;VYT M/CPO8CX\+V1I=CX@/"]T9#X@/"]T3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H M92!#;VUP86YY(&AA2P@870@=&AE($-O;7!A;GDF(S@R,3<[6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W M(%)O;6%N)RPG&5D.R<@8V5L;'-P86-I M;F<],T0P(&-E;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO#L@1D].5#H@,3!P="!4:6UE M6QE/3-$)T9/3E0M4TE:13H@,3!P="<^/&9O;G0@3L@5TE$ M5$@Z(&%U=&\[(%=/4D0M5U)!4#H@8G)E86LM=V]R9"<@=F%L:6=N/3-$=&]P M/B`\9&EV/CQS=')O;F<^/&9O;G0@3X\6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^("8C,38P.SPO9F]N=#X\+W-T2!W:&EC:"!P2!T M;R!A8V-E2X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@)U1I;65S($YE=R!2;VUA;B3X\ M9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/CQF;VYT('-T>6QE/3-$ M)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@ M3F5W(%)O;6%N)RPG"!S;VQI9#L@34%21TE..B`P:6X[(%=)1%1( M.B`Q,#`E.R!"3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E.R!/5D521DQ/5SH@ M=FES:6)L93L@0D]21$52+51/4#H@(SEE8C9C92`P<'@@6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT M97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`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`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`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`P M,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,S`P/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4 M.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5)) M1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#,V)3X@/&1I=CY4;W1A;#PO9&EV/B`\+W1D/B`\=&0@ M"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`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`C,#`P,#`P(#-P>"!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,38L M,S$X/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z M(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E M/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,3@L-S$Y/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$ M,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4 M+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4 M+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU4 M3U`Z(",P,#`P,#`@,W!X(&1O=6)L93L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@"!D;W5B M;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#,V)3X@/&1I=CY!8V-O=6YT6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@ M(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`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`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,RPS.3<\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^."PW-#`\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%# M2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U! M3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#,V)3X@ M/&1I=CY$96)T(&]B;&EG871I;VYS/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV M/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E, M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+ M1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\ M9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X M('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@0T],3U(Z(",P,#`P,#`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`C M,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ M(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U3 M25I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0 M.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,"4^(#QD:78^+3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E, M13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+ M1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%, M24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T M9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O M=6)L93L@5$585"U!3$E'3CH@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^,S$L.#

6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!D;W5B;&4[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO"!D;W5B M;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!D;W5B;&4[($9/ M3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4 M+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F M.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/ M4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L93L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`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`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#$P)3X@/&1I=CXT+#$P-SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(')I M9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXT+#$P-SPO M9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU" M3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R M:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U M<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P M,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E, M13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/3E0M1D%-24Q9.B!4 M:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXR+#8X-SPO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$58 M5"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4 M+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU4 M3U`Z(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T M:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@ M/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q) M1TXZ(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^ M,3"!D;W5B;&4[($9/3E0M5T5) M1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T M,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L93L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!D;W5B;&4[($9/3E0M5T5)1TA4 M.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ M(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#,V)3X@/&1I=CY!8V-O=6YT6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P M)3X@/&1I=CXQ+#DW.3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#DW.3PO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXX+#4U,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#4U,#PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$P)3X@/&1I=CXS-"PU-S<\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-"PU-S<\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS M-"PV.#0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#,V)3X@/&1I=CY4;W1A;#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,3`L-3(Y M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,"4^(#QD:78^,S0L-36QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^-#4L,C$S/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)W=I9'1H.C$P M,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL M<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA2!.;W1E(%M!8G-T#L@1D].5#H@,3!P="!4:6UE&5D.R!D='1H.B!T86)L94AA;F=I;F6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3F]T92`W+CPO9F]N=#X\+W-T6QE/3-$)U=/4D0M5U)!4#H@8G)E86LM M=V]R9#L@5$585"U!3$E'3CH@:G5S=&EF>3L@5TE$5$@Z(&%U=&\G('9A;&EG M;CTS1'1O<#X@/&1I=CX\8CX\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P M<'0G/E)E<'5R8VAA6QE/3-$)T9/3E0M4TE:13H@,3!P M="<^)B,Q-C`[/"]F;VYT/CPO9&EV/B`\9&EV('-T>6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[34%21TE..B`P:6X@,&EN(#!P=#L@5$585"U)3D1%3E0Z(#`N-6EN)R!A M;&EG;CTS1&IU6QE/3-$)T9/3E0M1D%-24Q9 M.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N M)RPG6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG6QE/3-$)W=I9'1H.C$P,"4[ M('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D M9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@ M("`\=&%B;&4@8VQA"!$:7-C M;&]S=7)E(%M!8G-T#L@1D].5#H@,3!P M="!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&IU6QE/3-$)T9/3E0M4TE:13H@,3!P="<^3F]T92`X+CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG M3L@5TE$5$@Z(&%U=&\[(%=/4D0M5U)!4#H@8G)E86LM=V]R M9"<@=F%L:6=N/3-$=&]P/B`\9&EV/CQS=')O;F<^/&9O;G0@3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z M(#$P<'0G/B8C,38P.SPO9F]N=#X\+V1I=CX@/&1I=B!S='EL93TS1"=C;&5A M2!C86QC=6QA=&4@;W5R(&5F9F5C=&EV92!I;F-O;64@=&%X(')A=&4@ M870@=&AE(&5N9"!O9B!A;B!I;G1E"!R871E(&-A;FYO="!B92!M861E M+"!W92!C;VUP=71E(&]U6QE/3-$)T9/3E0M M1D%-24Q9.B`G5&EM97,@3F5W(%)O;6%N)RPG"!I;F-O M;64@*&QO"!R871E(&=I=F5N M('1H92!E>'!E8W1E9"!A;6]U;G0@;V8@=&AE"!R871E(&9O"!R871E M('1O(&EN8V]M92`H;&]S&5D.R<@8V5L;'-P86-I;F<],T0P(&-E M;&QP861D:6YG/3-$,#X\='(^/'1D/CPO=&0^/"]T7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA#L@1D].5#H@,3!P="!4:6UE3L@5TE$5$@Z(#`N-S5I;CL@5T]21"U74D%0.B!B6QE/3-$)U1% M6%0M04Q)1TXZ(&IU6QE/3-$)V-L M96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-) M6D4Z(#$P<'0[5$585"U*55-42499.B!I;G1E3X\8CX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N+'-E6QE/3-$)V-L96%R.F)O=&@[($9/3E0M M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U* M55-42499.B!I;G1E6QE/3-$)W=I9'1H.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG M(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D M/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)R`\9&EV('-T>6QE/3-$)V-L96%R.F)O=&@[ M($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[ M34%21TE..B`P<'0@,'!X.R!&3TY4.B`Q,'!T(%1I;65S($YE=R!2;VUA;BP@ M5&EM97,L(%-E3X\9F]N="!S='EL93TS1"=&3TY4+5-)6D4Z(#$P<'0G/E1H92!E M28C.#(Q-SMS(&%S M6QE/3-$)V-L96%R.F)O M=&@[($9/3E0M1D%-24Q9.E1I;65S($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P M<'0[5$585"U)3D1%3E0Z(#`N-6EN.R!-05)'24XZ(#!I;B`P:6X@,'!T)R!A M;&EG;CTS1&IU6QE/3-$)V-L96%R.F)O=&@[($9/3E0M1D%-24Q9.E1I;65S M($YE=R!2;VUA;CM&3TY4+5-)6D4Z(#$P<'0[5$585"U!3$E'3CI,969T.R!4 M15A4+4E.1$5.5#H@,&EN.R!724142#H@,3`P)2<^(#QT86)L92!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C.65B-F-E(#!P>"!S;VQI9#L@0D]21$52+4Q% M1E0Z(",Y96(V8V4@,'!X('-O;&ED.R!-05)'24XZ(#!I;CL@5TE$5$@Z(#$P M,"4[($)/4D1%4BU#3TQ,05!313H@8V]L;&%P"!S;VQI9#L@0D]21$52+5)) M1TA4.B`C.65B-F-E(#!P>"!S;VQI9"<@8V5L;'-P86-I;F<],T0P(&-E;&QP M861D:6YG/3-$,"!A;&EG;CTS1&QE9G0^(#QT6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@8V5N=&5R.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,7!X('-O;&ED.R!415A4+4%,24=..B!C96YT97([($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`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`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E# M04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M,"4^(#QD:78^,3$L,#`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`Q,'!T M.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W M:61T:#TS1#$P)3X@/&1I=CXU+#`Q,SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@ M5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED M=&@],T0Q,"4^(#QD:78^-2PP,3,\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#,V)3X@/&1I=CY#;VUM;VX@"!S M;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,S`P/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=. M.B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U M<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L M969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE M/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4 M.B`U<'@[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#,V)3X@/&1I=CY4;W1A;#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`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`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T], M3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ M(&)O='1O;3L@0D]21$52+51/4#H@(S`P,#`P,"`Q<'@@6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9 M.B!4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%, M24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-) M6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z M(",P,#`P,#`@,W!X(&1O=6)L93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,"4^(#QD:78^)B,Q-C`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`P,#`[($9/3E0M4TE:13H@,3!P M=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,"4^(#QD:78^,RPS.3<\+V1I=CX@/"]T9#X@/'1D('-T>6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C M9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#,V)3X@/&1I=CY!9'9A;F-E M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C M8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F M9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D M:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P M(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R M;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$ M.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B M;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q M-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C M,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO"!S M;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F M9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\ M+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@0T],3U(Z(",P,#`P,#`[($9/ M3E0M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,S$L.#

6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!L969T.R!&3TY4 M+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED.R!415A4+4%,24=..B!R:6=H M=#L@1D].5"U35%E,13H@;F]R;6%L.R!0041$24Y'+5))1TA4.B`U<'@[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@ M/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X M(&1O=6)L93L@5$585"U!3$E'3CH@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,"4^(#QD:78^,3(L,3,W/"]D:78^(#PO=&0^(#QT9"!S='EL M93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/ M3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!S;VQI9#L@1D]. M5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B M;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!! M1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@0T],3U(Z(",P,#`P,#`[($9/3E0M M4TE:13H@,3!P=#L@5D525$E#04PM04Q)1TXZ(&)O='1O;3L@0D]21$52+51/ M4#H@(S`P,#`P,"`Q<'@@6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I M=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@ M,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q,"4^(#QD:78^-#0L,#`W/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED.R!&3TY4 M+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\9&EV/B0\+V1I=CX@/"]T9#X@ M/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L M93L@5$585"U!3$E'3CH@"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@] M,T0Q,"4^(#QD:78^-#0L-#,P/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=4 M15A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%- M24Q9.B!4:6UE"!D;W5B M;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P M.SPO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO"!D;W5B;&4[($9/ M3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L M93L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[ M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO"!D;W5B;&4[ M($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO M9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G M('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,"PV,30\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ,"PV,30\+V1I=CX@/"]T9#X@/'1D M('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA M;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)4 M24-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS M1#,V)3X@/&1I=CY0"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D]. M5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1) M0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$ M,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$ M15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@ M1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O M;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9% M4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H M/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=" M3U)$15(M0D]45$]-.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@ M6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U3 M5%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!" M04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%, M+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^ M(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT M.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D]. M5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F M9CL@0T],3U(Z(",P,#`P,#`[($9/3E0M4TE:13H@,3!P=#L@5D525$E#04PM M04Q)1TXZ(&)O='1O;3L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^ M(#QD:78^,2PS,#`\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)#PO9&EV/B`\+W1D/B`\=&0@#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#,P,#PO9&EV/B`\+W1D/B`\=&0@ M"!S;VQI9#L@5$585"U!3$E'3CH@;&5F=#L@1D].5"U35%E,13H@ M;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/ M54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=. M.B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,24^(#QD:78^ M)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]- M.B`C,#`P,#`P(#%P>"!S;VQI9#L@5$585"U!3$E'3CH@6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@ M;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@ M3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z(#$P M<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P,#`P M,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E/B`\ M9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ M(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^+3PO9&EV/B`\+W1D/B`\ M=&0@6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E' M3CH@;&5F=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C8V-F9F-C.R!&3TY4+5-)6D4Z M(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($)/4D1%4BU43U`Z(",P M,#`P,#`@,7!X('-O;&ED.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$E M/B`\9&EV/B0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)T)/4D1%4BU"3U14 M3TTZ(",P,#`P,#`@,W!X(&1O=6)L93L@5$585"U!3$E'3CH@"!D;W5B;&4[($9/ M3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/C$L,S`P/"]D:78^ M(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO"!S;VQI9#L@ M1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D M;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2 M;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!6 M15)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P M>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^ M,3"!D;W5B;&4[($9/3E0M5T5) M1TA4.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D M/B`\=&0@6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T M,#`G('=I9'1H/3-$,24^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^(#QT9"!S M='EL93TS1"=415A4+4%,24=..B!R:6=H=#L@1D].5"U35%E,13H@;F]R;6%L M.R!&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N.R!"04-+1U)/54Y$.B`C M9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[(%9%4E1)0T%,+4%,24=..B!B;W1T M;VT[($)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L93L@1D].5"U714E' M2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^)B,Q-C`[/"]D:78^(#PO=&0^ M(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q%.B!N M;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[ M($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!D;W5B;&4[($9/3E0M5T5)1TA4 M.B`T,#`G('=I9'1H/3-$,3`E/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`\ M=&0@"!D;W5B;&4[($9/3E0M5T5)1TA4.B`T,#`G('=I9'1H/3-$,3`E M/B`\9&EV/B8C,38P.SPO9&EV/B`\+W1D/B`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`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!& M3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#,V)3X@/&1I=CY!8V-O=6YT6QE/3-$)U1%6%0M04Q)1TXZ M(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P M)3X@/&1I=CXQ+#DW.3PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U19 M3$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z M(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4 M+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U) M3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D]. M5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=% M24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXQ+#DW.3PO9&EV/B`\+W1D M/B`\=&0@6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[ M($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=2 M3U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E' M3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I M=CXX+#4U,#PO9&EV/B`\+W1D/B`\=&0@6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-4 M64Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE M/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q% M.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I M;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I% M.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@ M-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXX+#4U,#PO9&EV/B`\+W1D/B`\=&0@ M6QE/3-$)U1%6%0M04Q) M1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$ M)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#$P)3X@/&1I=CXS-"PU-S<\+V1I=CX@/"]T9#X@/'1D('-T M>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO"!S;VQI9#L@5$585"U!3$E'3CH@;&5F M=#L@1D].5"U35%E,13H@;F]R;6%L.R!&3TY4+49!34E,63H@5&EM97,@3F5W M(%)O;6%N.R!"04-+1U)/54Y$.B`C9F9F9F9F.R!&3TY4+5-)6D4Z(#$P<'0[ M(%9%4E1)0T%,+4%,24=..B!B;W1T;VT[($9/3E0M5T5)1TA4.B`T,#`G('=I M9'1H/3-$,24^(#QD:78^)#PO9&EV/B`\+W1D/B`\=&0@#L@ M1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V9F M9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS-"PU-S<\ M+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/ M3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V9F9F9F9CL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P)R!W:61T:#TS1#$P)3X@/&1I=CXS M-"PV.#0\+V1I=CX@/"]T9#X@/'1D('-T>6QE/3-$)U1%6%0M04Q)1TXZ(&QE M9G0[($9/3E0M4U193$4Z(&YO#L@1D].5"U&04U)3%DZ(%1I;65S M($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q M,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!&3TY4+5=%24=(5#H@-#`P M)R!W:61T:#TS1#,V)3X@/&1I=CY4;W1A;#PO9&EV/B`\+W1D/B`\=&0@"!D;W5B;&4[(%1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT M9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[ M(%1%6%0M04Q)1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1) M3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@ M0D%#2T=23U5.1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-! M3"U!3$E'3CH@8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI M9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^,3`L-3(Y M/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!& M3TY4+5-464Q%.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)U1% M6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO6QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M4U193$4Z(&YO M"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@=VED=&@],T0Q M)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS1"="3U)$15(M0D]4 M5$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q)1TXZ(')I9VAT.R!& M3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U& M04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5.1#H@(V-C9F9C8SL@ M1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@8F]T=&]M.R!"3U)$ M15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U714E'2%0Z(#0P,"<@ M=VED=&@],T0Q,"4^(#QD:78^,S0L-36QE/3-$)U1%6%0M04Q)1TXZ(&QE9G0[($9/3E0M M4U193$4Z(&YO"!S;VQI9#L@1D].5"U714E'2%0Z(#0P M,"<@=VED=&@],T0Q)3X@/&1I=CXD/"]D:78^(#PO=&0^(#QT9"!S='EL93TS M1"="3U)$15(M0D]45$]-.B`C,#`P,#`P(#-P>"!D;W5B;&4[(%1%6%0M04Q) M1TXZ(')I9VAT.R!&3TY4+5-464Q%.B!N;W)M86P[(%!!1$1)3D#L@1D].5"U&04U)3%DZ(%1I;65S($YE=R!2;VUA;CL@0D%#2T=23U5. M1#H@(V-C9F9C8SL@1D].5"U325I%.B`Q,'!T.R!615)424-!3"U!3$E'3CH@ M8F]T=&]M.R!"3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S;VQI9#L@1D].5"U7 M14E'2%0Z(#0P,"<@=VED=&@],T0Q,"4^(#QD:78^-#4L,C$S/"]D:78^(#PO M=&0^(#QT9"!S='EL93TS1"=415A4+4%,24=..B!L969T.R!&3TY4+5-464Q% M.B!N;W)M86P[($9/3E0M1D%-24Q9.B!4:6UE6QE/3-$)W=I9'1H M.C$P,"4[('1A8FQE+6QA>6]U=#IF:7AE9#LG(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`^/'1R/CQT9#X\+W1D/CPO='(^/"]T86)L93X\'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA2!4'0^)SQS<&%N M/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0O:F%V M87-C3X-"B`@("`\=&%B M;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE M;G0@07=A'0^)SQS M<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6UE;G0@07=A M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M6UE;G0@07=A'0^)SQS<&%N/CPO M'0^)SQS<&%N M/CPO7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'1U86PI("A54T0@)"D\8G(^/"]S=')O;F<^/"]T:#X- M"B`@("`@("`@/'1H(&-L87-S/3-$=&@@8V]LF5D M($=A:6X@*$QO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%]E M,C0R-#'0O:'1M;#L@8VAA'0^)W1H92!"86YK)B,X,C$W.W,@<')I;64@7!E.B!T M97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE M860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT M96YT/3-$)W1E>'0O:'1M;#L@8VAA'0^)SQS<&%N/CPO6EN9R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^)SQS<&%N/CPO6%B;&4@86YD(&]T:&5R(&%C8W)U960@ M;&EA8FEL:71I97,L($-A6EN9R!686QU93PO=&0^#0H@("`@("`@ M(#QT9"!C;&%S6EN9R!686QU93PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO6%B;&4@86YD(&]T:&5R(&%C8W)U960@;&EA8FEL:71I97,L($9A:7(@ M5F%L=64\+W1D/@T*("`@("`@("`\=&0@8VQA'0^)SQS M<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N M/CPO'0^)SQS<&%N/CPO M'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO'0^ M)SQS<&%N/CPO'0^)SQS<&%N/CPO'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^)SQS<&%N/CPO'0^)SQS<&%N/CPO7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\>&UL('AM;&YS.F\],T0B=7)N.G-C M:&5M87,M;6EC&UL M/@T*+2TM+2TM/5].97AT4&%R=%]E,C0R-# XML 24 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.8 Html 74 154 1 false 18 0 false 4 false false R1.htm 101 - Document - Document And Entity Information Sheet http://www.ashs.com/role/DocumentAndEntityInformation Document And Entity Information true false R2.htm 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.ashs.com/role/CondensedConsolidatedBalanceSheets CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.ashs.com/role/CondensedConsolidatedBalanceSheetsParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfOperations CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS false false R5.htm 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfComprehensiveIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME false false R6.htm 106 - Statement - CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY Sheet http://www.ashs.com/role/CondensedConsolidatedStatementOfShareholdersEquity CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY false false R7.htm 107 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.ashs.com/role/CondensedConsolidatedStatementsOfCashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R8.htm 108 - Disclosure - Basis of Presentation Sheet http://www.ashs.com/role/BasisOfPresentation Basis of Presentation false false R9.htm 109 - Disclosure - Per Share Amounts Sheet http://www.ashs.com/role/PerShareAmounts Per Share Amounts false false R10.htm 110 - Disclosure - Stock-based Compensation Sheet http://www.ashs.com/role/StockbasedCompensation Stock-based Compensation false false R11.htm 111 - Disclosure - Common Stock Investment Sheet http://www.ashs.com/role/CommonStockInvestment Common Stock Investment false false R12.htm 112 - Disclosure - Line of Credit Sheet http://www.ashs.com/role/LineOfCredit Line of Credit false false R13.htm 113 - Disclosure - Fair Value of Financial Instruments Sheet http://www.ashs.com/role/FairValueOfFinancialInstruments Fair Value of Financial Instruments false false R14.htm 114 - Disclosure - Repurchase of Common Stock Sheet http://www.ashs.com/role/RepurchaseOfCommonStock Repurchase of Common Stock false false R15.htm 115 - Disclosure - Income Taxes Sheet http://www.ashs.com/role/IncomeTaxes Income Taxes false false R16.htm 116 - Disclosure - Reclassification Sheet http://www.ashs.com/role/Reclassification Reclassification false false R17.htm 117 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.ashs.com/role/FairValueOfFinancialInstrumentsTables Fair Value of Financial Instruments (Tables) false false R18.htm 118 - Disclosure - Basis of Presentation (Details Textual) Sheet http://www.ashs.com/role/BasisOfPresentationDetailsTextual Basis of Presentation (Details Textual) false false R19.htm 119 - Disclosure - Per Share Amounts (Details Textual) Sheet http://www.ashs.com/role/PerShareAmountsDetailsTextual Per Share Amounts (Details Textual) false false R20.htm 120 - Disclosure - Stock-based Compensation (Details Textual) Sheet http://www.ashs.com/role/StockbasedCompensationDetailsTextual Stock-based Compensation (Details Textual) false false R21.htm 121 - Disclosure - Common Stock Investment (Details Textual) Sheet http://www.ashs.com/role/CommonStockInvestmentDetailsTextual Common Stock Investment (Details Textual) false false R22.htm 122 - Disclosure - Line of Credit (Details Textual) Sheet http://www.ashs.com/role/LineOfCreditDetailsTextual Line of Credit (Details Textual) false false R23.htm 123 - Disclosure - Fair Value of Financial Instruments (Details) Sheet http://www.ashs.com/role/FairValueOfFinancialInstrumentsDetails Fair Value of Financial Instruments (Details) false false R24.htm 124 - Disclosure - Repurchase of Common Stock (Details Textual) Sheet http://www.ashs.com/role/RepurchaseOfCommonStockDetailsTextual Repurchase of Common Stock (Details Textual) false false All Reports Book All Reports Element ams_CostMethodInvestmentsInterestPercentage had a mix of decimals attribute values: 3 4. 'Monetary' elements on report '123 - Disclosure - Fair Value of Financial Instruments (Details)' had a mix of different decimal attribute values. Process Flow-Through: 102 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Sep. 30, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: Removing column 'Dec. 31, 2010' Process Flow-Through: 103 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 104 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' Process Flow-Through: 105 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' Process Flow-Through: 107 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2012' Process Flow-Through: Removing column '12 Months Ended Dec. 31, 2011' ams-20130930.xml ams-20130930.xsd ams-20130930_cal.xml ams-20130930_def.xml ams-20130930_lab.xml ams-20130930_pre.xml true true XML 25 R3.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Allowance for doubtful accounts (in dollars) $ 100,000 $ 100,000
Common stock, shares issued 4,609,000 4,606,000
Common stock, shares outstanding 4,609,000 4,606,000

XML 26 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Repurchase of Common Stock
9 Months Ended
Sep. 30, 2013
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Note 7.
Repurchase of Common Stock
 
In 1999 and 2001, the Board of Directors approved resolutions authorizing the Company to repurchase up to a total of 1,000,000 shares of its own stock on the open market, which the Board reaffirmed in 2008.  There were no shares repurchased in the first nine months of 2013.  In 2012, the Company repurchased 9,000 shares at an average price of $3.26 per share.  There are approximately 72,000 shares remaining under this repurchase authorization.
XML 27 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (USD $)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Net income (loss) attributable to American Shared Hospital Services $ (134,000) $ 9,000 $ (230,000) $ 33,000
Other comprehensive income (loss):        
Foreign currency translation adjustments (51,000) (120,000) (111,000) (120,000)
Total comprehensive income (loss) (185,000) (111,000) (341,000) (87,000)
Less comprehensive income (loss) attributable to the non-controlling interest (22,000) (52,000) (44,000) (52,000)
Comprehensive income (loss) attributable to American Shared Hospital Services $ (163,000) $ (59,000) $ (297,000) $ (35,000)
XML 28 R2.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)
Sep. 30, 2013
Dec. 31, 2012
ASSETS    
Cash and cash equivalents $ 1,955,000 $ 1,564,000
Restricted cash 50,000 50,000
Certificate of deposit 9,000,000 9,000,000
Accounts receivable, net of allowance for doubtful accounts of $100,000 in 2013 and $100,000 in 2012 4,715,000 3,706,000
Other receivables 298,000 401,000
Prepaid expenses and other current assets 615,000 925,000
Current deferred tax assets 316,000 310,000
Total current assets 16,949,000 15,956,000
Property and equipment:    
Medical equipment and facilities 85,489,000 84,453,000
Office equipment 738,000 694,000
Deposits and construction in progress 7,560,000 9,754,000
Property, Plant and Equipment, Gross 93,787,000 94,901,000
Accumulated depreciation and amortization (42,265,000) (41,224,000)
Net property and equipment 51,522,000 53,677,000
Other assets 982,000 1,003,000
Total assets 72,154,000 73,323,000
LIABILITIES AND SHAREHOLDERS' EQUITY    
Accounts payable 867,000 263,000
Employee compensation and benefits 217,000 168,000
Customer deposits/deferred revenue 722,000 747,000
Other accrued liabilities 1,591,000 801,000
Current portion of long-term debt 4,379,000 3,932,000
Current portion of obligations under capital leases 3,843,000 3,742,000
Total current liabilities 11,619,000 9,653,000
Long-term debt, less current portion 11,187,000 13,837,000
Long-term capital leases, less current portion 12,884,000 13,173,000
Advances on line of credit 8,740,000 8,550,000
Deferred income taxes 3,280,000 3,280,000
Shareholders' equity:    
Common stock (4,609,000 shares at September 30, 2013 and 4,606,000 shares at December 31, 2012) 8,578,000 8,578,000
Additional paid-in capital 4,971,000 4,902,000
Accumulated other comprehensive income (loss) (424,000) (357,000)
Retained earnings 6,508,000 6,806,000
Total equity-American Shared Hospital Services 19,633,000 19,929,000
Non-controlling interest in subsidiary 4,811,000 4,901,000
Total shareholders' equity 24,444,000 24,830,000
Total liabilities and shareholders' equity 72,154,000 73,323,000
Preferred Stock [Member]
   
Investment 0 2,687,000
Common Stock [Member]
   
Investment $ 2,701,000 $ 0
XML 29 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments (Details) (USD $)
Sep. 30, 2013
Dec. 31, 2012
Assets, Carrying Value:    
Cash, cash equivalents, restricted cash, Carrying Value $ 11,005,000 $ 10,614,000
Receivables, Carrying Value 5,013,000 4,107,000
Total, Carrying Value 18,719,000 17,408,000
Liabilities, Carrying Value:    
Accounts payable and other accrued liabilities, Carrying Value 3,397,000 1,979,000
Advances on line of credit, Carrying Value 8,740,000 8,550,000
Debt obligations, Carrying Value 32,293,000 34,684,000
Total, Cayying Value 44,430,000 45,213,000
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 11,005,000 10,614,000
Receivables, Fair Value 5,013,000 4,107,000
Common stock investment, Fair Value 300,000  
Preferred stock investment, Fair Value   1,300,000
Total, Fair Value 16,318,000 16,021,000
Liabilities, Fair Value:    
Accounts payable and other accrued liabilities, Fair Value 3,397,000 1,979,000
Advances on line of credit, Fair Value 8,740,000 8,550,000
Debt obligations, Fair Value 31,870,000 34,577,000
Total, Fair Value 44,007,000 45,106,000
Preferred Stock [Member]
   
Assets, Carrying Value:    
Investment, Carrying Value 0 2,687,000
Common Stock [Member]
   
Assets, Carrying Value:    
Investment, Carrying Value 2,701,000 0
Fair Value, Inputs, Level 1 [Member]
   
Assets, Fair Value:    
Cash, cash equivalents, restricted cash, Fair Value 11,005,000 10,614,000
Receivables, Fair Value 5,013,000 4,107,000
Total, Fair Value 16,018,000 14,721,000
Liabilities, Fair Value:    
Accounts payable and other accrued liabilities, Fair Value 3,397,000 1,979,000
Advances on line of credit, Fair Value 8,740,000 8,550,000
Total, Fair Value 12,137,000 10,529,000
Fair Value, Inputs, Level 2 [Member]
   
Assets, Fair Value:    
Total, Fair Value 0 0
Liabilities, Fair Value:    
Total, Fair Value 0 0
Fair Value, Inputs, Level 3 [Member]
   
Assets, Fair Value:    
Common stock investment, Fair Value 300,000  
Preferred stock investment, Fair Value   1,300,000
Total, Fair Value 300,000 1,300,000
Liabilities, Fair Value:    
Debt obligations, Fair Value 31,870,000 34,577,000
Total, Fair Value $ 31,870,000 $ 34,577,000
XML 30 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value of Financial Instruments
9 Months Ended
Sep. 30, 2013
Fair Value Disclosures [Abstract]  
Fair Value Disclosures [Text Block]
Note 6.
Fair Value of Financial Instruments
 
The Company’s disclosures of the fair value of financial instruments is based on a fair value hierarchy which prioritizes the inputs to the valuation techniques used to measure fair value into three levels.  Level 1 inputs are unadjusted quoted market prices in active markets for identical assets and liabilities that the Company has the ability to access at the measurement date.  Level 2 inputs are inputs other than quoted prices within Level 1 that are observable for the asset or liability, either directly or indirectly.  Level 3 inputs are unobservable inputs for assets or liabilities, and reflect the Company’s own assumptions about the assumptions that market participants would use in pricing the asset or liability.
 
The estimated fair value of the Company’s assets and liabilities as of September 30, 2013 and December 31, 2012 were as follows (in thousands):
 
 
 
Level 1
 
 
Level 2
 
 
Level 3
 
 
Total
 
Carrying Value
 
September 30, 2013
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
11,005
 
 
 
 
 
 
 
 
 
 
$
11,005
 
$
11,005
 
Receivables
 
 
5,013
 
 
 
 
 
 
 
 
 
 
$
5,013
 
 
5,013
 
Common stock investment
 
 
 
 
 
 
 
 
 
 
300
 
 
$
300
 
 
2,701
 
Total
 
$
16,018
 
 
$
-
 
 
$
300
 
 
$
16,318
 
$
18,719
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and other accrued liabilities
 
$
3,397
 
 
 
 
 
 
 
 
 
 
$
3,397
 
$
3,397
 
Advances on line of credit
 
$
8,740
 
 
 
 
 
 
 
 
 
 
$
8,740
 
$
8,740
 
Debt obligations
 
 
 
 
 
 
 
 
 
 
31,870
 
 
$
31,870
 
 
32,293
 
Total
 
$
12,137
 
 
$
-
 
 
$
31,870
 
 
$
44,007
 
$
44,430
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2012
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash, cash equivalents, restricted cash
 
$
10,614
 
 
 
 
 
 
 
 
 
 
$
10,614
 
$
10,614
 
Receivables
 
 
4,107
 
 
 
 
 
 
 
 
 
 
$
4,107
 
 
4,107
 
Preferred stock investment
 
 
 
 
 
 
 
 
 
 
1,300
 
 
$
1,300
 
 
2,687
 
Total
 
$
14,721
 
 
$
-
 
 
$
1,300
 
 
$
16,021
 
$
17,408
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Liabilities
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Accounts payable and other accrued liabilities
 
$
1,979
 
 
 
 
 
 
 
 
 
 
$
1,979
 
$
1,979
 
Advances on line of credit
 
$
8,550
 
 
 
 
 
 
 
 
 
 
$
8,550
 
$
8,550
 
Debt obligations
 
 
 
 
 
 
 
 
 
 
34,577
 
 
$
34,577
 
 
34,684
 
Total
 
$
10,529
 
 
$
-
 
 
$
34,577
 
 
$
45,106
 
$
45,213
 
XML 31 R16.htm IDEA: XBRL DOCUMENT v2.4.0.8
Reclassification
9 Months Ended
Sep. 30, 2013
Disclosure Of Reclassification [Abstract]  
Disclosure Of Reclassification [Text Block]
Note 9.
Reclassification
 
Certain comparative amounts in the consolidated financial statements have been reclassified to conform to the current quarter’s presentation.
XML 32 R12.htm IDEA: XBRL DOCUMENT v2.4.0.8
Line of Credit
9 Months Ended
Sep. 30, 2013
Debt Disclosure [Abstract]  
Debt Disclosure [Text Block]
Note 5.
Line of Credit
 
The Company has a $9,000,000 renewable line of credit with a bank that has been in place since June 2004 and has a maturity date of August 1, 2015.  The line of credit is drawn on from time to time as needed for equipment purchases and working capital.  Amounts drawn against the line of credit are at an interest rate per year equal to the Bank’s prime rate minus 0.5 percentage point, or alternately, at the Company’s discretion, the LIBOR rate plus 1.0 percentage point, and are secured by the Company’s cash invested with the Bank.  The Company is in compliance with all debt covenants under the agreement.  The weighted average interest rate during the first nine months of 2013 was 1.44%.  At September 30, 2013, $8,740,000 was borrowed against the line of credit, compared to $8,550,000 at December 31, 2012.
XML 33 R7.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Operating activities:    
Net (loss) income $ (3,000) $ 647,000
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 4,746,000 4,563,000
Deferred income tax (6,000) 0
Cumulative translation adjustment and other 840,000 0
Stock based compensation expense 69,000 62,000
Loss (gain) on sale of assets 0 3,000
Changes in operating assets and liabilities:    
Receivables (966,000) (372,000)
Prepaid expenses and other assets 193,000 (542,000)
Customer deposits/deferred revenue (25,000) 263,000
Accounts payable and accrued liabilities 1,437,000 (228,000)
Net cash from operating activities 6,285,000 4,396,000
Investing activities:    
Payment for purchase of property and equipment (3,293,000) (4,103,000)
Investment in subsidiaries by non-controlling interests 139,000 169,000
Payment for repurchase of common stock 0 (29,000)
Investment in convertible preferred stock (14,000) (31,000)
Net cash from investing activities (3,168,000) (3,994,000)
Financing activities:    
Principal payments on long-term debt (2,584,000) (2,946,000)
Principal payments on capital leases (2,916,000) (2,796,000)
Long term debt financing on property and equipment 3,109,000 3,925,000
Advances on line of credit 269,000 950,000
Payments on line of credit (79,000) (600,000)
Distributions to non-controlling interests (480,000) (679,000)
Net cash from financing activities (2,681,000) (2,146,000)
Effect of changes in foreign exchange rates on cash (45,000) (120,000)
Net change in cash and cash equivalents 391,000 (1,864,000)
Cash and cash equivalents at beginning of period 1,564,000 2,580,000
Cash and cash equivalents at end of period 1,955,000 716,000
Supplemental cash flow disclosure:    
Interest 1,522,000 1,782,000
Income taxes 42,000 147,000
Schedule of non-cash investing and financing activities    
Acquisition of equipment with capital lease financing $ 2,625,000 $ 264,000
XML 34 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } ZIP 35 0001144204-13-061966-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001144204-13-061966-xbrl.zip M4$L#!!0````(`"R&;D,O/L*]=UL``%#C!@`0`!P`86US+3(P,3,P.3,P+GAM M;%54"0`#8T6%4F-%A5)U>`L``00E#@``!#D!``#MO?USHTB6*/K[1NS_P/KN MW)Z)D%R@;[FZZX;*=E5[VU7VM=W3._?%BPH,*8LI!&H^7/:\>/_[/9F`!`A( M)(&4R&=VN]N2(/.OIEY/? M'SZU1R?2__KP[__V\W^TV])G8A%']8@N/;Y*%ZJG/CBJ]MV-WI?@]=.11/_H MM;_:S^V.K'2E_T?NGLG]L\[X_Y7^O]LO_[]T>?\@M:4?/WZRY MU&Y'\WQ479@#QOGOCW?74N=4"7][>71,XXS^6P*P+?=,G;N_G,P\;W'V[AT= M475G;*QW=&9YW`5L@@=-P_J>>)(.#Q^QWY=/NH:60_"H,J[__YR?:_-R%QM&Y;KJ9:6@,4H M@#W]O.':O8XR+'HC>")Z02<+AVAT67/?&;]3'F[PL3-52/=MY M_02?HX$TV[<\YS5)-I=HIT_V\[OP1[8R;5EI=Y7E:[[C`,_EO1?^2E_L)%_4 MB9']#OR0,0]YT6;9S]-?,EXPK&?B>MFO!+]EO&2IAN9FO\-^HJ\HR5=<0\M^ M`7[(>MQ;.#G/PR\9+_AN^TE5%\MWIJK[R%8V_"$#BQ>S@'_^^SK&U+[G%+`- M_'H"DBM)/U-!.',9B]^1J<0$X\Q[79!?3EQCOC`I_[+O9@Z9_G("DMV.A/CT MQ=5/I'=$\T#]0.TPTP0Z`=M/!'`[CY5E:^P?]3BCS82N=; M-_@[@&CY!K$\PWL-OUM^:^CT^ZE!'(E!31)81A0_O_KMY(,,_QOV>J-._^=W MZ9>CJ=ZEYDI`L"".8>MI"$"L'0^T+/D0+:FL1..L?HN&BJ&CKUX"D>DJJ\GU M\)4X2+')HZ]"&H9C%Q*V\V#+XV]=F?W=1,)VMB$LO#1N=^6:";ODV+=$V-HY MM@L<.P@YMMM$PG:W(2R\-*B98[LQ5?"F"%N7*A@>D8X=BJ1CAT?$L9L3MCZ. MG;@W5N,(&L1/7@9EHE\JHHRR5)1-I(P25XU54R9T=.11XR@CCY(>2TV4:8S> MC_%,9S^4D9M'&7D_E&E*H!NCC%(K91KG126D:7?;1),G%\:<6"Q;RT^?).WY MMW-[/K>M>\_6OG\A\T?B^"Y-'UVQ5!B,ZCV\+LCDQ7#W3-VTAT2>*##+^<(? M=`#D96$:FN$%T$MZ1(I?3L),V%D6+M%O:^C__"YSW!6B[[(`$MM'6=H;7&T1 M5KM>&QJ3[5N'3(GC$/W-+G@6!8Y;PG'-A5GS??G*>5K]WE,]0M&Y_-,'^.&I MA6W!1[?9:\]!2RQ=OZ>H0/XVT76#>GZJ>:L:^I5UKBX,3S61'Z+'"@ETY+RA M:?[<-^EI@!MO1AQ*(H?,*"&?R96EV7."?++DD[+$.FZ>N2.>:EA$OU0=R["> M7&20Z+%LRAPW-]RJ#H"(/+#T,6/T..Z5_VI;]&?'-DU@]BMXT`'/&SDA>JR( M/D?&&=D'KS#Z$"SZ:,01LR0+8?#2C."EB:R%L4^C8Y\&LAR&3J*&3@UD)HR\ M1(B\&L@X&+@U(7!K!&,EKBU@O"=RO"?J!8TD"V&\U\!XKR&LA?'>\<1[S6`Y MC/<:$>\U@YDPWA,NWFL&XV"\U[AX3U3&2ERAQ'A/Y'A/M.O-V2R$\5X#X[UF ML!8ZWXUPOIO!3.A\"^=\-X-QT/ENG//=#,;"=.81I3,%8[ED70&,\P2+\_96 M00$/8C8N4#L(;Z`I:K0I.@3/8'0N:G1^"&[`\%J$\/H0*X_Q<1/BX_US!IXF M%#CJV%/]$CP.V,"H8W^\@5''L40=>^,9C#H:$'7LC1LPZA`LZMC;RF/4T;"H M8V^5,3'J$#;JJ+=2)AY*:W+4L3_>P*CC6**.O?$,1AT-B#KVQ@T8=0@6=>QM MY3'J:%C441]GR(/P4)\EFWIFK%F81^_JK.&UZH M/8F%.G?/.,COCP,21_-DVDIQTZ-Y:I37"D^BV?9LAJV0$@LE@#66Q_R8)EJ_IO7\@S MD.6^TY>10XHY)$VI0_%%G<[V2H=\4@WG[ZKIDRMKX7ON-7DF9C?.(LL'/KXN M__P5%DEUM-DK>[S9[%$6O[7GUPEVA!HD=L@!.:7AG+*W0P]9B"O(*9MQBO)6 M=0IR2H,XY:`ZI8.AH.>/_?G^1,[CAVKV.,CR#)[8?^QL@'/!]:A;=>`:&2Z\"??6K/P<= MXME.FMM*@Q8G>'K$C`DOB&7/#:MX2AZITW.N#QK]&L.\!`U!+-*D2X)$'RBU M/C__1[M]:;+S+-(]8;FI=CMX5"?&V86M^?0WVG]>"GGRCDQS-QY.&'B?:))+ M_Z:D>>#-=SP(V@6YP;DV1$27)Y=W4^^2K=_SJYN[R0?KVYO[UZF%Q+ M]Y=W?[\ZO[R/`Y><+H-NL(*.:EY9.GGYC;QN#,\XZ2?D#AR?^=QWG`3#;BN# MBGSRH1W9U**1U_'^9)C$.8>?GFQGUXE,WH40C5>HU3 M(3%-!,7R$+EIVC]42R.?;.?"]A^]J6].-,WV+<^](QHQGM5'DX0XK3-Q'FR= M&!=3VQUC89DJ8?J_G]]M!43%&*PE`!S43\$\`,N9!0Z`A12D9X&]F:U?6<_$ M]:A5=8L6..\NW^IUZEBQ^"F!R*A0KCI#64GAD`'7EL#SRY_P@!\7`E\6;!I. MGJON;&+I]#_TV/:S:M(G+E\TTZ?+@W5VCO/;MR,6Z:]SO M,QIO"4?E:.3P?$Y7%N3OU<(^5A.6?(RDU<#IDY> M9U`(:&^H]),^4L&DNP&81\EA(8#=8;@+@5WJ51M7)ZEEW8_IQ3.%XE(`N M?\9=8,LC7;&EZZ6L='G8;AVR4`W]\H4>V":@&MC5U8GK$F]C`G:+[=P@Q7\E MIJX$VAR2=HO-V;BS,[079$K@!_U!?0F>VT*HN\76JJLD1:9@RIV@RZ-AL1GJ M*O*VT&W)@<7&11F,>\F@IG#]MN2K8GNA],?]07D8OJC:S+"(\PH<1RWV@GJN MGQW;+0P&D@`5VX51OS=*$B5_SEV@RR-7L5$8]7K][I;0W3KV`HSQ*[T[X,6? M9J);GG[%=F'8':441=&LN\*81\5B^P!\OP6,U)$/_1>7.HVV!6ZDS[8`KBRV MX49<=S->[!6;B"$3C3"&*#=U%<#F$+7'L1##?F]+8+GKL"%5BXW$N#L<#GNK% MQJ;7Z0S6'.Y*(-P?YGDK66SB>DJGT]L+YKD/@F-1?AV+[6-?Z7)9DV<[(M(AO== M=M8\S(M-V[#;[73+S!HF/&[5UVUV^?K%!FDT&&:F5Y*S;0M3'F6*345GT-T" MINB*7'A#ZMI0'PW3\(S-"+H^"Q3I\V!MN"EU2D6F:X^_$C`/. M/E%_K&3HS[QI=P4RAXJ#8B4_DG>!\=JVGAZ(,[\@CQMGR@;%FK_7'2:S'!ES M;05.'ITXJ;%QM[,I.&'AR6NBNN3FT32>F+.\.9L5FXGNJ)?4R<73[@ID'OF* M[49WV.OL`.0N0EIL,11EH*3XC,_U.TACL548#U+)LY)J(LZ,6[BF@V([H"A* MRETNF'0G^/*H5FP)E.ZHNS5\.8RX!16'''/0&8UZ962@4EAS*#KDN/Y=95A* MJ>3#&E'_VK#(S?0T9].6D"/*GK@+8/#(7VZ7!*'5$9W-@&?//;%,GCAL4R"U/2<[N_GC033H9 MZW-M`TT>J3C[_.-Q9[PA-%\,RW;@^Z@8<'G*<(Y^C92D+DU/M#D@>40IMC=K M6WP\0-9I!K(;G"&]I?M%MC7Q/,=X]#V:+GRPLXLJEZ#/O#FD.Y.,^&1MRUG4=YR+_2Q4NNC9-V(6?>W<#KQ,!+T;'8;/4ZW1K!*W$A MCF.XNH/>L'[X"LC',66=<8H-2\(7E#"\6=!KU"#X7\!5\(A%KV7=^XN%29-0 MMIO>9BO#C;R3SJFPKQP8U4)?0&W.,>A1]W#0E^!E3FZOF]HR.PCX!<3GI/Z4 M5""W+?BQ4RZIPRT;$.<9L MT!_M#\XB>G*L&KCUV\(9QL0N1+]+WL[<3RW%G\7F;9CR'@OFWAW,(G(66[E! M9U`_F&6XDW,D01[M@9QEN)-S(&'<[6\+9_#4]OS(B>)&*7V9F&X;6(JHQ(FM M^KWU^[5;P5*F0$&Q'1G)_8KH4H)[%$[DTU?2B>D"6-AYX%O'GJ8S766XA5<; MH9_2LK')-H>CB"*<"@>#<7]W.,IP2;$V[_?'G>K@**)'L;J&$+XT/>X)2SQ\ M)A;H'9.:1GUN6*P&"FU7$M[IVH)U.-L\J5WNGB#P\^Y&ZI\:!9^FCK3;+MN`@WGW,U!GU]3FW!ZN(5)Q# MR:EKJY6`58:C>*<&1O6!542M8D,Q&/8V!>N3[1#CR0I.H&GQMA?TZ8]D"K^O M;0Z7XC>.64CM7I:$HUKPBRA=NI[-7B$OP;JM.L!41L42)MEI@*\.?O*,#=<-61#>.-A8Q#C%AIG=MGGK9"RC&SA.PQ"I6$:+\2I0I%7L@.4J^AEJ:V*H2NB':>T7CKI M40JZ("^Y71#-J3.Q9BY7,<=UVHD;`I$&<[A>`X[$Z(,?W#"X=Y: M*88<(+X2;Z6_-C_05XIU.(!I3AV'3FC6BM+F4<&I&@((M@'<;6(I(QRF25`T@9=B28W4ZJ5,=.\-2 M1!3./:\"H5\KR!!>5+@E#JO!_5%U#6T+EDD9HEC#FAAL':"3?"IW8V49LJ;? M!<8BJ@W+P)AT5"N#KPR'C3:@8;]&&(MH."X)(X"H[`CBA6'Z7KI(?AEF3->- MV)890P!V@[.`F.G2$=LPY$XPEF#*=!6);9FR$CB+:-FMA#%SP,R[,I>?_89@ MG'TR@].'^C_](/J.+MAEW@NY5=>O^Y9B>(YMZF?4(-D7-B*2LHB/BDUK6TDE M$0]*RXQYHU%VOR!5BO%XF>M1^@1=I0`?AAY%W%,<"[<5)7VZ\5#TJ(D?BN/K M=JIPY([P[0?=HN4NCK[;_4.AN_G*<8JKM)548;J"R7>'LX#DG,(J[?Y:DZ:R M8![2,)5PQ#@E6]94RYLU\B6<14ZUF;=DY,MP'L>[[*X=V6^PD2_#/1P7<:WT M;8-L?!EVX/A\J8H`0MOX,JO-<>E$L?%E5H[GG8U+<^[N$4&^ITY>.HGR'G-2R\]U2/]/@7CINE3;4JK8%1QT4A<8&DNOP!7? MEDJ\HR']5"F_QI(I^Y5MR5;L6'9[P[UHL@UZ(%=B]LIT3NZG/#-NNV0&4=#O M^<)W*$6(8]@ZJV$9[<`1G<(%^K.H'(/R8"_155*0.4%VL"$:IU'CEES`06X115 M:O,-.974FD"67Q,HL8M5Z7!J!#9%5*HT*AU. M/4(QZ9&(OW8W*AU.L<,F$*%2H]+A5%44-XI-$J4JO5GLC3:!$KOIS6+'LRG< M4*W>/+P?&B0F#YGDZ22J7>8D5)529K4(F?KH47%TTDE4W,Q+,(M+CJKM:J+H M9PXY,O89*B#''5GXCC:CSZX)W<:)Z@ZG8&CJ2CL7@%H@KF*YBGU!,="LUM'A M%#X5`-VZXN(.I];JX5&OR'OCU'(]/)X[^6:<,K!BR®A>G=FQ=V`8F:%^: MN(1?E>%U%X(>(4M[C*\JU%Q9]_ZC:^B&ZKQ^?(6%.E]?J#RL\_>K.YPJLTI? M#L#?`ICJ\2BP_)PRM!UE*`X:^;O2'4[Y6J4KT&I4':-P:N6*B7:U7@ZG/*^@ M)*C-\^%4!A:3'!5Y0YSRPV+BOI.'Q*EL+";&E7I,G"+*`AOC*M1_\?ZHF&A7 MK/ZY.Z`BDJ`V]<^I%RTF.2I2__QBTP+BOI/ZYU2M%A/C2M4_IS:VN#%,!=J? M4WM;3+2KU?Z<$M^"DJ`^[=\,=["6C6Q.T>[V8"2J)MC-!'#NXHJ+=K5V@-,. M4-[9#D3)R'2U[`NB.41U"2V4?4%;1]&+0K3.=MY%H5^#FT:;YQTY9;''J5;A M50&Z9P(4)"PYU;>'J0:>#25`0:J35^#[.`A0=9*44WC\V`A6K8?%*9)^=,2K MS3?CU'D_-D)6Y-5Q"M,?&]5V<@4Y!?2/C5:5^H^<@O['Z%M585E+7S\Y"H)5 M:UDY_0F.CGBU659.5X1C(V1%EI73G.'8J+:39>4TCS@V6E5J63G]+HXQ:*_` MLG(Z-.QK/R'=Z>3("5F59>6>RC@JJNUF68\]@JAQSR/=GN9` MV6!NS[^"+8UTYYKTZ:W>*'D2?+?.@WG["NG>-.F*H4IE[0^K3FVGN]7DBT]E M0%=KJCD=9VI!H#9SR>GY4@L>4HG**I#H#[-4SI)4!DR56D>7A^+ M5"O>RN#?3?=PNEK4!G6EVH?7T:)3MMM[[=7)4R$KI[U$IZ\<1U'V*L)33D^) M8VG%4750S.DCT1ME53YH)-EJ,TJG&XE[5ZGR=U8JT^TD*L*C2$>DF^HSD8S'>#(L\F_7)=HCQ9)W[#N@:[?7!42V7`@)\ M:^GLD\EJAT_T?_I!G8.HBWDF>P*CHBTK'@7O,OI M8X*DW\M>?K=\`Q5KJT!ZB9:C]%K+^G M$RY=F7-.I]?#I:CQ?')7*7V\%TE?WRGK+J>_$"[#WL^*=SF]D-8V_'!A:CCW MWBW?G@GI7]G)_2ZG,Q3R_OYN('0YW:O:G=0-UH.NQ>5T2C1XZ_)%FZG6$[D# M-&_`-KHSF(3^A^+[K)H4U8TK.W8YK:[:O>1EC$V`J0&13@R15%J0T\&JK73D MRC"Y(,`)FL'6%OXV2;CDDSE=UG^5[@:9PJ`XA.H->\ET=!DH*H2\B/:KHWLAGV$V0*VS^!;TWL^-]:%X2YLEX6B-].)ZY)M#"N_ M0U*IB:N`LHB0'*N9U-L;09KFTRL+`DO;!W-Z1S0"IA5\GBW(RKFV/DBJ[3)` M5`AX$:6+;61WV*D!\%N'+%1#CTQ":`G`TC*/=EO6YO3Z:2OC+@>7,G#5BEW! M0G&Z^?1[O(7:!+F@+T!ZA'-0_&"['?"-J)"YT5!WY)E8N>UABU:,DWCI]&-= M"C:$I@Y4BI:'TW@G=#5W0H4OA+?J*Y5`ZK-JFN,3_=I0'PT3%&)N.]NBY2DV MM4HO=:1A.[AJQ:YHQ7C1=NI68378@=-$H[A;QWXV=*)_?/W=I3[QS8(X8/ZM MIPD`][SM>A7;]D%GE(R:R\-2.19%Z\*Y(]5-U9[>'@M8-^K'N@_V1(.HVB$P M!KSEO=Z:JN7!S$ON5N6PJ+8(0"[FRID4QJ6RK$H6@M.!*W(56/QR796 MG:UOIK%MK\W7@-,@)@/N_-DK@[>`VIQ^+JG[(17";#W#&AF@PL!'""S/MA3G M7'+IE<,@!YZ:\"E:$4Y=&Z52?'(T6="@:4?;P.E;TNXJJ7O-Y8&I'(VB!>$8 M[>YXW*L(#5C"<#UOIM>V]?1`G/D%>=S"%G":=G3ZHR3,>3/O"&$168MM;F>< MRO'N`F&X?7Y-?:B;1]-X8FF/;5BZV,1VQ@H?Z!Q@JL>CB/B<7FW#\EI3>05R%#5)"9Y<5G6_8$['**W:>K M0!=/7PFP1<3E7`0<9KO\Y8#-<7V62F<7=Y)3T[W=&8R4,GY8!C"5HU%$?U[M M.*57*ME0`HWL+?RJ]B\YM<^[X^1J;`),#8@4K`BG`GI;&0UZ.Z-"[7'V>YPP]+!W1&.5 M80V.3]%CMEN(`"=;W>^D=TA6LVT!21$/%YM,93C:!)+PN`1QMR0+QQZN;1O% MI]L.FB+2%!L\I;>VHY`%#N4WEF",MGJ7CO(?AC>+QT)+Q;P%X3CAY2#FW&\( M3/5X%)&<$UZ&^G1'-.+.=69'\:W<#$Y)D\J59X$NT&$R2[GFS,XD-^ZMJ/8'4G$@:,4UWH5(1HES!/B]478\^_S!T;_;+";AL M?XE!YD1@W4XN+JZ^?FY_O'EXN/G"\'TO15\^W-S"-X9U(H$%-IZL7TX\>Q$; M18]&^>/JXN%7]NA[Z8^;NXOV'W<3>/41'*7O[1^VHR?6AOY-_W0]!X(Z]DF= M+][_#W``V/?O8C_0C^$K[/5WGIXQ_\/E?S^T)]=7GV'%Z(DR8_H*@`1`J;YG MYT&5C5<,Q"FP=&(%5\MQDOM,M,H_I9;YI]9/+F61G]:6=C7W.SI:U2/O;^#E MA_RU_FI[1%).I8^J:[B2/97BNH:[_'F\\,YS8G]3":E%&QA6\`_@+X6L$_); M/CND:9;D]03UXMA5`#83BZNO%Y=4=5:)R94G>C$CVPK#H$4=82X!" M?6(6HL5^4C7PN1:J]4J]#=]2P7WW"'/U='I@B/T5&A[X,(WL#$P:&1IF550` M5#5-25V>%W6EO])7#;;O0F>V+?-5LFP'S*/D$,UW'/J#2L]0@,'\FV01C;BN MZKQ*GBTM`I:3IJKAP&N3.?"XIEH2RX#HTJ^VRSP4JM&?#7@O6+-11QF^SX,X M.BHHJ8RI[\G"8Q"84C"5$`#W]?PM(9OP+9GFD,GI:J<;(YG[I/$[51]4$JH+IG!'B2>J<'8P) M"0OA=XBWPO#N2#,5L'@DQ`+WR`&,8%7`"Y(B7LMBJM/:10\U1B8J#S,0O*0B MX(B_.[-]$UB"RHVJ`^/2=_[I6^P*$G@W(!E,T12L]E*N7H$HH?RLLY'!"E41 M-@5]^#Q07#'1=P&/]F\PA0E/+6>^I\HF2!E2"8SNVM#WYX;K`I3(;0?EMDR6 M"%=[::28A@'UPC4%TE_I*Q%7=.3W*3[I*.__QAB!ZO8?,]LT7]OV#PN&8^\K23J6_Q@"F7\>A!9H3'8)QT)ZG8*TSWEC^GGR-8IFFUYVJ M&S0L?")@:5A!G@`62/JOS MN2K]9AE3`A]-Z19BLZFAV=+]Z>3T_#0UVBUQ_#0U?LVDAK1.#;HG)GTD*AC[ M98)EG2K7'R_C,[36J)(W`Z/+Q'ST__2)`_]0&A7,,_G\6VJB_U*U[ZYM/1NF MR7OYOU(O![KTC[O[]4?IM\EYHF?C9`N6.H-H]$$(P!\?#>G>\9:]-)#[[SG21D')7ZX91Z9)NIHVS[3S.F:PNUQJ<6^/S!-EM" M0&EZS:41`76T/>I#S@GUC$U)(S21[N:[\Z&;P&Q*8#J<[_1N-,C,.:`&/H=E MJ"WJV(+C[1F:#US_R000=?CVBE[QM@UX]HL*/KDV\UWB>?0C=1G@_Q<+HP5$ M?E;ITY38_P7`D-?@[R_D!11*\/<_;.=[2WH@,(OK$M*2;KZ;Z@Q6!OZ:&3;] MZ44-7),_#)?%3%8@,8!`P-;ULW+=/'%$[`V\"J^Z=L2OKN2`20WN$-*[->KB M52++4T;`N2RD7'M$)PO589&RI'KLF3C;0ZA*4NM?MS,2%UN&GVY`F.Z!BBY` ME+*I0UB9EA72K=!YHX::[G8!1X/M^F+K03T7YH($PSR$P\35^=67NX>D];B: MJ^"N?_:9+^1\L MZXXQJP@&![0Z&(A`\="%R-R2D(A6P:A"]]9V&Y@,LC+(BRB M2\W0H^_2PTTT.`'38ZE!G2B6K0F9*F2(W^`-G7KJ=#HV43#'>PE\O2"_Q42* M_M<##GPDZGS)AF[DE`-95@YDW&B%GCUX9.P/ZIK%!TUP:VRPF*<8-U/!&#%/ M<&D&]Z)WEFC$U^*1/('\+3-O2UM.:&)2^M,'.0533X]BK"B0\\[4]AUOEGAG M+W@%O"89+F4B4*24*VT*I)$!)&@F"AS5/Y3M`,C>GH#\_3<*(@16&DLV4FI2 M'H7O:$JR`'3&4M31JA;0W`V+XJT&$784DS1NF!*]\%D^GF7:PD1UMY6;9Z., M:@'#PJ14,892N^2-UHH6].?P:3?B]F38&=-6:4"OK[Y>MG^]O/K\*UT(I?^7 M),W6EH5Q5L[FW4KFHCQ_(G)>09&4D.5K*Y18/GNNZM0-B';R&6XL'%X]1[52 M:ZFJ5]\[Q*52!>)FOIY*00XL/A+=#T@G.TVZSP"V91[/;'VUK7:L(%5@EF`8 M!DS<_,5/+=EN6`3+=;-,TVPF^9HGNR?VY-**A M;U@.3(KJ@4'\ZK$X.9GB8T\GW6PO'@"`7_/Z+^HV)#?`;-]SC3`KFW!^)99; M@XGFE%&9W0VW`&BH'L%"/2J:#%N.N!@DFU0!![N22.9"!_ MAFQW'Z.4)^KKU*X+4,Y+J0YQ3ORRE=C MAJZV:6MQUF);BHPM5R1NT9".!/2S0V\05B:@O&8XFC^G_2?`/3Y-A+]I#B&L M3!MUCT+EZG"(5>!A<&7@/?8"*^S(5!JK]8B&\D"&@&+=5PPBQ3:VP:KE=\F"!QY&5ULI;2_V;I+>P]-[O49*ID M`9^N(4JI0$'\SRH!Z\J#EBS+2:@HS2N=9=23UV?9Z'/*F!*@;7G@+I,-H%A_-#[""(4'TW<%'S]/4_??UI>;+5S<#5 M#8XBNL;#X-@2^IY!CW6&09X*=G2YXS"WZ5$5YN82;6;9IOW$ M3G\$^?W`!0C?`1TB`:EHR+^^Q[6`CY02^['-$]-,!+,L0:5%.8;(^UDZ[Y%Y M7AT8)2:0V0JY(W88D7]H+_$AX*5':C<==NDB0II=OCBC=R_>!] M67##@WM[(YHZ.-S._M*7X,3_=%9_1F??8Z7=*[[HD[Y(E%\BGCI/'UGP]Z"^ M;-X&<5A\8U1)M6PM"<=:S?:PU<0M<=@AMETN-/76+S0=\@;2GBUW\N(&S_BQ MBR"=NA1%<_Y*J#1@PN`HI30)CKVOJZ&"ZS'HJ=7EJ=%U8=UGP5#00P#Q_".Q M6)3J!U<70H\N,\"V?.9W0QB@LQ=?PGEOR)^D78JWZV>S&O MGPI"HX)[*/32B`8^2*!5:0P5XD)3D$M"4<_C:6U';M>]WEAI;UC3R%6.ME1=.7S9,29ZPP=8]UDG"PN\W8.QKR,X7*2()4O M7T8:)+E\\=42@*^[&0#709AN?W>^QC3*84[H!2P8F&6:\ZKSK`?HE223;'=A MD[R$AS"2.4%A;6)_M"Z'J=,LT]SLB.%[B:V*:']B7]FG-/=MFU'N-(XINAG6 M1$"F2++$<>1UL1+ M5`6&,IZIN?KZZ>1#;R`GRP]N!%,="!45WAF40F@@!D)E*@D-RR"DR&(A5,1R M(T%8[B)PC-?&V$**QJ76J%,&I3RHJD6JQ#J-Y%)(=<5!JH1Z&"EED.J6DJ;] MKE014IU22/6K1&IBP=1AVFM51N$R](!H+;/SE5]U,TW;NR!#NKFDC;I\5/NI MTKZ5@+I/_(N6NL?'OZLT%/\R2JF$O]+8]2\CZB7]82>4PXTRY7K^K1@C"RI;O0(]O7PS+F/OS^.]W=/4SB%7"^1JFFHTTGSSJ M2UGRE/#-E'1LM3-]MI;@FR`A^1D>]-Q-/)%O`)OG&/3,'X.;WG9S[^Y_+REQ M)3PX14G&:M7B6"\%/SOTE'D9,GZUK_$"8^_$U M_DL&A4OXANG\4@TTJ)K,?R?T5@+M!A4>.'VPZ5>Q&#V(X0NZ.M1(\Q))O?YP M4"G-RQ)D;2&HT`:6.[C:'BQ:H'?8C^$$E^%&QC:>2(F,8)P4&X-4.5)\/[XG ME\@(5HK4Z@`KZV>ZY)&0%\]MUW/76,3=_A!H3U;$.@2*9>B39>ACFVPY[Y\. M^_E#<&O&;W$*MINQ*[EQ$?PJZMUO!CN3OW9PY#$N6ELC4U#%?1]':9;COZ&S M,S>6]%^^1:0..W\@Y]=D<>/-Z=CA!%IJF]8+!X6I+^\(T0(AX=V!:->^(\L# M*6B:O`P=).K,:PNGSNS0RPU*M2U'#2Z MVK\"(I$/R80H#4QTUY8%KL'XJT.]X2&Q@@,/T6DR1@PG#$^"._Q1Y!57QF-09.&-_\K/;TQRCC2$Z'!+KI6.AO$M;FSP=I4.I>2?6PPF.UT)<#L M^$YTNH_=Y,]:%'ISC):6H+R?7-Y6R)>T0!$)O6)@3\NVVM''L-0A>,GA#5'] MV7#A4QH*MMYL=E9VU/4U>EUZ55(PLU*20YX-VP?Z_;`#M@KU\7)R+<[C"Y@B M%!YE/.Z'I9AD)13/P)=B@.31:$F?B$_I<2LZ>3CTJC:CMWHI=N"=S>/ZC_^D M-]L!L>""+*T#&3O>OCSHLQ*&T(T6^']Q]5ULFH96,DXC>HLLP8A)8," MM@Q1HK>D6$^,H&`,;?9`;QVSG@[,-Z!7%[2(-,&MSI"4"4ZA-7$+>#A`G1*U M4J2S#MTOF6&))2`45,VH]GCC,./\=30WQ?29Q8JY%8$/<_SW+?HL";.]K'8! MJE(SV%W.96^&W#.'H9)4PZ)']DIUT^O,FFIJ81&*X$`['>NCJ<)[]QJX0/`4 M.-)^,#^[.IM6EB4G9JHC?;,W=J,5A#-%A32HOJ4FR%'I*=&0/P.A#(IV M+.\&AUHVJ)NQ\&DA$=>?APQ-:_;3LZ5.6(8J*#427`DW'(8?D8#AV0'4-6,0 M_:#'GR[P>P(P(ZU#BU8N!P@H'`>-6M[EA6C3F)*6]&S3&B.FX8&]!08U='H+ M^=4@IAY@#K3[WI[2\[91D3I6S"14$U1XZ3%]2E6VV/1^-%N":O!B&*ES>B&? MWJL'Q]B)'3F-#J&&L%@KTVQ0<_JG;X1V+"JP&A95915@HD(LT:%B!G4+B.:S M9:-?4;7$%#Z;+8[1A!40@-]H;8HX^VG)?4"77H"GMV.C^BJ>^A(5GPEY*6C" M4WGA#T790]V/089-8:2?F@&/`8ZT9D>(_(X50=C]\W!%JRV2L@]29=P@B[0) MO?P?H1]^!SX&$(N6%DG?A$F(%;TE1*IV%=:L6&TU8JM;P'Z>>V&P#&?DOT;? MDF6:-5`A*ZJN^#/.EKE<&5N/NI:CHVR*79TW=):42P(4NPZP)M/YQ(NS,,`/ M.CDHTKU4E8_A$0PK]>2"!NKMP-=@]Z&=KF,5/OU+=Q4!KBX*S&,AT<"JY5BRM6O^ZTQK*&2'/JCQ[Y%DGTJ4`:F`1::<^5E#L_M4%R-W,7GW/ MRVKR404XUK6$-KJ]]VC>\\Z@`6IB".J^ATUQ631NQ:^?5NLH@FH<)K#_RRIF M-ZP0T5-IXJU6>KU9)R51C&CT/FC%ZS08#=?7*6JL&Y**57MH%0$@S^(CQ-<3EO(0$!I!H+X@]8! M-VA-0LT,*@[:K-&#H1D+-6B11"MM_J@5N6G4$3*5A;=]2T_'5"Q_DI8Z/T8).=H-,61#XKZ%^M/NOWDQP\!SM`@6"<3/7&DM-#'1=MD/EN('K`7<0D M+*=*N0AF]&GIT"">#G:1:%(SONT?XDFCN#3/TJX#4>5TE24XF!PL&Z(%)<]# M!@[VG.CCM`-\N"^MDT=O!72ROG[P6G@X8;5Q7FWBLI>3**.)Q4`]H'#MOS\; MW0TG/X*^(C'UQ_;RX0G#"1B4VHZPO0)X1:S+?8MN$P-WD6<2[ADG.CB`Q#S- MJ!&F_A<3@K"(NJ8ZSBOEV<1>06QNVGO"LKV@@[E&]P9HI)*GQ4FPL<2T@E&$ M`TR_[A8%QV`H"6A6FSV4W;G49-@`L'0YHSWXJ'0&;8)FA-N>80\1VWJR*9(6 M(;H;\T=IPHL*,)#!G05VBWJ0?M!G0P=BFO8BKA2FAN-Z08Y<\UJTO\D3.#*. M#2)]^_'N07*95QJGSK)&,NO<06L7L]6*.^K+;:I46>+5V0+0!+X%X:S)-FA8 M#?._KHCYMYH+YGJ%W7$'@VP2JOWNX&%(^%1,A*7*%K'VEN5E"'SA>VP M]L$_2$(LB602ZPG$AK*TL>RYX(7]6`/[&8I2H!2692(?01Q^,!V8YH>"0MFM\A'BLU[SMI[:%&F>Y5 MFQQFVDT*%'N`CAUYV'JDKEZCT"..4V*;T01ODK9A3FF^L,D?W8VW?8_MT2X/ MC\0\")+4#313RRCFJ=]9.6_K*5H3VS&>C*`E9@S.I"X`$AOD.:8*TMHM6!+6 M;V6YQK3K:KB=_\@Z2C,;X=HF506Z3Z)31CHQU==@]PN4B1?M)81*#>(4%IR' M1;!1NO?<7-!;;^$9-+OLM(J=;F!T8M`S;9\N)E)?D?_Z_6\2PY6=_8LZ+'VY M_/O5S5?FSX9F*FK>0RQJTMVP+'K(S<$CC',HKRQ+HX/*H3W&`S/C+^R@>*Q) M&/?10Z3!>X8%GH=IAK7(5\(6(D+!CL[^,7$HQ(L)R*7T!21`TFCV@!XO81,F M$5A9]4!8:`%XTPP5#(,GK'T?`$F%S%E*_J7OV`L"8OJ[%6DI*I`L*J6-RRA@ MRX8O;ARF3',?)CNH-Q$<9[.?'+KO]DCH1W9P[_%U!3$]%[&F6&*`JQ%]5P*; MXWP4Z9.45EWFJR)=EV%`Z`F\P,H0?:7^8L=+6*@5'2D&I9/K6T8Q6:B7"2_& M$'R7L?3^6?Q*=.9+5V&.[)8X]&0WK0*W^99;_%[N`I@GODO8._D@G\KRLNKX5GSI?== M?U\Z\K2L_S7X\C=6[L9RJ:4?%NP/]T\^='JI[6$.!&LWT,BC=P5:R/'ISQ'! M[\`"/("+MPW`HY,/[$BB:GU/G0:G_BC+TLQ!;[K4V%*G+^*N!01Q7A#IFD&+ M\:!MD9>;N-0-D$<2]!.DSUQ??;RY"V98F#"!9I0UX9%3QR` M9C,\P)5YM^'5\:"`3.Q:9OPVX!84+*XF,DX?"-@6LC(87KXLC*#;UP401MD< M&04@AF_[;7G4EI5BH%.3E6?5W>BM*%SMJO1Z91BG+'6+;C"G8"LX'@*4'0U[ M^;RP&01Y.EPI[G,RZO?+0T`IE]&S98LE$ZR7R?H9E/B!DBT.I8A[!B7K",9[ M:74TA7<&)?M]%H5-KJ\^PT*$$=9J4'9>I>J#*?W3FH]\[G#F97,:T?,Q%5*( M"C&-1P(Q;N#YEP84GL\`.USC1#:BDJV'&DZ+L'/K69?`+/*#:4,SY"$M,#CL MWHLJ/8);&`21R\2CP:[^T>ZSK*%XN!DI]U@\&D`^5^ENGO?*6LS20:O$9.(_ M`6FE8)\BN1>YMQKM*6)!Q*X[Z@^+YAJ"JS74=Z;I&I;3==E>1W@/E.Y'!ML8 MX+MH0*^P%00HC>^LVFI0=6@_3>^"OE`A\"KK51WX[RD$6?M#UC`]>2>&MNX( MNH'^2>\$5GWQ-@&MP%%*I6L5Q[FU[.H8;>8_ON9?"*?[9LL-Z^7%-4JSO;?^ M9?N-03;26'4=I4D_MMM.DTX6N[^U.DVB/CF$[+7/YUI/K21SQT[X!TF^>->? M(!O<94=P*CZVU4ON\/UE/ZH@:WNW57'3Y-8PJVTR)>&C[3@VW6G.5T(U7H<: MM?I9Y02R]L6;G2?-B>C6BC=I,Z+[)@2&GU3#^3O-&$]DP^HUU1[63$]:[=Q_HQ+N$BWVQPL4&;%MM<^%494L:]*-?+6KNG73VX/HY M$7;RBAZELNG>+ST+0?=;;-^%Q]V_G8F](9A4AON(&'+]G*I($42#M7%S>+=,._V-,'@=@OT%V)-;M][T4/G%]^>DA\_<8WHD) MEV^>WUQ?3V[O`6P-F$9=N.2]=//WR[M/US=_G$G/ADM/)"^?9KF.?##N@M.Y M:P_P$S`A0YA`JJP$S/+<+PR9E5J)Q_P'@__N`;,+-K8T^0ED]9R3T"% MAZOSR74T,#"!9\_#!_\((6*%[\+T47?PE_7<03Y;9VD%41>?*.\^&![JBG2^NV%$X]G_<[#0W$K$K!WW[# MGH^3\]\^W]W\_O4"V$?3IE-->R]!5'ASMV2G;9=_2%]E,%YC+C5[]QOA5*+LH MNRB[*+M'AQ[*+LKNT3+WD:.'LHNRB\R-S(W,W:!DV)3]KPHC)LS!@)KP$U*/ MB8M>-8JJ0OR$U$2E\6NFF167/8\QXY>BA]*'W(GLB>0N=GHL*G0=$195G)1XAC->>J.VL%Y==H M=;]GU:2ENUD;>\\Q-%J1A_XH?.ZNF9:U5O3^LUJ-%;%Q6+2F?S`VSM)B"NTF MVQ=^&9MI8%$(&^T_X/X.2A^BA]*'TG=4["D^>NB`"K>,*(0-X=)J*LH@US8X M\5/O89T[UA23];L4/O'73-LJ+GKUJ:]Z<]7]5A/J6C73QHK+K4>.'FX2H?0) MS)Y'CAY*'TJ?P.PI/GIBA<_H?Z(,-B]:VD^RY\USK\"YGIH/^=CSN6T!0K2E M6=!ED38K%#[O)V!)_S=/`-P5;4IJ6P3T!&3@-T^`8]F\:I`8H)2CE-=%@"X0 M0+=]UG;R&,6\&[8V%ED`4+Y1OK=-C(EFO%&*DO>V]8"&ONNP1?SSS(S!Z*+THO2B]344/ MI1>E%Z6WJ>BA]*+THO0V%3UD;V3OXTYQU7O`[MI0'PW3\`RL7/;FT,-R+4W) MMHN`'DH?2I_`ZX?2A^BA]*'T'0=['CEZ*'TH?R)Y"YVB$KD(VT33;MSQ7 M6JBOM.Z\I%JZ9'LSXDBJICD^T27S\*D=W(39'CVQ:H'NN4Q)JSL>"K^JS32[ M*).-]BKJK;30H/5#Z4/T4/I0^HZ#/<5'#_U1T5<591*9%IFV$@_U3/1G MU=)@>MN23,,BDCV5-(?HQL&JU(N;ZQ4?/;%T6+U9[5%KV,/2%`UD4D0/MY-0 M^AK)GD>.'DH?2I_`["D^>NA_BK:**(,-8=+])'K>/-,*G.BI]Q30!7GT)/O1 M-)Y4S[`M/.>#72&P">'Q)K1%0$]`!G[S!$`)1@EN-`._>0(/="K`V)PZ.'_2>P_\01L_>1HX?2 MB])[Q.Q]Y.BA]*+T'C%['SEZ*+THOR-[(W@U+<55[R7E(7V4P7ER>W]Q- M'JYNX%'?THE#2YAQKL%J9/Y('*FKM*2.K'2$3X`VT[:+BQX6>6E*?EX$]%#Z M4/H$7C^4/D0/I0^E[SC8\\C10^E#Z4/V1/8\EJP.'EQJM*$4%STL4M24_+(( MZ*'TH?0)O'XH?8@>2A]*WW&PYY&CA]*'TH?LB>QY+"F:FIL'NB[QW#/A4W'- MM)+BHH>9XJ9DBD5`#Z4/I4_@]4/I0_10^E#ZCH,]CQP]E#Z4/F1/9$^A\S-" M]P$\5]U92]+@WQ+YTS>>59-8GMN2'.)ZCJ%Y1&<_"I^[:Z9EK14]L1J;UIME M5N360.D)OXS--+`HA(WV'W!_!Z4/T4/I0^D[*O84'SUT0(5;1A1"Y-(WS:4" M)WKJ/9QS1S1B/*N/)G&%3_0UTY:*BYY`G:$V4E>]EH+-'`Z-'@JCB&$E;@JA M]"%Z*'TH?4?%GN*C)U:XC/XGRB!&2\BMHN=VZCW$<^N0*7$<0G&RM>^283T3 MUYL3RQ,^U7?('J*Q5GE(`-SX;&`V6P3T!&3@-T^`^O>GJBG=CU+>%/0$9/*W M0X#]MR;>KY@KK:Y\L-;#*.&'9_#&2OB./<ZL'V5%/X;*N(7NMA*)#533"FC/9H]/?OS>^/6%E.0:\U["C" M2THSO7M4!*@(MB#6UF%]E8JA+;S0H$Y`G8`Z81OB;=VG^:`I!%0,J!A0,8@1 M-0Q:,D8-*"DH*5Q)&;9Z\N@M2XH@Q=7K/>-W>/=!K/V%PZ.WO=\KY)V6/>*/ M)WT$1@^E%Z47I;>IZ*'THO2B]#85/91>E%Z4WJ:BA^R-['W<*:YZC]1=&^JC M81J>@27*WAQZ6)>E*=EV$=!#Z4/I$WC]4/H0/90^E+[C8,\C1P^E#Z4/V1/9 M4^@Z9!X^M8.;,-NC)U;1 MS[J+&(R'8^%7L9EF%F6PT5Y$O8+7H/5#Z4/T4/I0^HZ#/<5'#_U/T58191"9 M5/A5?)O)GGH/Z4ST9]728'K;DDS#(I(]E32'Z,;!:LV+F[L5'SVQ=%:]6>I1 MJ]_'TA(-9%)$#[>'4/H:R9Y'CAY*'TJ?P.PI/GKH?XJVBBB#R*3"K^+;3.S4 M>XKG@CQZDOUH&D^J9]@6GM/!/@[8.O!X$]@BH"<@`[]Y`J`$HP0WFH'?/`&: MNJ?<[;7ZPS?=3$D$]`1D:/$)@&T`49#?!J>C[ MV*C@\(T*Y%:_<[!#HR+L+8B`'BH"5`0'5@38^`]U`.J`MZT##ILC0$6`B@`5 M@1"*H-=O*?)`>$G!1G\H*8>7E([2?#+8S19;_\EYB#[5-]=7VO;.I\4+T]R>21DS37:B:83VQ%^GGA:KK MX6>&!4M]+O_2H[_>Q?]T5G]&"/S\SG?;3ZJZ.+O79D3W37(S_:0:SM]5TR<3 MUR6>.['T6'7T+T1U?8?H-]8=T7S'`1@^JJ[A/M`1'\B+]]&TM>\?_OW?_OW? M).GG:/#ED!>&JYDV'<%=/BQIMN7!ASLR_>7D5E:^P?]W9*7[8,OC;UV9_7TB M&?HO)Y]4S3/T;SUE_./F=Y@E6.%UQM8]X(B` M&7Y5K2<@,I<+5N(;E]]5.CQ2/Y$F8_-$7S(E(1O6B?2LFL:3]L;T%0@2T$?U/3N/.MDDWII45+0D)EOT.O0GPU(MS5!-Z*,Z9(SC!5G2(8K/:HNT>F5 M>C7^QLP@CNIHLU?IQ\S09M+",6P'+,"_8'PZN&$M?'C?L]DG^@X[NBUY1)M9 MQI\^/.;3<>&!>6`RXJ,;%GO1(00\A&=BNJ=52GS.ZDO7="I)B6!7`2;?4G6Z M!`#IG[Y-_S-7G>_$H_C22@.P6M3F/)/P>U>:V@[8(B">H0$M568B6=7)6)U) M0$WU&&'"I9)F:D"VX)%72A95@PG@U>#!D$AT521=]<@>"=*)$R3\,RBA"6A8 M$5U"@OPPO!D0)2(E0Y2^9S\"`,_,#E(*,5PI;23X$%'FM241@PVL&P[1//.5 M_FI8T:<]XMQ-,D$,^O![BD2XN#$,#&K]Z6([9&H"S/$U3HBC_<.BK_OS!;O0 M`.L.#EU$E>6WC'H1PZD.L)0!(\&4/VS?U*D`40:DE`:&:>+Z?)1*Q6`O`U.K1(!\F3^"JNC*+8E& M`.S!"Z*%WRKLVX[T@SA4*D!>3=/^X4I_A57U9K;OPN/NW\[$YK+\T+,>L2U@ MOJI($3C$URSL3]*&Q0N!>YR*4>+14SK?,B:/`XW0R"Q*7(1/!`=R,GZ/X9V8 M3V'L#6@&G4A4O>2S=_O[S[='WSQYGT;+@&2^LD\B>Y8(39G+4' M^/%:R!`T0Y(5K^VCP5H]IY(.L@DA]'Y#SHE##9P]XAP(6T"7\C]P*#!A9PWU MT,$3:04;LR&&O%@'+W9$6D'DQ3?-B_O<"D%>1%[,YL5]'_\6@Q./9_W.5<=Y MA7!@10*6QW\C*RI87VF("F_NENRT[?(/Z:L,QHO+\YN[R>Q1TX0^!#7X=&K\-Q)$VO^57F2I$&KWQB_"F4791=E%V7WZ-!#V479 M/5KF/G+T4'91=I&YD;F1N1N4#*NWS._AEUJL^D1O"#TL[=F48DHBH(?2A](G M\/JA]"%Z*'TH?.'DH?2A^R)[+GL:1H:FZQS2YEG0F?BFNFE107/>PF MVI1,L0CHH?2A]`F\?BA]B!Y*'TK?<;#GD:.'TH?2A^R)["ET?D;H[MGGJCMK M21K\6R)_^L:S:M+2;BW)(:[G&!JMR$-_%#YWUTS+*D1SOV/H8Z8H+5GN"[^, MS32P*(2-]A]P?P>E#]%#Z4/I.RKV%!\]=$"%6T84PH9P:34599!K&YSXJ?>P MSAW1B,&JEKO")_Z::5O%14^@1E,;J:M^JPEUK9II8\7EUB-'#S>)4/H$9L\C M1P^E#Z5/8/84'SVQPF?T/U$&FQ MB>O17H'"Y_T$+.G_Y@F`NZ)-26V+@)Z`#/SF"7`LFU<-$@.4V>3'1I!JE&-E<'`(TE=\[K:&\S_ZWPG&\P+FV>L]5[;NOHL!) M]!Q1[X*HZ[;/^J0?G@(55N/?T>3GT46@W;(J:_@3D"=L$^=<,#\`6H%U`JH%40)&;H8,J"D-$I2A+"?RJ@U M5,9O67($J[T&_P[L38FTV'!Z]+"&.ZZ*]H7^@E MMZGHH?2B]*+T-A4]E%Z47I3>IJ*'[(WL?=PIKGK/UUT;ZJ-A&IZ!=''I8 MK*4IV781T$/I0^D3>/U0^A`]E#Z4ON-@SR-'#Z4/I0_9$]E3Z!R-T#7()IIF M^Y;G2@OUE5:=EU1+EVQO1AQ)U33')[ID'CZU@YLPVZ,G5B70/56#JLWJSUJ#7M8FJ*!3(KH MX7822E\CV?/(T4/I0^D3F#W%1P_]3]%6$66P(4RZGT3/FV=:@1,]]9X"NB"/ MGF0_FL:3ZAFVA>=\L"D$MB`\WH2V".@)R,!OG@`HP2C!C6;@-T^`H]ES5EJC M(?8F0PEOGH0WM<,@"K8@M<(;R_EHV\J)0*?5&7??L@@(G&?#+H384@0;)8C7 M**'34KH'.X0JPMZ$".BA8D#%<.!>0]B%$'4`Z@!A=(`0SL%ABU9QJ@!)0?^#N]>B+4A<7CTL/\$]I\X8O8^ ME%ZCYB]CQP]E%Z4WB-F[R-'#Z47I1?9&]D;V;MA*:YJ+SD/Z:L,QHO+ M\YN[RQXY>BA]*'W(GLB>QY+5P8-+C3:4XJ*'18J: MDE\6`3V4/I0^@=2A]*WW&PYY&CA]*'TH?LB>PI M='Y&Z#Z`YZH[:TD:_%LB?_K&LVH2RW-;DD-QF086A;#1_@/N[Z#T(7HH?2A]1\6>XJ.'#JAPRXA"B%SZ MIKE4X$1/O8=S[HA&C&?UT22N\(F^9MI2<=$3J#/41NJJUU*PF<.AT4-A%#&L MQ$TAE#Y$#Z4/I>^HV%-\],0*E]'_1!G$:`FY5?3<3KV'>&X=,B6.0RA.MO9= M,JQGXGIS8GG"I_H.V4,TUBH/"8`;GPW,9HN`GH`,_.8)4/_^5#6E^U'*FX*> M@$S^Y@EP+%*NM+KRP3H/HX`+R]_B$V#'EN,'DVN48V1TD0C05([OM`:C@Z7< M1.!X@5-N]1ZG>K`]U10^V7I(48^WZCL\!;*:"<:4T1Z-?AY=!-IVV)I864Y! MKS7L*,)+2C.]>U0$J`BV(-;687V5BJ$MO-"@3D"=@#IAK\["(3,(J!=0+Z!> M$"-H&+1D#!I04E!2N)(R;/7DT5N6%$%*J]=[PN_P[H-8VPN'1R]+B..Z9V_H M'^BTWO;XXSD?@=%#Z47I1>EM*GHHO2B]*+U-10^E%Z47I;>IZ"%[(WL?=XJK MWA-UUX;Z:)B&9V"!LC>''E9E:4JV703T4/I0^@1>/Y0^1`^E#Z7O.-CSR-%# MZ4/I0_9$]A0Z1R-T\;&)IMF^Y;G20GVEY>4EU=(EVYL11U(US?&)+IF'3^W@ M)LSVZ(E5\K/N&@;CX5CX56RFF449;+074:_@-6C]4/H0/90^E+[C8$_QT4/_ M4[151!E$)A5^%=]FLJ?>0SH3_5FU-)C>MB33L(AD3R7-(;IQL$KSXN9NQ4=/ M+)U5;Y9ZU.KWL;1$`YD4T^I^BK2+*(#*I M\*OX-A,[]9[BN2"/GF0_FL:3ZAFVA>=TL(T#-@X\W@2V".@)R,!OG@`HP2C! MC6;@-T^`INXI=WNM_O!-]U(2`3T!&5I\`F`70!3DM\'I:+OR6'XPZKUEEAPLBH(>*`!7!@14!]OU#'8`ZX&WK@,/F M"%`1H")`12"$(NCU6XH\$%Y2L-$?2LKA):6C=-^RI,1SC.\\6FHJ/E"$NF82 MU3F#%9@E$4SCE\*$`;4V/8X;DKO[[2=579Q]4@WG[ZKIDPO#U4S;]1WB/I`7[Z-I:]\__/N__?N_2=+/ MT<.7?_J&]_J%>#-;O[*>B>O-B>6Y&6-(FFUY,,P=F?YR[)ARY3-2O$R^.2IL*Y M[7K;T4#I?.LJE`:=FF@P*J:!DB9"650B$JAS]^P.GG,,S2/ZN>K.)A;[#Z7F MLVK2U\]5QWD%'F5#%/%!"O8Q!W:0E#X#?F,@*H1^M8))Z#LR!WIYH/1V@SY: MLSNB$7@0)-G]2KQSWW'@E?)T[BC%D/9EQB4K'LF<;TN@.^& MEJ6L/D%,Y?`'$/5[0U&O1W@C%%\`^)Q+%"OU^LF MS6=LFHT@R"-+EV-%>OU.2CEG0%#&P"Q-?'GJ=#EV8S/[O`2@(JAS*+`@=Q1:H>N;J'H\7R!@;R'->!@V=D92X[O<%CT=DX6]3C.03I75*\8U<2H M/!>@-]R#.'*PW)U1.9[#8=';G5%YT?CVG+H6MJ]'[#L9JQXO'N?G1$I!5!MB MN7:.EVGF9T@.BUCM)I+CIC1HY>LA4)_G*=7$0=>&1=R;Z3DKT+J3/Q$3N"U'I MH_J-!:&@[SB&]?11=0UWJ_QUG[>'H(R&212V!*DVS'(ED./$='O]X5!HS.J. M1_H\7ZE!:U\3A;B[)C7Q4%7N<)^[PR*GTDN;VO9JO-L!=Q]&D0=[A+-N6SG@ MY7,Z2G>?ZU)W9F=0/K-S4$1WUA@#7HYG3:?N2^!J8F3NED^_,Q8'W]T9N7SF MYZ"([L[(&[M/F^%;S_>>K7V_(PL?%E]UR:UC/SGJ M_*M/V>5F>C]3'>).?!C7,?Y%]`?[(UD]K.?C(X]2^,0]#Y>-&D?IZNLGJAQ2 M..T$6SE$[\A<-2QPP;;&.(_[AC(?XV&G!+Z;@LA!7+_PJ0?-[_#M,'1?TGWO-E9<"G@5]5Z`HIS;P.LKLG$[\FLRLY$UWRB M&T,,M.A+=AE'-JP3Z5F%(-#ZY<2S%UG%:?ZXN;MH_W$W@<8UM/T:E.RM(B=:DI@7NU5W9J1^7* MDI3Q>"RIEBZ!%55:DC&0S3/=EQ)72P<^QDL-^A*V_2#U)$: M&D\07O8>L,5"M5XESX;'EOSB+^@7*OS+4TTZ:B9@D6KY*462GUH_N511_;1V M0RU@:*4%-H[^DU@+*3"(=#;#@__\L&`RJJ6!:RFD]H)8TEQUOA.O)?V8&=HL MACA(V'1J.'/`%DA.O;#3*D'.81_I84;`M_U!_V79$0).S&DR`M@!-->3+-JB M#X30FS$LJ7G9"Y17E")*IY58\#B4E:[N.'=E50^85E*?(>!Z(M+",32FF?ZS MRNFI`Y&<'%R-`(`]69L_)@_I2C8/8$]U!W,P?7/,IQ7400T_0`%0R M?:]J:X.D?;?``\V;FNO4E?)21[$+P:4E+VA6I8/#G7^R.1E0>A-$.I^/S(?PC0TIL.GMA.XDKYI@G9V`5;I M%-^MW@A*O@4)@&@VIC!#5XPO8H;G-5)S`@347-%WY(\FWM)%.4W:DKFA*N_2RRRT!W?=-C MPCR#\"Z2:#TETG]]!$T[-;R_K0MW)+'>S"&$I396P7(HN2[5MS#F/5EX+`4M M=>56@#<(#]64K[D*8DDJ4*M)9HLFWI]VX'QH:@!6%$?%]RA6/]],[XAF@O)B MXDWUTBZ!5Q\#+Y$#KX-$5?FI\IS%:#%YSA9G%E&-,U(F_-SY'L*B$2[QF<5DRV?6/'Q$Y@H2O\OQ1NAA5.>$\=3`4GJT*C@0%!?(G`@ MW<@'!4O%"@@RMW9J6."?&N![N!Y\P8ZB!"[1(P%'U%E*51#AP;O@?\SIGVRH ML%K,G[[JP/($;#+J*,/W+O647?BM3-I64$>AM/%GWL+/_]%N?[)MCVG=>^K& M@0,)[D"['3D3IF%]/YO"(^#RDFOX(+VPKQR;XCKSO,79NW<_?OPX?7ETS%/; M>7K7D>7N._KS._K@2?B\][J`YV%RYEZ>?&"#OUL;';[_^1T=RCBC_V90_%]0 M2P,$%`````@`+(9N0UUD7;E2"@``S)0``!0`'`!A;7,M,C`Q,S`Y,S!?8V%L M+GAM;%54"0`#8T6%4F-%A5)U>`L``00E#@``!#D!``#M75MOX[H1?B_0_Z#Z M/#O.Y9QV$VQZD,UE$<#9&$ZV*%`4"UJB;78ETB6I)&[1_]XA+3FV15&4[<24 M=Y_6ZW#(^>8;DL/AQ1]_?TGBX`ES01@];QT='+8"3$,6$3HZ;WU]O&E_:`6_ M__6/?_CXIW8[^(PIYDCB*!A,@RLDT2-'X7>1RP<@?O`A4!]^;7]A3^WCPZ.3 MX!^')V>'OYT=G_XS^&_O[G_!]<-CT`Z>GY\/(JA!ZAH.0I8$[;9J)R;T^P`) M'(!B5)RWQE).SCH=5?YEP.,#QD>=X\/#DTY>L#4K>?8BR%+IYY.\[%'G[W?= MAW",$]0F5$A$PU!EJ!,SF=X/.6(,DD5HKK[\8<#\];*!': MRH>G)X=*_),EQ1&0K4-5\[=\N:8O$6-N[H_[862[?@=8W:[^/)RD/ MQP`,:F5)PNB#9.%W%U5*13?7ZA9<.L&/Z`4+%TV6BF_>^B6C$:8"1_!!L)A$ MJ@M]0K'RPXZK+IWT![\:L+Q M&,J0)SRC>2LPC/6^!Q[0\R9FS]LA8Z&VN>XABL,TUA3!6/%]"0-^D1BJC'(4 MJI7-/%B/?M!JS,*EEF(U[C*^;*ZL(3VX#I$8Z!$V%>T10I..LF,'QU+DWVC+ MM@^/LH'VE^SK;Q="0,N7*>=@A+R!&`UPK)O]5E(N-Y"KL@5NX8MORN`7-%+_ M7/\[)4\H5D1C()JI]%+<"QB/,(;J! MX.89D]%8PN?Z#&['W?I82$Y"\'PSL@MYB3B?`K2_H3C%%H>L79/O=*\-S$SW ML0]T+_BGF#NH.\=NXDTAU@V-FW849M9^]8&U+XS",C/"KXH[3/SG&W#5.Q3*S;,T!UIV__C%&_ M=0D:D)A(@E7/U!N68Q:#J80RI9Q:?+5:=#?==$&OZJ6:J;`'7<>5EM7N8X+C M<2B3I^1Z:*JR.^Z9R%4!ORAS3$2N@O"8J.MD$K,IQGVLA^9:7!Y MOX#S,A62)9CGX56>M>GC)TR-6S-.4HT@Q`F)Q_'D+!<:ACRMV:.J!!O!GBL8 MCS=FNHR.'C%/KO#`(2ML+-THJHP(/-Z(N403(E'I,WB`FH]E)K6JJJ@0; MQ5H5&(^W7_38L.AU7Q@-W8;',BF_J*L5W%MQ^7R&Q.R`3EPZR#:840=T'L.1[0:R9P;D<;RRL*6[@-FI'U:+-IC(:G`>!SE%F+KVP6=BOUXLQPC:K+A#HY=S^$X,)MX]>MIF;17!>=QZN> M/I8(`O[H&G$*LX98VK$>DM"Z!G(1;A2S+H`\7A'=$^5SV(6*6:0ID5A'-0^'/R49?GL'R-K"U^LU)N9V?:AT16:+I8R`.'-AK8 M<#1]KK/'L\0KD!O`"0X-'2^%OO?JPI_PD'&\\++,:G`((^QR+;-X]`[+,8._ M/$$1W2\L!+^K%AYX4-'K5]WG72WBL7_.)P.G($Z]O MA$&UQUU5"EE3WF(@'K%,&LR?T8A5.1PFA1$@%]`EG-[QM>T:. M%32+/E=4[K=1=C'YS\:6:@X+)9M%5D']ZA7%[EBY@8F`C.CLF%XX?>2("J3O MS"F(LXG"OJ?@7(,'+'HP-3J;JPE].7]J(W_+K[)+KPK\]`F;=3S>GYI;(QOE M/L'49(^>2B4\\`'7)9)!>Y^[Z5+N8,/S66O4Y0&Q3MF3-:`UXMIOU=.K.]FK M*JCA<&S!*K6S'XU7;-X/$J>/.DNH?$;O/(P`IP MCZDL.XA4O@R`(%#_+V,O^E3X\?QQ7?V;`>;RA;#/YV M4^`/.N7M:Y0Z?UI_%[&I\1GM'N9$+>)#KJ[/7>'9OS9GK57-S@(,I1\L>Y\( MT/=I^A5(N:7S).<%#%1/^@*+/?IPKL2'#K@&O8:XPQFRQT%)0\]!U'39AAZ2 M<'F0S/%,7;GX7A#J!M7CB"F_$5H_F5HIN2<$5Z#T.$%^.;N@`)&;/=BO'5YL M5N]>^,6&-O#XILC#&-9YGY`.D1/EZU7#?9G`7O!_*?$=$;N??TB@C] M6!@H>3^\F%##S&^;EE4<;WW+M>HI]$4KXG9 MS.RI#[-W^>"5O:*K5I>%1R37&OCM%3;:+S8%7Y:<\<%#2JQR0]2%S0TSI\9* M//"$-\R<&B%[G+'IP]0US38K%M](M)!=+N(!M?7=N?@T0QF\ZASK[F(\D]8E MSR36I+:TEKUENQ3QVQR--(9P`"G$.-*';W.]YK#N:2_EX5BI-\Q_RJ/BEU*V M4&>C^=X"?H]SLR9D74+5S^U6OB_J(-MHYFO@]#B/:AJG7!EVD-T+AAUP5B=: M=S>%]S+E'UE^'4.GB[-GBFP]N$)P+\BM`NESLO5Z.%0/X@RO7V""H2/<1Q+? M4_,JQ,)SO6H\8'T;ZZQZH#V>HTNZP.PVU88+;6,E>^(`=2![/(&_CE\7(9B" MXW5^Y[!.)1[07]_ERT?]:L!OLSRO7)V]7H>\I0_I0)"((&[NQ>ZBC2;/':;' MB;'<\VX8A[AROC1T>W#81;C1%-&UL550)``-C18528T6%4G5X"P`!!"4. M```$.0$``.U=:W/;.I+]OE7['[R9SXXMR_(C=;-3\BOC6B=RV<[,3FUML6@* MLKE#D1J0=*S9VO^^#>HMH?$@0;'EN9]N;D)`??J`(/J@T?CMC^_#:.^-\31, MXJ^?6I\//^VQ.$CZ8?SR]=//IYO]LT][?_SW?_V7W_YM?W_O&XL9]S/6WWL> M[UWYF?_$_>!OZ:S]'C3_?+8G_G"\_R-YVS\Z;+7W_NNP_>6P\^7H_+_W_O?^ M^__M73\^[>WO_?KUZW,?>LB*'CX'R7!O?U_\3A3&?WOV4[8'AL7IUT^O63;Z MM@]F#WZ://GE/0U7GO[5GCW;.OC/[W>/P2L;^OMA MG&9^'"Q:B6YD[5KGY^<'Q;_"HVGX)2W:WR6!GQ6NTMJUASXA_F]_]MB^^*O] MUM%^N_7Y/>W/[8)G^MG\9Y8[Z!Q,_O$3N&MO[S>>1.R!#?8*6[]DXQ'[^BD- MAZ-(8"S^[I6SP==/_C`M"#D\;Q^*7_K#A9^&:6]PSUG*XJR`=<4R/XS2)_:> MY7[T:4_T_?/A=@6MG[X6?!V(?SPPZ.0`[*QFZ3WCCZ\^9]UADL=9:F^EIH/J M%CYF25#0V;],AB,6IR7=:=9/=7LOD[@/O8N?B=,D"OOBK;[P(_%J/+XREJ4F MUIKTXL+6X3")"\_<]<,21JI:5[?MQ@_Y MG_THAY^X"6-@*?2C6Y@0>2Y\,7LM3.PT[:FZS0]LE//@%5X)\,N"0GO7&G:T MC7?K'J:B.'ME61B8CEW++FM"\0@S/"L8[@UZ([$6@-FI_%2!=;<%Z\7TRMDK M/!.^L5M8\0R9$QC2?NO&TQL47[?7).K#2NSZ[WF8C:NCD?>Z#6[`RILH^>5F M8"WU5MWVJR0H9KANW+^.,W#(;3Q(^+`8N";6JMO/[?-Y,#-Q^L?E;N>+P3#. M#OKA\&#ZS($?19^TF)!EZ6Q5*=:CG0)KT5M5D^#/XEU(XOT^&_AYE#DT4-*W M0W.3H1_&]5@[[;JRL44_^T,V?&;TM_#&=_4KD/[.H^&T/?]@[/E[XJB'+G_SG!=TJJXL'O>/6BL4+?KM\U788 M8[->I\/-:F(?\&1HY+[I;R9:J_,4+$A&PE:Q=$PX?.Z_?H)_F`SB+T$29S"2 MKJ.B';P([$7\8?'O40*?WZ^?8/'/&F?M,6"QS\.D^QX:#;GEY[WCHQHY5$R# M"DX7-&GXW``BI_6H,8:F]OV,TQ$+PD'(^E<:=.6F4+W8H?0AM@H:W?W*7;TKL8.K]DYSJXNRJ_9S0JOV#O[QV;3Z]U7[ M[)O=.:2Z:C^W6[4+(!]ZU=ZI,T:NNFH7WK==^G70\/F#K-H[K5U8M9>CCNRJ M_2^PA'G-6+_[QKC_PG[D8H$TW8U)>WDF,EA$@HY0_@(%K5;]>)U:0^K2:SW\ MHV@/C]@Z'@%P%4:YV,-:QV'/--:3USG^&%PK`2K7]]MGNQMG85_8&[ZQ1Q;D M'!S.TNOW(,HA9+@!_XB]XWRBX/<&USZ/`4FZ&B0HQH"3_KT.S3@>'QGN8,O' MR^GVXD&CY*\=#`M/FUL,E0P+.V>$PD+A/J.P4%C]$<+"^\B/?_A#IHD&EQ_S M.G4&\E6"0$&*G+T-^XG%?C/[M.'#ZH/>29WQN'F4M^%>-0M+QA.+Z,KS0"MV M*TL(V3CM@:49#X,BWPR^W#_!J^G#X\_O*\L;"4_*=MY)K2*)V0I,\E+(R=)# M<19S;>3BP5]XMS$$^&+IM[QB$M:C)!BT\D[JS`-P18$I$&)AD!O-]Z1.L:*> MSST.1!EX[+J">%*KU%!1\SW!E]9*0'+&SCX*8[36#2ZITZTESAU]E^[A]_E? MF<^5WZ&UI[P3"N*+J4T;K,U4? M=[J/5JN$-"']:OU(XNOA*$K&C%V%G`70*E5^P/`&WDF=$JKAMPQY$S8_8AH< MB-N;$Q[\^$6GCLZ?\4YV3QI=-1YQ?V/[MH5U>I5G\91W2D,2776KPO5+9B/. M;TP_*.-\8A\*:Q:T'X#&M(+O_GLXS(=:/E:>\TX)2)SKXUS.PZ;="`.-Q?[? MP75&#"P_YYT24#@-&=BP&V&@1.CNAH&E8A*7_BC,_&B2C_+`4L;?6/\FX3=Y MEG-VFZ;YM/80QI)U7]XIS50>?-.Z'$1D;[2$I(#M(W#FI^R*3?Y[&[M@U5'/ MWBD%7`$<8;DQ@*FR_6LW.ZG(MI3#CF8KQXY-X?%V4>?OF\WRLPI-_@ MP2R]C>\9#Y.^8@YP^T/>*)(JM]#<_YIW6JM@ M1GY4+9R`#*WF4MXJXOPS2T6>;=R_?A\QL;'_E(B_6DJNG23?UCC>3$WP3@EH M3%L=A%:>049F8ZK53&&[8#$0E:4`0^X/Q=`R[L,[K5/UJF-LV$%#R&U,$RL] MLB=+0;'R8_TZ%T>RW_'.:M7E*$T@*'QD(#68'R0*=!9V7N4<9K2)K1/[BW^< MSH77[XP'8"B/"^Q:/.QA4C]W!PP[MX^:BBI*G'<[J ME)!L3SNT%258-LW^",<=W&1$GM6I$579Y3O3UR+;`$+L)(3;_+JS6@69BAF1 MPOL(6TI`Q,Y,N&:,U@ZB2^K(GJY8%&E_@I_2S(F;#WMG=2I4]4R("`IBQ]97 MK;P$;"\)#_]11"+:;4A]8U@!T"CNA[!A0AV.B]AIC"UP26OJK(%4W0S:6'+& M/?3%.)^>S=+2*7L<\!'87S9]N>0LXKB('>-8VB?5DK7Q+"`BL$M,9A!C0&^L- MKM@H24,9`25[\LX([.M(?+Y*3A5P],YIS(YXRQ%ULTN?\S%`*BZ$4B7EVO7D MG1/8G=%2706E.;\FS;US`OLKQJ0:(Z)V0J0;!$5-X0<6 M,!B!SQ'[P;))563EUU#1S#LGD#-LS)P6";5#)3^2&##UV<+@5,\7WL@[)U#. MT9@M#0YJ9U`@HASY89&$$Z<,YOI>]LKX!*V>-(/6WCF!J-N8/5-`U`ZO7$UU M@2?_?6*LT1RI:.6=$XCIC&G3`:%VTL7T_5H;>`32G\V_6ANF4SOL066TQ^AHC`UCQL?+1NM2 MR?%&WCD!Z<28##F7&G343J2@:(OO;YFWL&CHG1.06"HR:8#0W9D0J4HV#19% M&J_(;\MX7I2#N(W!M!?.TA1[UZU#`@I)2:9L85([9X'"UDVAZH8`EH!` M4M?;MP21VNF$;A#DP[RH%P+#DK,@G%;?'D6L\'[<[PX3GDTWLU"(:G7%R4^` M`PE(,17'B%MG4#L.H7).R>4Q`-TE24)ESL8& M\;YI%^```N&CWFWNU6@3"2A>4&D)%V'66+Y.G63)D?!;MSG3W!_;& M8NF&ND$KL)Q`G%B%)&.0"#V-)<1,UDQ!P'/+-T_=$,`2B.I@-+F&=+D(J.Y-X!/@EE2ADE/X`X",D])LLM`19AO\-+=##S$^M<^C\/X)5W)(QF$ M@7))JV\,H`F(/^7X-46'4-I<[=`-M%:K'P!%0/(I1QF&!J&H,9'G>Q@G'*R[ MC3/&6:IZQ]8?!4`$Y)QR],BQ(.0T=V'O!C:8S">GS.]%!ATX.LMX^)QG8F/[ M*1%1D3APET1@RHL!I6Y^`)Q'0/]Q]9Z6]P`R?,BF^51([P'`'T4N,D**4'N^ MS:*Z\Y7[HDC+E5@81.D3])6#73M95;?Y"^LMJ^JVVG6&]?9E==$[1V5V_UY7 M=U95L]6N,[BO4D>R($I#Z2:4#UU:M]6F43I2X7^$,#6D#UU=%Q#2JA'IECVR M!7;-+ZQ6*BK&MUZWVG4J*S7-I+;XB-7JK7K)>JM=J[1B?G.Q)0UZ,IS54'U7FL7]G;U!QX]'G4.T-JOL,3"1@/J%#?Q51^/V$RN46[4T M?*M-M3:\XDN$X2!6';?^BN*UBHA5JL,7=)B0AP.C5D=W"VS2^E350:ON$U6F M,B^-BN,$Q%W3-TM.(`**6@U>-Y7\":3Z56,+QT6NDJZ;&O%M`I39B;;S=@\K,OA__P4];FG6VFL=$\BP-*/$&I:[DKA2@A:Y9@M;$#9D MCX*-)/(D35V/8Z!6SO9GS)D?A?]@_6_@`I$"UHO-IBU-2X!+(C/29@(S@J2N M9+N-?=Z[I6,+N[^]VVHN^Z'T]FZMU^W8;N\6#C3;WL5OU/FGW-X]KE.>JR0% M'>/W.>)0/O;V+A'M1^%_ZPU"7/7Y*-N[U"0>M^R1W=Y=7B'<^(%(7AM_]]_# M83[L#D6EHUZ>I9D?BQS&Y8OCE>E^Y;H$/]$,9!6?S6I8B6T#R\!\5Y9M422-,2T-*, ML!4D&D$B=B\K;K/A/&S6`6"G&7V7HG,3&;%-Z3O#J@HK]08Z)`X3EITU)_8K M-Z"WH87<^"$OCA_W!C=A[,=!*#2WV2!*I_+(+NHB[4Z#I0E*ZB*=.@-JZ[3W MCN)(SZ;='T$7F;\-%^/Y'_\4,@XN?!W?L3<6:802LP[`8623:#IH*&>#C9B4 M,K?W._/3G!=XTTT0VDC=JA_P1*U[_,:2BPUQ&NK-<1/391H;`;3TFP:&`EF1 M9V[T;3S*L[1`W]+FARA:`5H"4DV)=U7#-(:4F%`CL_>H%)]',Y0G!(296OE< M04I,JY'9VR[%9WN.DH!&4RN?*TB)23>5,\]/R)XFQ1?-&`YB`DSMN0TXK@^V$D!"CIW M-:H04-1."JQ>/*8@:>V&LM8)`8;L!%P9`G?G`*0IS`\P@'@89*Q_Z:>OXMI: M^(\H`/3F1V()?.ES/@[C%ZP&K'4?@(I`.4*9IUO`P;FPGI8 M5,'4WS\A?1Z@$:A'J.?,`(2[$P&DCM6<$#B2;C^0)J,/ M;PA@"8C^+J@TP8F0VICTL83;[+,*,`@H4T[>O'50"#<-RQWS7:2K,!4I6#EG MQ@J(HBU`WE%11`L*X7%;.LG@3WT!(`M52:RG\6\)%\_\;D)#'\T\4199MA MH&OJM[BE=>C1"AM;^]0\@,;Y3QX%0+W8"EW M[`/4:CMK;+54^DSR&:E:;<*!\J$ML_LCG$E^?/4Y6[P1]SQYX?Y05[`-;02. M(5NU[0ROVJ;!0^R\L=QDLYAT` M')HI1Q*2RB!KO%;<90(/QV`I_"%-HK`O[L6[\",_#MCC*V-BYT"D!;^R+`QV M5*`YWSV!YIQ2T;C"@68"S?D'*1KGJ)C^.=F2<.=X)(A#H:;(N*W+?DZCLIO" M_PAA:DC4-!C7I!%37YRR1[;.6C>*DE]BC7"3\*LD?\X&>31+-5CD>AJQMFN;*:!QI`>B(AM`D&B-;4+:!1ZES-!9TS5&FO4$/5G;3%)<=#+B.#G?N]K*C0TH[XH4# MC0*NPN[?`Z[9.NOHD.H^>$&43V3\+0R*ZD0J#N4M`"6!Q';+CYX*"KEP*7<*IIW#M28!#H$B`-5=2%.[J M2CM:/LR^E;=QD`S9'0P*RLZ&8D&<^)J`^_H M:.?T#A42=W6H7=$TFR!N`/5E$L.LDJ@,9I`7`(Z#9E&$?@4*M M,O!!5/%\P"-@':C=KP964MP MW!6]KH>IJS#*,V6F,=("X!$0Z:1.+J93(<IH'*3F:P MMIM+]"F;P=JN,^"USF`5#D2T?XG=OV>PSA/7:BT+72F#M8W>!:J`\K$S6-NU MAK55,UB%_Q'"U)`^=@9KN[T3&:PEV2.;P5HR@&T3#6#Q#YP$`+D:4D+(ZXW&='SYKG;\D2NS^4SC@9]N)= M3F*AOIOJC;)VX)XZ/T^5=,=C=&O?`!(Q_7'-4*V,)7T>D-7ZR;'7'7'_(]M< M."QBVJ,SPHAJCLZ8(ZL[+M4#0LO(H\\",@)"EN)U01=X,AS$9,ANOQ].;+GW MP_YM?.F/PLR/M"PIVP%2`LJ0-6,&F(CICMT@R(=Y)-;EF)"E9]*T#_``A8P. M:U;M\!%3YQ[$W5PQZ\^24K1TRAL`-@*'1$X,2- M-2F;$(CI2W(I3$N-JAG@)'"6Q9HJ/21JA^>+]=**IN1X$\+-#X#SB.X]J,08 M=\C)'?6W*+8JJ4C:(;HOH"!3#H+:07W571S8[23&;0$R4=E?\Q+J05$[VU_W M/4!''0(AOCLFEU%1*P10V#TIH;TQ^&:G$\26SU`<@=05[;+O#)Q"0!LH074) ME-0J!2`X)J/5%?>JWL`M!"0$)^3K8;HK0""]`6QQE/PV?LR?T[`?^GQ\,89E MV^7FLDTV/Y?H!9`1T!',""P-C]J9_'_.[,(VA>Q"NZFB`0=1JTJP7@WCB@6< MP?PH"F%)B`H:HHX'%EW^:!*B*8>CJ)[RC$P*:CMT(L%^BF!!7I9W^L7\*?H`KZYC+"YA``AX`.#Y5801FSE./13 MXN[MK>/GP*\$]M;=CIKZ_$0L7VWYSA/X<\2F*E>)2V"PYH";P'9]?8S*1Y"Y M9X@EQEVQ`>.<]>TKRVI:`EH"V__;'P<&3B&6D'/`Y>12QFTWKA&-FU/"6PX;7L\J'Q!+\&09*#^\!Y+'S3[,28-/>.S@B<)?IB.2ZK9MV"=,B3(`< M0F'Q]4IG-N*W8);J!]`14#"K\5L!.,$[E)#YZMX?B\E*"")!P'/6OPO]YS`J M/GRE)GQ5A^`<`@IEW9\`O0>H)4J::[9.-J3`"02$2+="M2UZ:OF'B/V3/&!' M>Y.*SL`I!#1))WN36I3DL@?]\310Z@9_ST/.`!$,VVQ\'_FQN)9-''H<#=4Y MSN:=@!,(Z(=ER4,V-RW1N[N@2;KL@U\/&.L7M^A),_GE,[EI4Z]-H4*R&P;M M,%.[S&DV[FX2OCA15]QD,BNA8_#*XHW!800TOGI>51UJ:E=!H7:#&W@6PH(3 MHLY)*%*:>*0K<`@!26]+PT#I`VJW3IG[Q,EJS3LZ)R#AN1T(MNC5%UF1&0(W M8>S'@:.%NZ(S<`H!(<_)PEV+$J&^L:Q"F+BFLUAO<)?$+T^,#Z_8LXI@K`D` M)*#7E25&3K,:*T)F8Q*=S-JI''4G]*7>.;1>?#]?=\SB14VT7;E/0$U7>K,DW9$SD"'0Y/WD&Y#$9TV< M*(35J#+S3]L6(!/0V=R^](:@$9X;D]UD`1HYN-99F MM]`&9X?0E^]_,))490T!+%UMINR;;(`8H;X/H=%AOQ"WN`8+07"TBPVA#_$2N.-S\20ULQ"&RZ\=IM`F^_ M7=AMCP\ANC&Y36ZK??J]13=>^Y"`Y&9'M#T^A.@2HIHT#),;!.-P4L7U4BB^ M@S`0XW$PS>M!@J\2/0'"G5'(*D%$2&RN:E\^&DW*9?C1K!;+;3Q(^'!R>$,O MAQKV`/`)*"F6-4ALH"',-IC.-BG*)*Z;4":I+1X#(`2$#RNORXG;!(6PTU@V MV?R$'4NU!*T\"7`(B!-..)+@0FAJ[KK1*391[PS^N-CPBON2E?=5F(H20SEG M)K=L5^P:'$9`O;!?]%3'C`R2$B*5="%49"?-#BW-=="_A-GKLDH^MQ=9!%GV M`L@('!!TP\_F5!+DP5.CA<5941IQ/<>7KU:4L^/R2O('U MX60B@C^LSS_P5][LUY=^]$Y1IT[7Q&M7S9VN8#A6I4[U.!A]=KM69<6^=IWI,/VF3S_\#>Q%ED/TX M^^$/L<^9[%'`W6#05O:CAB.II7*<'1>7`(;[T2TLY][_@XV59*P]"Q@:C)RJ ML2&%4DN9.%,Z)H7GLQL(!OSHK\SGUW'_"MY_A!'L<4#28`!4EA0UFEK*I]F] M)C=AQ/@E6/22()N-8*! M>`3`[N!$M8F@GG)8ID[O@C%]8=!-Y&.OQ0#3X%&1JKP@<.HI MTU2.&['6-F=F_C0`:3#/Q`TO:V#4U9&DVR2_'8B?>/935CCB_P%02P,$%``` M``@`+(9N0VA0'(B>.0``NNH"`!0`'`!A;7,M,C`Q,S`Y,S!?;&%B+GAM;%54 M"0`#8T6%4F-%A5)U>`L``00E#@``!#D!``#=?6UOY#B2YO<#[C_P>@Z+:B!= MK[N#K9Z97;AL5[5QKDJ?[9ZY06.Q8$I,)[>54@ZE=#GG4I0H4IE) MTO.I7#8CQ""?"`;)8,0?__UYG:`GPG*:I7_ZX=WKMS\@DD993-/'/_WPR\/G MLW_]`?W[O_WW__;'_W%VAKZ0E#!BWO*)'G/SUOR+XX9_/ MOF5/9^_?OON`?GW[X:>W__+3^X__@?[O[=?_AZ[N']`9^O[]^^N8OWW[X4W5\`?9 M\J?GG.ZU_OZA:OONS?_Y>G,?K<@:G]$T+W`:-53`IH_NW<>/']^(O_*F.?TI M%_0W680+,52C_4*#+>!_9U6S,_C5V;OW9Q_>O7[.XQ_X&"#T1Y8EY(XLD>C` M3\5N0_[T0T[7FP0Z+GZW8F39WXN$L3=`_R8ECS!9\(6/\(5WOX MD.0'!"U_N;L>%.CC'J^2Z`WOI:M^WA)&L_@JG=;A+K7[GM\7F!4']+U-[[+W M#UF!DTG];E.Z[/$W,FV<&SJGX\N-)IDVOBW*8_>X4'MK/:C*:";P_QO>A[W> MD>>"I#&)J_X!M<:N"N;"'@L3"6RS:(]A`L8Y8[WR"EY+G"\$PVU^]HCQY@TL M4&](4N35;\22=?;V76F-?U?^^C\O:1XE6;YE9+Z\R-8;DN9B';@C";5E$K$98 MSMU^A_'B:!WFRRYG"]X%2<]^N?_AWQJ&*%NB-DM4\D2"Z0P)MF>"+ZH8HU\K MUO_Q1]GWSH"S[&=VW!%O M0R1`C?G4[O4#-PJ?>*]^.X;*#'$.5V<&QT*C-',3I?G441K@C03S`;4Y>$SX MGF"1U, M;D"Y3-8V"Q[.,6HC7Q>F0'LFB=$>9%OT`:U*!XNZ/EA4EUIIC=RN8DZ$K4-O ME"R*9M$SV9<-$+CW'8=ZKO@]O"%J.3\AF7W]\"O>B<'8^X*.T09EB,(S>+1> MV`,TK$^EJ2J[@7K@UN#UTPG`_+3K],H6Y,' M_&QUVJ&E\G`8KI-!/0&'UH@W#_7TPV!.U)-NPPGQBBP36Z\G"P%;.CLW`*Z@ MC)K)Q!C@R[OI@@C->)N0^;+VM,_SG!3Y>1K?4+R@"2THR;\2#-V-Y^D=B;:, MT?3Q$\YI_H`7B9GW<=SON/=0CCQ.RMI>\H?K\V8W-T/R(PBG,6I]!E7?0>*" MO?P2$I_BB@(?0T&IRTE@IO@)I\.8.X6'1=ND@RS[\ MDN8;$M$E)?%EML8TU3J[@S0>'-?A_@_!9H9:K=&OLGT(*!J;"]4C-)H(#X;G MAJ;DFO]H9'5:C?V9G':/-L%W)B2- M=@\,ISEWFKA3]84#]Q-9\K\_X&?=]:PI!_<7M<:R*3>^A32Z86N'5*5J]TI,`U!#V^R/#],#SL<`M+#KFQ6$`7BEZ"'00O9 M^_;[!$+"W^'X<%D*&U7"%@V//&0CTZN&YD9&HX/NC,P59BE-'_-;PL33'X,# MO&$2YV9$T_LNVJJFB+>5;\!&#\U1? M5<;`U-4-,R2Y4X:_<$U=<9MWSB<./Y)OV_6"L/E2]"V?;PM((A*7I_611D,L M^3A7&ULYNRBLZ%')`$D.<#HM>:`6DYFX%8IF2"2(\*MI/@3WKY:38-W5U0,P M[5V!+VFRY;]5^FJOPL.<0E%BC:P'HKGD'*0&>Y(Z`"T>P[:A'IL!VYTFGZ<% MC:%/](GHZ2;4SBSWQTX`7[MKKL4SR)=;9-=4[LD?@[U_ICC4M7 M*]I\4<,859P1L$8MWI"!0O6I9TA^P:^1\#9(R^X@9?:#Y-*F'%7+NI;F!"KF MSO[<\HG_AM=DY%YVOYES:]#I91>O\&<$?P_F&K9O6+NX&1Y3]],_>M/:;>@- M`H-WJBT0!'./VC^\0T#P>V-Z1_*"T0B<(W@&\$M*B_SN_I>O!!PG#3)&Z)P# M94R.+FZ:]D@0($&!7G&:_$?TJZ3S?')V-)GR[:A,+O7#"'-==;$`G(GVX'4N M5.+MQP]OA4+P7T`$.4EA06_GCP(]'50'(RIGRF`F0\][`$FQGUA,6%;_H+&8 MEPHRUI,R&3"WC&;LKP0S+4"45DX!H?9164.A!8(F@IB-&W&_`!SU,WO M:^P5:(/N?@=0P;C\P\.M@\Y4U[]W+?J6I5?K39+M"+FDC$2<*MR,(U/@?M-C,]]IYWSN MN_WLSG[Y]P`LOW9DNPC0#*M##-#4#`/[[=QCH--/!0/R[R%AH&]D%0P,#ZO+ MU,[K=9:*P[0+O*$%3N3U^!W)"7LB\>>,?=X66T:N\WQ;EI<:PLD$7AY2/=O+ MJ^9!!A[R='6&2C958$7%"'%.2+)"%2_?J9\/%[U=6&#OG/"<,5C4Q/.DQ:ZO M``$Z_XY9/%-#4"&*K;H.D5MDQ"^13C=X!S!/I2C!A_A?Z0IDL7B3C12<19M MUU5"!:=#=1['%#[*@9+6)C&2.,KE&+`*.4N.G*5$#BTYOO9^&7,L.].YL#FN MD7'XZKBN*M,&?@OWGW9*X1D!^;DH))!_X0V+_#J5<->X6J1-8 MH?)3,R0_UM@A[L"00N2HR=B24$!>'D3<_S_'M:?%JSUZ/"+\?V_9GD\%HEC:^>-R02=:;A5ZTG*O+0Y(0&T;P++\Y*6HSN M*4VG[(9(=UAUA+N-XM>S_>=8LCLOVZ8>/.C',;1]@UY8#_I+LL"VMN389GF: M(7&8#**,M?A$4K*D(FUMO\@:8VO!PWVZ"`OYE/P1541-12P49T@?@]CU'B*N M/*V5@D5M0T.>X>>!PUFGR29LP:IDGYB&U!?@.LE30'E*?,I#L_[OO!PG:&"< M3N#I[!_<7Y_XX/[4?HS5N+F[\'@1KHA.-X_F;XPKIN/24;(KEUO(=2^[([LH M_EAZ1U?/A$642Z(S51.8^2DF92OQ*;=7U7?R8"S/\4;H.'NA9H1"LC&3-:>W M@-4!:N,A/W$K@?]MEHO;8*/ZAB;D_G(8ZZ4:SFH\;]=]J"B#JOI@,W&#N8^- M9\UE`:RJM/T#_]1(Y']?8P_%KGIZK$;J5(T0M`KF5<#P<*O%K/1C[3).-"^^ MDF*5Q4V?="@9:.\AWK._WVI,9UX@V1"U6OJ.V#3K?//7$_6W(.P4O87@6<9V M4%5+%)+RKYI:F*LQGJ,8GQS'>8'SU7D:PS]0C?,))\!<)A;BXW5!6$&7E',C M\^4EVI2)>6-]G1N=^_`MEQCKZ3)(%_8[*&W\22 M"_\]+59H@=/?<@3!L?7&@:9Y08NMV.F]1M<%PDF>03YI^8FL6!&&?J-IG,,( MXBB"#&PY*E9\6%?XB?"?"'HD*6&<6<0WC]POY\/,F4:"HML/OI<6M$!VE190 M*7J-=]7?$6ZB?)=;^"AOBM,=*NB:B.D5W2/+)8D@3TDBJ4&XF.'O/33PIVQ; MH(U(UY%FO%\$1F!#^#>*W6MI_EIXF2%2VS\*-5=0E.`\EV6'^,"N,?N-%**: M95YGL)NAJ&4J2V%FU3"B?)6QXHR/RWJ&5O1QQ;N=4/Y).+ZL5T(Y+GSWC19\ MU!$C.*:\(5^)GX`W?+#(T&]I]CU%>"VG`4*@>?]G8FCXP*20CH0/+66\GP5T M;ET[8L`FX9H]S2\`^5?8&\B)QEP==Q@M996JP$&!.2Y^AO M6YS0Y0[Q"21,]KE9$%ZC>8<5GW>"TUSYQ`[&"+!%)+:@0C?,)/RJZ9_G8/`# MG)5V\/?!GHJ/A&G]G3XO*L]6.+::C9(U)X])U4QEU:0D&_329F4A$,]I58\J M+)@R_WN:B5@=3KTV`:@.#RH:*Y'79L)<'SMV[?@10-6Q(K>^>5[_WIH@E^M6`X)DV? M\G&MTQ$YUSFM!#W)O43CEL;E86F;E3AS<>30*%H`SSS&`=55"U,T.4Q?SL@& M4Q%FG.:$^Z-BG,_SG!0&VF%$[3[1N9%,:N96085*,F&,)>@D92!;J\.$*V-R M94BR/,63QX4%PH*%?ZVR0*22!MX6CN[T[)(L">]`_("?97^,?#XME7.]TLO0 MA5S5&@J/UBI4OD\&_[N,P*K`BAZ)/!LCKZI$Q[!QN MF@Q7)-]KSY@A[JPEIP5[`;Q']SPC/18=#&Z5,%H/@K#\MRS;$%;L(&%^`2^Z M_K:E&[ANX$IE$*=H1N[!QS*22O5#)-E,E$0HY)/"BE0N#Z'4VCU00B$:J6@" M*+EK@T/5L;(%H3+FI+1U.T*8D]AOE-%JR^ M8Y9A6'"Y5`9Z%5`OISIS@`@GRF*TP4S$5,&]4QF+MD.;+>-?)ZUP,M+*Y+$@ MB)%BRU+^7TZ%-YN$BK_`X[><Q,LA*K"ZO;^$F4YC%-6LN._*-/*_';.89A`%2U*1 MQB`A57E?Q&R5*JA!$((S-N58[E)<"0>(?/_0GY-ZCW1J)T1;(>3 M3;&``;@W8QN`,<)PW)LAJS#BW@BR`(Z73B)7P`Z/=G]@@SJG`2G;]5:4TN+: MSDA$Q3+&?^9&$!Y6IO'Y.N.+RM]EY<81NCAXFNQFLN,5;KM$MIOZ-P[$5JB>Z MY@3:%,"J_8U,/0H/:<664M@??8>\6O?+!.?UF]X#;_]*:`(RFW-NOS>?!C=% MW8:>[CXU=R.R03`W/./]O;^_>KCW^1K<<$B[3\`#N&[JAVW_#:WO*Z16F-`W M+MUHD,%`>^<*-]3O_MC).@:G;NI7_>QZ'TK@@18K77@;`,7U0C*Z@'A;.#36 MS;M?--A#&1T3"CCWI[C?V/J"WPW%B_)J%_*G0BHQ>(;+5T'PLHJ=@8=CSL(Y MA"VDZT*H15IO"J`@>R!>TB&279]_NKZY?KB^ND?GWR[1_<_G=U<_SV\NK^[N M_^EW'S[^`5W][U^N'_[JT\,ZSL0%Z(#9ZEO76DQ3-O?/Z&[Q#AY2F#^@ZQ)X M>SJG]'SP?5G9,I`G"/;]W\B6_I5"#YJA5VPZQ+C/N7]'Q,E?2S_'L6]`ZRW' MODZ>H=SZ9R41VK?!(6C'(6+M)]`'9V!1IISWKSK&\!O*GF^(O>G)WK9YD:T) MJVZLJU<,=^2)I+WI"HRHW"9Q&Y5!?7LB*5`=_E(_O"F)_(7R'"!-E1GJ3?VF MAIU4&J,\7=;B/*Q(_7)B`Q(4I!.KL]U`F5O>YWS)/;&,B;Q0PBNK8EC$%]L1/37S]EM:B)"" ME^E,)-B3:9H@(@=R4Y7)F4C#.A/)I&0<3E6.1FY=NI,%/<Q)16FW<# MUVWX(,3;2(0#0?8N:`>A2U+TJM$*YR+,9D?*&!W>^^PQA7KGOM,VF9F=O11- M-C;']3%H%+&MI7*AK)LR% MN@8GM7PQ)_6O%1HD*20)7Y^2*AC\)_,E@RQ@C=YP8;DT2- MRI:!Q(("M4@"63+L!5*5)&OHJK#K4NH$V`:PF)@!4$D/9H$^+SG48>CL85@7O.34 M:[FX1DOD.*G/['I#TFA3[.UML\1KDE#T_1#):!IE:P()]4+8%P6CBZTLW?.0H5LLO*]0HB_MY(,JO65C&5]) M!$D`T8CV\8?A11Q>9.MUEHI^C1;`4)IZJ-FI]%8MUPE-D&@SD][(#,GBS[Y+ M=IKV/8PY*L%X2A#V]G38)]:/K[3M-+$I4M MWXF6[W_TKS%#:%/K9^J@YC`>MZ[1=HMI?)V6N[]6]S3Z8D+L/D[71"+5\:]+ MU0$59%8JZ6:HK6^>0W@/%`W2;)_1.IN.?VTQ1Y\2Y&L)/2]Y.<0))>_2AJ_O M),WI$[D6CO%-ED-RYOF2>Y8Z];+EY#/+AJ&LNOP0\M1]CP>23-`K8/-CG8F< M\PHBCN&X\I>9_??D+W=2KQ*0/P"%G09N32H,>V2[K'188)J2^`HS*+&;[V7P M6-)(>_YH0NRAGJ&!1&I5/TF$*BKT:C\'CB#\,0B-/$Q`4E+Y5S1SZ*FU"NUP MY_/YDC,0!E&0;6^/&$MP3H-,T@Q^=U68A9HPIJ4_?)SM7>3CFF@[-3>(^0)0G< MI%3-]_NLW?&Z>C;?3.7;14YCBMG.OR(,@4K)>*Y%E,\5X3HM*U[? MRHOT-H(>LGW\&*C.L3X0P,HS<60,U'2&:MZH9*XL8`.:&^2*=J21DJM@/G`Z M?R*1-WRQS>+[`K/"F^"?9$;G4V7=EB)>I:-I*3T)Z-=S.<0`CGL[AUN_<%+/ MZ&)_1DF#2S73%Q/4FV(F`),[019I3)..1';&-:0\+(.1-E;(F_QJ_BMYXMI[ M__Y?WGX55V`]NM#?S.F[^)Y>JO6$H`F"-NA7V6K@[M[5R^"AH6T_!=:/Z_1< M"%E>?"7%*HNOTR=N>>%I>UZ9X5O"9R8M\.-@3@13:K>Y$8QE4N^*^09+DJ(6 M;>U[HH;:8[*$R>(U[5N"P(:R?=\HK.0MJ^*J3GD':91+X0!IRTG;[,D*A3[J M%,3%#JWE=-.&N^\\`78JN9<1 M__;=;I`,<%_C=`LY/[9,),X0N3<@S0[\W3/0=?AIHWHO`S[+BIZ[K_B9KK?KJ&<"QU`"OW;@ MZGE#F:Q7@PORSE+E%>H@M%N5J1>^\Q[X-J0(:,/35T/9^E332#;?^CB`1Q/5 MTX+1Y3NX17$M2C/"HE_M"^]XE^"EGLYY':7T\`IN3!;UJ=BB0`W)K#G5`2HD MR'R_?W,GD]O7<$:X4Q_#68`N!"TR]%!-&02D4R,^UP@,`W(T#Q)QAOY"Z.,* M(E#/^??@0'%/T)`US<1KG`),/SZBH3/HV>OKW7W:U3_^3+D18=%J=T.>^*@]4YT+9LK`.>*-)>O""EI7CTEK M`O0KM/9X(3MMPKJ0FS);'L#XE>!\RX@X`U3[>9FM,54N)OK&R(R//V@:RCF, MT#9`9?.0(&HSC8-(M9]##X"]3C?;(A<*]&XP#L6(RA\8>V70&4=),$."!+T+ M(&K%8EX&\38V*7[1]7X2NMX'A:[W$]#U/G!TO;='5^^D^$77ATGH^A`4NCY, M0->'P-'UP1Y=O9,R.:;FCF^X&8T*$E_@?'6>BG\@CO,))[`P5RGAAO+*3.#A M-`K'5C[UW6Q%CX`2<0[RAQ8/H[QYI]Y:'T-8:#Y#$8A'&JH98LT@1**)$X%- MHI4.E5C40:J$P6M9%!!.&V`,('BI,QB(%F1=53_"C+2'!N?PB@A*%,4,?\<) ME"/:YOB1O$95-T6^^C7>04,!#P##`5%V6B.>/]9:),T@:S@D;;!#9(NJJ7-^(04V9@?8>\D'T]UNU]'6[,DVEDY(`QDD?)D@16CY7+834 M)`^C^/%6TY>KZ.2:9/:L?-KE,UTK2>XF.Q7YFL)S!2=]AFF0UGR95ME?T M*C`5,X-A<2GGLPH'DR M[,V#RW/2NF>ZI'F49'#_9)!8W(#6O8]F((_BG`B:&6I=,S9TP606/XYD`:06 M-X:UDA[]U#R8>_+;H@SKT;D\NZ#$.>762 M/JR@1GTB#C2Y>!O>1S&#'4G[SGISM`3IGX2=E&?#90<#78Z9,/$N3Y92=C%8)G$4TW!,J!I?E7L(%'WZI(T.1O" M4CU[N';5<"I675;KZ4F:8J>0YBP\5/GN".2-.7F21O4I,$Z>).$$M77#PD[3/%7]_#7G/P>7CRT5+W\GE=/$_O M"%1SINGC)YS3W"R\93)'?T]%K&7OHGI&J03$C:>2":!Q_1'`+E M4+:ED[>CP6U#>V#YF:9\^:`X$9[[(AD_W"N?DEF6/#*]',E_HB-Q72=))H%0^@L:H:8W*YL$DN1B?#Z7`B^%D M^,;4:.X*/5D@N!K,3#&,K&"R4YC,BQFZIN:>Z`VRZO^$MJ:)GL1I*-5([\UA MXOT9MNER![@Q)GI`[37)%#5NH^/FI#7C/Z0:=#TK6-RA%AA8&@^)T<3B& MUO06GSN.ROBV'W<$ECR^#3Z5(;'_0"`69<+(F&M1S?SE&QFWX_2R[IFC=+%+>3OLHNFUN97F+?%J1?HC'4Q_OYBV3/)6IH,%T'M`,17 M4%9DW?'H]^Z!9K'R'9,'"[ M=;:1S-(H5(L?Y^#['=(_@I@FKY`.DA,$D`^)N+V0Y@%>(]52QU)J>%@D:X=[ M?DQDKY5[QR8357*R$2FKG=_#6RS.FL_DBA0TPHDFBM.0SJG),)%CH-([$D1H MCVHT6-,5G(SGIXTBR\EQ&,N8)-EWZ-KGC%UFVT6QW"95`%;S"L@@$Y`='_=Q MBY9R*M%`%3WB#%#%`=5A>PV/4/+_'$W@)1=;[1G6((6']S1#?1]XX"6:5IO&&9+-?3^6L90A MES*4CA+5B.#V08P61NK[%P,,>52"5DE&&TW8(_.O#OM2F.G$:"E.;XIA),V^ M=F0AU14U`=FHG@PBS)VR7*=1MB;W52I<@\=@@Q3.562X[UT\R9:H;AK$?L%P M"KHH,AI_AV?;."'<`7HBZ9;<$_9$(Y'&5'>@/43A_A1[L._*\0VT1&53;E_+ MQF7^W`#B,7DU@1';E^[SY=E?PSLZ$![+^_8 M^_K=^VA]OJR4()CWL3;]%R^12KP'\`Y6"YF^5^8C>'&8398R$A7S#6$B6_]7 M+-+GBU.L[6:30+I;&&X-_(TYN,\O:RR;\MI$4**:%+5H446,!+7G8JV316Q+ M)*H=E.W]*Y,E))6TLU/PZ#)]\X;WCXI[&WCTNLY80?_>>XVSEX%70^4A<;-. M!O7I5M-ZAOC_$B+*+A5OL`%&L<>FH. M9T/+J4:!M%3.%4@O@_+*4R0(J-RV9E&ZT_G[KC1DBBBQ M7%ZS6I)H>"5UJ2`&T.HJB#&N/.U?3/F@W/O\(B4))SGXQ=9[0W\H7A-4PH[^((^D:MGJ'JG,[FF#-P?H)I* MIIRG2L(9*DFE5[]'C$KJ()3B4$&E6[\O'Y%$_K7(#I_*,>P$<+J\WX)"D'DQ MKF1*2P_W6=V^JO=8LD50NF'1[6`@/P`+]:Y-@PF'>]=JBR#O_F[XBJ;;L_:U M=K]7[>VSLK&K]W+E%>TK:/AC`$Z[;?^I:.8?V1JL*)O0,:"X-]-5^3S9(P-K MW27P9K25G@\:P:9`I&P;E!&W$T/FH`P%^GH0#=EV'8)S-/]$EADCLMT#?B;Y5YIFC!:[EB#[7`8RQ&NURF$O/,4+N1KC@1@D MN<`A0"]JNH":/J"%Z`325&PH68D>SK@OR%WMC,4TQ6R'KJ%NN[@3$=70,[G] MJ/H?P,(:QBPD8A;*H98&#!7PK1#,F'-3T!]CYL$.N#:XO.NE;_^)[U_UIXB# M%)X,65_?!^#.FU9;1O2J;'WTY\BV#H>E#%P[J_TC>K70RN!>6P=QU*]9(R!R MIP7R8'1D0]ENY!SK>SWL0N,;*;H;1_[?9!N+E[5PZ9REZ+PH&%UL"Y$YO<@" M7AI'9:7MUFIH:4;[6CH#H6QC5)WL&I$AA71G-_BP-:M[6\$>LGWU MJK1+8UXF\')NA:;(.VJL/%LFN_0AQQB!&Y+G/Z&6><"=`4BS]*P]`K3D%8!7 M/AGQ7>4]$.Z>=-Q4?WWKYB2]DX_N`W``3$396UD5#3I?$T8CG,HG@#'Z.II MV0ZR[$C`S)!H>V)=-W&AK64H%6+#1:D2<8DDQ&=H`:3MI`NBD?AK`#MD+F-JTXL[EPDOR]?)\Z56WAO1+XJH/?"4Z27`1O1WACL;52">$YLC-6> MU"1V0'7^<$OIW^>,$?J8RHQ;T>Z!X33'4?GB3/POD>_/XO_:RKO&2J+R8F#_ M[$6B5!=6Y[8?OAZ7.1OGH>=J&BM3=@55?4&MSHAXI%9W4-,?:9ZRTCP-70NY M.`2R>QSG;2JJ<8ZJ<2Y:XXIKYJHXOM>IO(0/[^T?&_'GBQG`,O M'7V832_['9'>:Y4E,0>Q#'FQV^7HZ'WN;;1R#>]HH,Q'B[**:@MT0S,^>9IM MC.G,>8"E[`YH89:"X1ZK"ZFG\P?#`3F4DR`)LJ9=.&4A369D$&/CT^'P;'2_ M+Z-5(0?:NS\7'>CW&(8"JO^H'7KE9'!\W+VD9AVL"ZEIZS,)ZV`ER(M6YM4` MJC^.#K4F*ZG?>H_G<4S!L[N%G(9\"Q886C9['A(1. MVSE5D#IM0MVA]HX4?-TF<771-PK1(0+G>!SLN5IK3#9$]45N.`#3#W\7329C M[S#&7QR-C`)FOYG[./_]7O;4E1).>#"(Z!M5)4Y[<$@=1G'VQI2.HD%/YC[& M4R^%$D;8'T@=$'Q,ID4)&32>$X='3!85-D(HJV%2?:*G>L8,?2*/-!6%>Z_)!5\>X+S(JQ*Q`36L0[K7\ZMTO!+I4?OM]/C.M-1',/4]=!4* MAXJ-6M`&57AX8NW-V6DJ;AZO.N^07,/%>0/0%%/CXBLXVB5Q[U/XJF M3QJ:854/S,F=K@*&>F^._\F%LIL,,]?I_7:1TYABMONTXWOH"W4/W1<,,8F+ MTR+:]C*JJ54J#N@Z10T/]&D'C]'11<\ABJ<7I$<7&%2NX@%E>18[V^?G!XL< M9]$6^M*[C!Q19G%I$W/5>^(&2&0>HTT")AB(F"P*E).(ZV@!8R%R^Z4HPOE* M_"Q^('_;TB><")IB11"ICNFYW?Z^HM$*<75,H$(#_+6@_)M/L,##W_G.A.Q0 MQF2LI(SS$U^6A$"PP3O9'WBJ!66EX9=;V-LP^.^"?TY4':JXO?9;Z7VB@6G7 M?3_(NKASB;J9O2Y)Q`@WVY#4ZQ+R/$,4)LSG4`*#GV5,G,9/.MXGG#M/1QP= MPU-L*(8DOR%U>>\KFC0BJ/R2WX..$X[7!5BIN#L:`><4.;9F==VOTZB5E[!J MF-O/2?8]MXNF[B'S&43=)X4V=EI`6E"$&C(].#&:2.F167&:X@;ZRF,/.1+,=>XKXL+0*9%1O8+[P"3GRQ^;%5 M:JSA%LSSSZ,,0",AKIL'\`!T.IQ[LM,7:E(\#";W:UD]F&F3-`O\7?X_ ML5\7FX,L3$MU2JU5HY!/K;)^R@#7)7&GU0,>)O=:&%@CU?0*P0'<)!Q!QL!K M`X_A45-/."C]"3B:"E7^]?PHFJ&\W#R>6C@.&+>*H0DF3,8XW&,PRB4` M/_0?*3[-+A8EJ#BS+YBFL/."<[7Y[G.=%6:!NA([<+[G+G;HEA,5(EG,1JYO5\]569X*%NDXCA(8UYZ]U:H)`#E\/DO9BQ?]'1"!2ZZ!4X%.8 ME(3B!4U".32UAVY/];%)N/6IGN=1E&W3(K\C$:%/D.W-2C'[R`-0R5ZI#)6Q MHD4-L=_%;J)XS1\#6.%L@#>N5F.H\ZE0MXQL,(VK,Z3RZ*@J@SSJ@4YE&(#2 M&4INHH9\Q2BYU2>C35UOR2F(LEU'&X1*VG+WE[?J?X?BI!X&]7&EML?Y`<\7 MNA^_V.9%MB;LD@A/.J]Z<4>>2-K[C')?,/XQ:+UPG?^XWH"`F#(M%^\&KMOP08BW42NZ8R=>3E2O,62C%#F=#U37&LLO4 MIKLRKOL\^MN6,E)=_HK[8^X'U#?(&M6U8>(A+:J%A&K2U%W]7*`DKZ_'9_*. M?2:\QM9%>P!GEL>06>R#V^G1-NU0`5(Q\*^V]A!6L\Q.P^_DPTG./R(DSN$9 M<6\.@WYGUIS4Z1&DH33J>;@D0T"'!A*I#/IR+HX9)PKV\E*D3!14G#""(T/3 M99)]E^XXG,[A->PF6SE2E(&(97HKD;9$1%=Z/DBSTFFEC1T M-1V!M+'2&N'9^_'59YKB-#K2\96662C'5WJ)+8^O:F8OZ/C*;@`:"5_"\94! MG`V/KXRQ[+*H4Y7T<+Z\R=+'!\+6EV2A4]1A$@^%G09[WY.IOEH_^8()C<\@ M/@)!\R".G"QDN>5;OXAN<-)DK.2^:E++!+DT_:O3&+34DE4FN/*K&F6(^@U< M^LX7"7T4AP*Z>U,K+D$HT+",&IV:ESH%#.H'&H(%:O$(3\/,A>U7NJ@4-0$& M`=R:3@"MB1X:(?8HI[G5%^NUUAYP=:P\SG^GR*\_&`:.2.AE MXW?-4U1Q!=7=>\1XI;^9<'UN?(P!$4-0+XUH68\#UV";6QGG9\G'$+[WD#FI M1V1_,$:OJP(Z9IYL*H;.GP^T$P[/SGHZ?4-3PBWV!2.Q-CN0`:W[TS$#><:- MG'0^!)U(7"LH_6Z7IPAV'C_)NG/@T_.VXCA:(XO3$RY3X"E'6G:H\^OEFZJ2 M`6T0'OT8XH;\^!.KTN'>^ZB-:&^/`U,E8^"9^.=!J%(3!5)E?1<)3U:CM1?& M"#V&/`U(H@MS&JA]X'GS:RV24M,AX"H&9L@;CEH:AUV(ERI'N4P)^A+%Z/)D M+UJ_[_(DW&A]T+XYZHI3Z7133LVSK734LHN6"4Y.%H5`P0V-?1)8*S;N<[[: M2=E;NZI?/8?3N0:PMAXHMEA=I7923;U!_\HZ!<1*OM;)"';Y2%WN*VXQC37* MN-_,PX/RO5ZJ46MEQ3OX>Q#KFV&'_>.\;_[5!]A#D^\TF8+,?$[R4:AV6OI( M?]#IZT")5M%$@-8W6@T[7$"3$$#;"X:>Q`'#2'"8`7N[V22B$AY.JDIXURGW M5MPHV)P>OB!>/56+A^F;X+[18M8-FZF.,@7`5:RY.`U3L950SQ=0< MX$*IYH&`22=@K.;C+P#EN`)GRR9^0J;GV@L;:X[T/$:='"[QGZM*ZYOZ??=& MY%#?BQ^I0TS$P>W^.&!(),3$(8JX;!#6J3[N;-=M]QR%,E'GVW$G!RF\.T]A MSAYQ6E;"NN`#GR4TQF65K%N.Q0I5\V7959S457;SRWI1>2#/Q:=$_XKK^)]R M[GN<8+24NJ^M3\S0WD>$HK4_`Y:V_A!JOH2:3Z%?X6-(?,VS3Q/:X&7'&#R7 M;M.I=+7K7YU641W>YV"60O++6\+$Q:^)D=+0N+^IT?1?N9XHV\)1+A*M`]+\ MDPOB]$YE#%7*!8H9I"9O4"Y+[P\"5]."%CNSG;XYJ=.MB*$T2C1+28;.(<)= M$%IM[%UYEC:3U78G[6?*UL[F)'K]F#V]B0F5)I;_T+6L_%=U3UH=>!@HF:%O M[@Q6([T>A-(>?D1KC^`Q&?H*,.;C[O!(LO(0+A*-A^_DQUD10:&O?' MCIK^*S>MT`3\2UG@[E=H%L#*-3H%RD&;V?B?RM)(0W=''B%2$:?%-[P>LC+] M39U:F('>*OZ-7)N:=@@:^K4KNH%NVY3Q43XM%"X(Y+A/KM.8//\OLM-B06GK M`0QJ?P?04#9$HB7B34/`P\!HJX#0#O6I$'$A"S=\YMM-G/R58':5QI?<7`V` M8KBY4UQH>JV6WY"5*61;!(VY8QLC:.X7'F-#WT:(V;B?UFQ\I@EA%_RCCQG3 M&XU.2P\FH]O7`8,AFJ&J70C6HG>055NA&>%3@>"!8:B!O>L6S/LF8@3^P;-!GOQ"E+/M\65?D;O:.@)?3A->@E M&7(A6ID:9_+@+$ MQOE%>QS[SBS403S5S)[SS\7PR<\)'C(3G39.Y[;;/R4*H?H[@@9^9[=W+-O3 MJQG(4VNNC(#6;Q$&VGK1Y6Y_!Y6ZC-P/8V.@'>T^1=<,]:D1(7_Z MSB%'VGM!1E^_!]%1[AU+D(CF82!D[,K,:!`@B2\>S%E+D;N MQ@8FPN$3QM85RV6VQE0)Y&P_%>MI[/XY8E^/QZ["9,,`+L.&QUMY4SL"<:A9#CQ`"P%JH96'[5GM+R&BVT81)*?M5^"2WSJ]9, M7D1^57.1F_RJM);P!>17U:#6,+_J*&3=9FF$7"VP3/,?FYZE<4\6V.8@PR!= MT>&LO61S/'`T>C,\`L\9*KFV]!G>O_>6GFR_=P\D_=$)QN8^6I%XFY"]Y"-T M;W3"S+Q\+*WI2Q5Y/)69_GJY9CQ?WI$([MKHDCM*)J^7C4C=OEXVDZ8G%W^E M@O,EZA*&\WC98J[V'B];3]1)X*3+_V!!&PR@=&D4QA!U^MP0)E>=4Z6#DF>< M->72-8GM1-UTUN%2W7"*)-:YO"[E>Q;,\((F$#=?7I0NZTPP>9W*Q/-%J!64 M3=7->U*6IMP[1'F7+X'*9#-?R7I!F,;-,R'VD'O50*+AJO=Y0$$QYI.C)CZU MFQF7M?3(DC!&8A'`,PJQ_N8>*N;U]EHMDE&UL550)``-C18528T6%4G5X"P`!!"4.```$ M.0$``.U=:W/C.';]GJK\!Z?WL[LMR\^IF6S)KUY7W);*=N]F*Y5BT10D,T.1 M6I!R6YO*?\\%J0CTE^/+_S[XW\&W_SNX M?7XY.#SX\>/'YR'4D*0U?/:BR<'A(?N=P`]_?W5C<@`-"^/?/KTER?27+U_8 M]Q^O-/@($;Q_[(][1[ M5K',SCWHQ7T-].RC65'U%E^YL1_W1P-*8J@X-<0-25P_B%_(1S)S`YW6:E12 MO:4#0I_?7$IZDV@&)C!OI:("&R-J.(01F@W581P%_I`M&J[<@,V\SV^$Z`TA M.K7L:D8R-ZI>/3N:KUC M+!C`4!0F;R2!^4?3=PVKW!&*9QCA2HF`(&]/;?\Q@&U,=#;_6?7`#K;P+HA]V'"M7 MVT[63"5723M8%Y58">5:,:`Z,C`3L/EPUB=97=5*<;?OC!(/(V M?B-@4D-$%9CA+QQ9];W7F$DLR;*:P'TE05JYHUO4Z79.UX;1;>G"&*GR$1/O M\SAZ_S(D_A?6>O:'%,;A46>A>_P)_FK5FEPCTO4]I_&RSZ'!9QL-SG/9HYN- M=ZFWK![^6"!R4[E9?/%EFDXOA]Z;'ZQ\8$2C21G#+AH3Z>*:Q=#":,K^EDUM M$87AZ+=/G4\'@')$**R5'C(S"5&D$%);5J-UY,:O::VS^'#LNM.,6Q(D\?)O MMDE>_+6S&I"NV<831E:V].A]^#&':649IWM\62?=:LHV*=8$Q.?YN%$\YY'= M1!/7#R4$%S]VNMVC.IG59(I/KP@.G]=N#;Q6&);9QNP>;,+KL*HBT"?.F]1? M]?#P:3U!3&LV+SV1L<^FHS!Y=">BF9;W*?C^*4(:MV@I4BG&PJ?P%#V%UV`! MR@2'(?GX#S*7><'A%X#C'%$Y5URXTL`?=%$$H50^/Q= M(.;OA;HL_.%Y/GF-`@%S&]\`T&X3.>.`X+-UB9BMQ4RP5K!3/2?NSQ(6Z,'P MR>=#24$PR4D3>=5%)E`2CA"SO33'"U2KV'JP3\!"C1Q-BQ@$7-4A^^ARU0,$ M0X;B+G!%G7#C&T"*4",W_E7H`T*O`V5IG[/-\ M$ASJ&TG>HF&N73`<5PSBL85`:YKDEW#J/:S2,+!@6I/`:7S_4%WTJ:'+K)JT-KK. M="4KYFP=R]2,1J<32:]D>$L8%9> M-K`7QR2)>^'PP7=?_<;JUQ M*-J4"E:`UDW1W%ZNSO!00P_OT[$;^O],6[.^^,E\*QSF6YH;F=9W0C6&`BOU M.V7F6\OWS437"?D?.O7.NO:M+]K@%4"WZI+ALT="E_J1[@7#_/?."9+->X$B M!9<%$&VX3[@$]3V,I\2#)209*J\5"LLX)RC.X\2,B29C&1X\MPLM=-P'R2U# M\\`M99RI\P*1 M,F]Z+5&DJT2ZJV.J013[BG`>D^+.1;?V-9_AIOL"UPBN,J[6!OQ"G%ND4:L_ M.QOP"UQCZ9HBDPWXA7!<_"-OP"]P"UYM$S[K("!&W8@&]"6V266X3"?"-LZZ#-+*^PT\41`R!@4(=N,2P\Z4S+ M\S]8-C6]A*)DG/_NN"FY+CP+9@!Q1*K&L$" M6'C2G]:GAW=1QN!I+*&W(.!)A6HY8X:TMW*^=SI'*'JLB"A1#Q5"L90V%85` MF07VJP69S0^="Q07',P8Y4"PE1.U&I7<6V;LY:9>.&3_8==PW]V`.6"FK1RK0S+RPU0[^SKSA]EK MT_5TYB<8IJCOL=197)OTDFN7TCD8);W4(^GMAC4YERC"3I3N4@6>K1RO&$;] M7)^(5YU"WSMTBCN7*,)5M%U"&Y.M)+$8_*#G>6DLYA/Q"/@^K',?2;)XH$&V M%I`45=BL95!%@/?CQ%[065(UF!C-=OB0LXE"CE-FVL%$EOI93$P M/:!DZOK#VP^65)/`#)=F_LLLI:9%Y+`"1H9?7*S:/"+^Y$! MU1K=):6<2Q0;>6W255`$9%L(_JAK)Z\Q>6^Z/(HS3?W9NM!X`87&,EL2)6Y0 M\Y`=36$1.A\$;O:0+.Q'IDS<`*?5$&ATBCN7*(XZ#09M34P"+VBD)/?-!?.% MA,[S@+_2*)8)K^)"SB4*J4Z;2KXG*/`)@E7VK./M>!Q(5RQE1H"TH'.)0M*K MZ`<:&`6^8"$G8?7,89FLP!+IL&#-A,[2RY[W(<`:`Q^QJ)OK%W8Z1RBTN)(\ MFP(5D-U(54YH,M7@+R\(AD(AQ>VJY^=`"KS!6)NK?S'8\[S99)8^@P'=@1+/ M7^2>F@9DD0NH-XEHL@@X$!I'KN)9^0DP/0K)KZ)_V36'P!/U5PQ"CVEHL#]'HS2+&E!@D)`;2,U MP0RA4A\"X,V2"O+-%O!E+.O5WQ5SZ39AT"FF9M?0A72K`-.A$`K,8GK,T`D< MPU@L1-&1%P>7`W?.3K+T3VTW"X!A4.@"9D3*SW)Y"`74-U(AO)U,@VA.R.*= MO)SIU%Z@+.MT.B@$!!L.H0E6<`D*113@+$ZB":%+361YHO5$WDG(#=+1*`6H M42@"52C6ABD@=\]RH,V5N>?1F6&OEQ<$0Z'8P=OH\CI(!2[12-'P(0K'+X1. MV*-S:C_@?`TF0;$5MT&^$)Z`\48&[5V[4Y_M2PA[+.PU\,-6X-1JA M"J4@KTXC0PMS62>4=_RV/@5CH-`,570)%@!<-`)J&RD-]H9#/P,R90G)<)DR=R,N;N1[TFV$NC`8 M#(7,6,X[=/$)'**1XF+14D9K1C`("G&Q'.$B/`*"&R@G?O/#B`*N^S`AP(RL M=V]_"J9`(1R6HY:/1D!L(_7!HEU@`LNRX@Q8)#.0E"34?YTEZ9/-$=L!LROR M40!-&6LXA)T?`,.C4!IMC1#E;2!POA8&+E8(6`13M4>6U,(J<(O*=YSW]4)! MBNO539\HF+#\"TC>4;_Q8R^(V"/V_5&^98MP,98!,$Z?BTC;/G#GN@^H5ZO8 M.3VO;\8H]Z[!*8H>:<'LHC&^@+8-+QZPRRR/[D25,CW_F7.*XA2`0PB?N4+; MV_"LP1*4\BV#S0^=,Q2B?8$2.7.YMK?AL8)UZL%T5OP>^DG\]/Q=F0=;6LXY M0Z'-,]A!1#:L[L$4_CO)SS`,N9!"C5+.&0IU74F@+I0V/$9@ MYSV@,R1:N.9\*0;1AH<'[+X'=(9$R!8Q)F!8BJ?>!PBX`^X`&DO_3EPJ'6"W MOG+.<(C.4F,7QU8>BC:\([#8@0U^</0\5Y*/<:W7E#]9M-!+:RVM=*92Y<=Q'` MFQ[FQ4]`"7TGP[N(WLV2&27W<3S+WF$2,FU M*;O#=T.R_]Z'-GS"4LW..0[)2<=#;$*VE8$?1<0B3:S.TZ7F"JC;Z*XD3,F0I=#^FA(4`O$3LK_JS)$[(/2:?5VYR&WE[\-W MF,"9Q>J_<;%N2]P+@O2"=?ZOU#B]S<`\"OY%W:,WS\>F1-/IP M^S/`@^*@1&3IXB$='T$;[F*L5Y4O\%.*<;?X,1@"U_F"XQ!PR?L4\*$X&M`G3HRB%9=!OH>4N('_ M3S+\"EMWE@ZX'^H-L8J28"-H[4GW(/1U2_TDJ>]MHG>], M)R<=MP"0@J,ZC>R>B).'J^4>.AI9-1G)N'DX(NJP'CY\EH MX1P1AX(GX+ZXD]V; M1+,P'\F=#XF34%ZV2C`J5ND@I9OO'-706CHKQ1!NRC/$[`*;*E['\("=\;,M%1@G@`K>U-1-ETH2H*EL$H; M$A?0`F7I6!LZD-JOOKC7WQ"P:IO\P?R3@*%\*57`1@, MEU:2HY%/N`FN-DAC*Y#?B,MZ13IL%I$KY3*C>L!\*'06$[(5[J(/NPTZVPKA M?3B=)7%JJHXRF$I2"DR#0F`IP:?",418VZ#0\4`>EW*#XZ5I<#SLLE,WV,#: MAN""[I=R@NS(-"BUEIVZP@?7G-0B89G&\'*._5A1A^'D-0B,R&8=:*J)0 MAW`QKC9<@[`2*(]#!=6EC4^Z&%D;[D-4O.V"0P:M1K``UL]K$"Q6$MFYIG). M%F%HQ36(7AP3K=PRFQ_"E(:BFXJXX3/)PV#KQD-"J-VX^/4SD-=N_-8+T_^P MAZ_?W8!M&JY=2N=^.$XW`8*`>:,ZP!XHDC+P6-KDLR0T')<@;.5F\`A`A:$K M?B3)]8Q2_K4)Z?=@%A3!PFK&-6#8NCR!@5U+E]-P//2FSZX$AJT;$M:'Z0R= MSF#,^1*PH3C,TAMRA0!L/:"!H>L]^.XK"UOS29K#E2WAWZ(``,5L"C.K,P646;H;+V74:7?6EHI>QX+<(T'[IS-/X`]S?\'?TUG`&)M%?5D M;%H5F!+%4989]8(U>"GL;7I&XR$*QRP4\D$S2(SSN=/!\52=#8<0X[/U8D7] M8P<+@TRW*.F[,0_L09G^:^"/4[Y4$<+B@F`F%)*W#3?006KKI8CZ'2)G,;V% M!!@`A?!MI<=OP[+U4D+]O&9+9$YHH+;")BD+QFJLZ*:$A>-)A%)*W`I;215N M51XL@4B!4U)F+LIM(6W3^P,Y98IC.#UECE,0#(5(HC-T"1.(NWM5H(;72OJ!`)R"_D3=-<_NF MCU&BL_:6%P3>FI=I]`*%,JEC6'Y7XN%I0R:&]`'7=0\:T&A,W8DJ[:BP$!@& MA;S(HTM`K`)+&[(L\#&J':HQM6&_`:5T\E>H!!9#,9B`88V9"E(EQX%EWV<,9?MC[)WU'NS MY(W='"3#E^@JY]_*Y^?+UNMT+E$H*R+B16Y2&7*+4HKRK?%$V/CIA^-=>9CI M#X#=4>@O-ERM'/86Y3'=,LLPGZ`SLX6^/W$*@[U0*#"5?$6("T7N4OX*4XE@ MX$JCU_0K`%-@C4_D4%P&6^.3FUY'\'$(2.$/<13X0_;2\I4;N*%'GM\(88=> MS,1O)/$]4X6-ZW_YRC?JEFAF6N6`D>:E+KVL54DQL*N>8G;9DMREEM[HN<0A MGW!(4M!9A-$*BM`E0ML$F#+A.E<,;(16BS`@O(!H9VI4K=O3 ME97B_J@_)701359#\,=]""TEJ_9H1'T(2@!=C0OW.#Y"$>XAM:C6KC4%\G/7 MNMPZ'!]AC.Y(23+9M:8P?NY:M_=XQT>X-(DB9Z:[UA31SUTKLQXN04*_XVYA M:,.N]=D-".RYWDDX(\^$OOM>FJ%0QBB_!)@$EQBQ19:`6AF85NTYXZ0_6@#5 M6/]QOW>..UC%!@G%$B@MVFW>^)1XR6*;$8Z_P8P#.YCTQ&0VG08L+QG809JR M2:\&L!P*T4%"*]\/C/"U*#[BAD";/3_C)QSV)A%-%@GA9=X@+@460J%"F'N` M"A.*:`@[K*?)"3,+K5Q^82H)ZY)28"$401+&K"LQ[2PXHN9I7G=Z!RN@R-YD MS"P'A:V7*I*()?.KD\JO-(KC`8U&TB2;N:_``"B$+F,:"QAL/5"!H4<^DP#J M''\E(0P]`9MUAA,_])E5$O^=W'Y,F6XLVVYI50"&0Z&&&9-O`L_6DQ<8_&+Y MI+S:`;:^!%.@4,:,F>;B:-/3%JO512;U/\"H)EMJ%;\&D^!2QK3VUT(@MAZV MJ'\NOHLH\<=A%I#@S5^H&\;@[>S@$-!>D1'\^XO[(6%;LP8P7`-%-"-PE1_$ MN,R\(B1C=LB*8A!?)H//>H#&6+Y9P#D^;J"N)L/2IH6@$4HE#X3-UQSP:R]D)( M[=/;RB2+I=D5+,;EVTY!"3`,"F6PC.<(P+3I`8]LCZU8EZX_`@.@4/S,V-QN MO[7'.&KOIH\D60]/O22A_NLL86?7+]%C!/\0)M#0(%V(9^.9A&7CNL"8*$3" M;7KY3E`27N5W.A"M33=,H.L)8`84&J)9E^=`L/8R1^V]_M:E['9W/"`TC9[5 M.+P7%0'3H!`)S=B5H\'Q_,9NJ&99$ST#GM/OP2PH]$$Y;7I4YP#9>G*C_J=V MMD'>^,$LD5[_$)0`PZ"0"VTPO0')UI,:VURCN0UP'4W@]][@&_]]L2&M)R?D MHDG]4=8(]O!-L6E:22*-:G*.NT>U'L$JQAO' M>R,\DA1T%F'\O%Y0",;OXI(VBIP)2)8C^GF]@%D/A5!1HN-N86C#]8*2*D07 MK0K1%=[6XT!HU06"PAH#`/='+^Z'UG4"96FP&%IQ0DRZ-K`67358!-06@(O# M`&"-FOY?D)$Y_)]9=I*V--6`!6+#/VP(M5F2)W6P\G[:`2RBD%6T'4X0K+-_ MF[7H*H7$^/!_P8QE-.#:P_A\QO(O.5UDZ]VJ@VMY(UBZXU'_P8!L)-B9\VG: M&=<*O/),K@VZ55=)A/8HYSI@H0:NZI6`=G7C!(=8O4@GO?%,3.3XYKEWU,)6E3W!-[&K[ZHG1)^+0G48)("M0 M>IXWF\P"MMH5B6)J!]"M`\R&(U3'V!G,$%I2N6MUC"?V5FM(ALL0):47\`N` M05!,9=%$);DSWH/E;D*G))163$P M#HKP+F.&U:`L:9(X=M$/)6-"3E$&RV$O%,LX?)$I1!/ M]$B@=EDP&2Y!3G\@4,.JG($'T9W'73\%>GR*0KNSYP=Y7)73]6!SA.Q=F8+; M+V^6D?3>!`EC52I4\\K`H"BTOQ*.4@)GY8P^B*(>!#;(^HDMSY'5!B9%H11: M<1TU4!R)@K@/P*X3OMR'S[/7V!_Z+IU?S6'!?%U<,/-FEA*U@%50J(9Z])<& M:"MW#H8AXX\9#MW%$0YM-DS58");^8/JO[>^G2WKAGB4P*C.$F7=L(2MS``L MSY9(4_A+)DI(7-C63SC'9RC47#/OM(N^V^&(4V=)5>#[ MNR#Z4*]%QMS"T(=C\ MD21L3H+=WKL/JY^K^7=8T]R'JUE[BO_N)3W36#^:5@2'12B/GPE1E97&V M*`&+L09RCD(#*SO,#LI%4Z"6R-W+LXN>` M$Q12C5V?VYVE6I09)?^T*OPY((O#DQ*OS8J*@\U0R#B[\P>^_^G;ID7/U]XL M&FS^-(FB)%@*12S?_KU(PRQM2E^275OSWXG\_#95-,$HZ4G;\L1-XEZ5Z@4K MHP@@W+?S63":M30K.$[#C*+(!/%3YRBTUGW[DLP:;7HX^*OKI\\G]L,;/YY& M<7HGNS_JQ3&1/A0G+0=F0J'A[MMI-(Q2^48$HGB)[2$T9[?%;7Z-':)^)6!` M%-KQOKW*U$)M>NRXB+WG>=$,3`^&)_Z[XMQ0I[AS?(%"MS:E6==91(C;=!&C MB'I`R=3UA\O]R&(;LGQ$5CF]E:L0#(M"]=Z5*^G;`,?SRX*`^VU8US"70&F'SW MU0_2Z;[45"6K$`R+0@O?]>2EMD&;[GKHGRQ8.;0%`Z*0O.T>J)CBMW:%HO:4 MW0+DV14J2V?_DLK`G"BT;RMG_TJ,,2/XS5H[E(96NX1,HS9U2#N!4S^ M#*1;U.GB>(O'#O]FJ&U=T<`T;-Q%=)T`(GU^=)G*56.X$!<&8Z-0DWR_ M!OXX)5,V!QG4`B9$(?KNWF&D!A#XD+[BNY^-\Q++RBS]<+!:J2VU`86V4KE. ML!AFB=?092R90^!`C8QDYIF#3>;LQCK@D,8R*\N"N5`HNG8''$W8`B]II,#+ M&V-UO419%LR%6M9V2F#`3'K=B6=QA2_P(&,$TG4+[C,TOT9E M4(W3/4(A[9JYB3E"@9OL5;SE;IKY4,#_LW1DU^Q$8^1[K!^,%G&&@JURB9K` M-@U28BN!%#B`L0Q;_5$.E&Z`0HO=M1L()=BN<30NDB21L^DT2"WF!LMD;/?A M***3C#J-)'EZ-8#Q4(BO9M.$$3B!9S0RE':9H9(],BN-OEY_!D9`H94:<<:G MO0A+P&TC-<]5D@$2*^G=^!),@4+/M,(P!YF`Y$9*EDN[L,2S\,=U3$(XY&R7 M;_S8"Z)X1HG&B%^U:C`V"L'3?,=0';4@1YYQHH0=O*B2AMTN[UZOCGS^YB=O M^>/$%5;!XM&P%K`*BCP)=M@M+C-+F4/@)!:"7/>5#OK*C?V8G2&NJZPC[W.? MCMUPD81IG9@Z2]"4;UM_M&#`#=8YJS5&0BOU`^>7=\$+N,=5((\\ MM?U33K>#0G>RZ`/\B6 M,41%@)3CVLX6MMJDTYN%90`(BGV^W-""LP,YJ'UWF5^_L%:^POH@M>;_`U!+ M`P04````"``LAFY#(;KQ5W4)``"Q4```$``<`&%M(279LD,QM+P;^%!] MB25Q9C@S#SD>OS=!"\;Z$?OO_V MFP]_"0+T(V%$8$4B=/N$>ECAJ<#A[[+@1\!^\![IA[?!-;\/C@X[Q^A?A\=G MAR=G1Z?_1O\97_T7]2=3%*"'AX>#""0H(^$@Y`D*`EV/#.>N/%,=T1DG4 M0F`DDV7$J%=(C"G[?8WZ\5;$!?UQ6Q?? M8DD*:&-+A8!V M5\67EVK&HW7&B%`[#Q18ZB&/X=Q.KTLL#)3=$ZGL+%F9A8EA&DH[CRG2+)UU M%DE#.P,46,@!`/6T(-(*C2FQJ"750E14`B666B*R$"34';ZR?9VVL0@%CPEH M$*J`/"YBS+#BXFD`[TN'<,;2Q"XD4J*M-6X#40!41-!PR?CQ,=6CILJC/%%5/ M0Q`G$E-)"U'PC)-B67%1=41FE%&C8N>P`Y&P8"\_@BB4R4(E81_:FQ*^_693 M?"I)-&+?FV<`3X(TPZLC1LZ?D[AY5Y5LRQGB.$SCRDISMO8:#B616P-TP5E$ M&(B'!\EC&NGV^A''.N9-YH0HF<'D0><&ZP@0FH`W28[6Q>BZU[^>]'OZ:3*Z M'/:Z4WCYV+WL7E_TT>13OS^=-)C5PVR,(>*K.5$4=/,%<)W)C>9Q'331F[4J M_MZ@ZXWNTM=R-!LM=!H)ZKBZ9@6#&]6W?JA.IO!SU;\&1$<#-!KW;[K3(1`T M>-;"\X(GX(DYT-![,H3I0T(\@;5QNA$^J8/PQ>AJ?-/_!'3#G_IH>`WO_0;K M[;$>S29S"(!S'DO_D4*&XH.TE<^-\[LM<=8P3SYU`>719:]_,_G;7X]/ M_X'Z__P\G/[:0%VO6P/](.8/OE%Z1>^&]KM:7;@[^80&EZ.?FR!M1?,CEA0P M&)>,S6"S%;CQ>:^G(E2&,9>I(/!B1"`^0V4A#0PV&,9$F%#73?1:1]YS-C^Z MW7^ZZ7Y@1X8?Y0(:U]MWZHTW7:UX]'F3 MQ$6+0T:>1FT`88RGIC(:EO.G95[??WSUO M\^O\C>]K#!53?!L3OP$C)W6C]%V-80.]R40W2]Z^L^\>49C&55IL8;Q, MYD;.;V:.WN1"42ZU`7P#U"XS>QM>7I1.V(Z\9_T->CNL M`]C`\R%T8^>[1M!`M_VJ@0TQ1[D;J!=6%!I\ODCBF#O1*W,L:-VXU5EQ6(+9 M@+C-VH.MO_F1NB'<8EWB_[H;ZC]ZT+\A,V1.Q9[I`X?G+4F31:Q/TYIO-V M2A1\-92P7Q?PK+Y@T/6>^-;H/.]?4;&IU,K8)K&2Q9=@)6HK^QUG[UT*6=CR MYUT5L=UI\-&DS%>\[*R+[9Z$ES)EQN5;L!)32YUG5RI\5%DRF:==/?+\NH6/ M#BNN[#%8":BEQ>8=#A\="A[]L'/]F]<[O!0HF,Q3#16>7Q4Q@PTC=_K@F%_D MBH58X]+AZU2'SD_*B MYQ@:VA5);HEHH2PAS>YVG44\P90-%4GT;*J%\*W4=SO5>4N)5.>K^IKB&:2( ME$=3PQBE(M]I9#2.]>Y202M38*8JU:4_"IXNSEL9.P7QV4P84M[?7E2PPK`Q MZ"!^)5CLBR'/%*I0_)JS/F3__(F0'A4DA`XO]\4&EV[5#4P0R(5[)/L=LM*: MQ@5>4(5CLU\B;V!Z+.Y)-.!BD*I4D*&4:38'R.S.-)*&V&;V#,?RJS7"W8VH M<)`^4-UED?[19^;O<:S7T_J/89SJ"]H7>KYE=M;):-8C"R[UV:ZR0T`/HK!X MVLHEV3Q)/?=(1GJ;W;@"UY%;79^GGVK94N&7O%QJ>=PL-(:Z]B$;"WX'GI:@ MAY1[ZPI?]:M:12H5AY&E$-,C,P()>W1#[@E+R2N:'>;'"7V;P$N*5QA\1>Y! M\.3HY'!?@MUSC:JPXE)=$37GT6KS20Z9(@"S&A.A!S!\M\1,F[/(OKYN%//6 ML\+.;A2993Z]I;`ZZKMS0ZRV:Z<.:->VPC0(VPJR.)A\V$/8!1;B"2*8V039 MVYBSI14U?;'<8_K3^J%D084/S&"^VC,Q,1LG^Q*9W-I5F:1SE153U$L%-(6Q MT2O+7<9X'=<\4)G"UXU4V^A:86[YSOC:?>YNKO]&5JET#:^*HH>&E3EU$="& M;`*5T8A"Q_OX!.DYY!I*\#C6QN21_4OD2-XQ>LML86M+_&<97SV!^DKC5@U3 M*J?`/"0DD@/!$ZNC*7G5MK&='_RT]S#]DK.[*1%)?FZ!W8W8>+G!/LYVM)[T M_W6!`6*QWSG-CF95Y74AD$B3+(UF2_*?J9KG4]M+W0Z7]>QQ.-G:DJJYI^._ M_>S-^.&G9!7F4I(_2UIKU;4*N>6AE]%L\U["_B#GI60-"_4)GH^QN=.TEJ.J MXOOKIG&>JFI#/[2S!6]C\_\`4$L!`AX#%`````@`+(9N0R\^PKUW6P``4.,& M`!``&````````0```*2!`````&%M`L``00E#@``!#D!``!02P$"'@,4````"``LAFY#761=N5(*``#,E```%``8 M```````!````I('!6P``86US+3(P,3,P.3,P7V-A;"YX;6Q55`4``V-%A5)U M>`L``00E#@``!#D!``!02P$"'@,4````"``LAFY#V)^/,BLA```4"0(`%``8 M```````!````I(%A9@``86US+3(P,3,P.3,P7V1E9BYX;6Q55`4``V-%A5)U M>`L``00E#@``!#D!``!02P$"'@,4````"``LAFY#:%``L``00E#@``!#D!``!02P$"'@,4````"``LAFY#E#"$5SXE``!)8@(`%``8 M```````!````I('&P0``86US+3(P,3,P.3,P7W!R92YX;6Q55`4``V-%A5)U M>`L``00E#@``!#D!``!02P$"'@,4````"``LAFY#(;KQ5W4)``"Q4```$``8 M```````!````I(%2YP``86US+3(P,3,P.3,P+GAS9%54!0`#8T6%4G5X"P`! @!"4.```$.0$``%!+!08`````!@`&`!0"```1\0`````` ` end XML 36 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Per Share Amounts (Details Textual)
3 Months Ended 9 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Weighted Average Number of Shares Outstanding, Basic 4,609,000 4,606,000 4,609,000 4,610,000
Weighted Average Number of Shares Outstanding, Diluted 4,612,000 4,630,000 4,613,000 4,635,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 580,000 310,000 580,000 310,000
XML 37 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Sep. 30, 2013
Income Tax Disclosure [Abstract]  
Income Tax Disclosure [Text Block]
 
Note 8.
Income Taxes
 
We generally calculate our effective income tax rate at the end of an interim period using an estimate of the annual effective income tax rate expected to be applicable for the full fiscal year.  However, when a reliable estimate of the annual effective income tax rate cannot be made, we compute our provision for income taxes using the actual effective income tax rate for the year-to-date period.  Our effective income tax rate is highly influenced by the amount of the nondeductible stock-based compensation associated with grants of our common stock options.  A small change in estimated annual pretax income (loss) can produce a significant variance in the annual effective income tax rate given the expected amount of these items.  Because of this variability, a reliable estimate of the annual effective income tax rate for 2013 cannot be made.  As a result, we have computed our provision (benefit) for income taxes for the three and nine month periods ended September 30, 2013 by applying the actual effective tax rate to income (loss) for the period. 
XML 38 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8
Line of Credit (Details Textual) (USD $)
9 Months Ended
Sep. 30, 2013
Dec. 31, 2012
Line of Credit Facility, Maximum Amount Outstanding $ 9,000,000  
Line of Credit Facility, Expiration Date Aug. 01, 2015  
Debt Instrument, Interest Rate Terms the Bank’s prime rate minus 0.5 percentage point, or alternately, at the Company’s discretion, the LIBOR rate plus 1.0 percentage point  
Debt, Weighted Average Interest Rate 1.44%  
Advances on line of credit $ 8,740,000 $ 8,550,000
XML 39 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-based Compensation (Details Textual) (USD $)
3 Months Ended 9 Months Ended 1 Months Ended
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Sep. 30, 2012
Sep. 30, 2013
Non Employee Directors [Member]
Sep. 30, 2013
Restricted Stock Units (Rsus) [Member]
Jun. 30, 2010
Incentive Compensation Plan [Member]
Jun. 30, 2010
Incentive Compensation Plan [Member]
Maximum [Member]
Jun. 30, 2010
Incentive Compensation Plan [Member]
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized               1,630,000 750,000
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period             880,000    
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures           115,000      
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross         609,000        
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number         576,000        
Stock based compensation expense $ 11,000 $ 3,000 $ 69,000 $ 62,000          
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period 3,500   21,500            
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 0   0            
XML 40 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8
Document And Entity Information
9 Months Ended
Sep. 30, 2013
Nov. 01, 2013
Document Information [Line Items]    
Entity Registrant Name AMERICAN SHARED HOSPITAL SERVICES  
Entity Central Index Key 0000744825  
Current Fiscal Year End Date --12-31  
Entity Filer Category Smaller Reporting Company  
Trading Symbol AMS  
Entity Common Stock, Shares Outstanding   4,608,870
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Sep. 30, 2013  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2013  
XML 41 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Common Stock Investment (Details Textual) (USD $)
6 Months Ended 9 Months Ended 12 Months Ended
Jun. 30, 2013
Sep. 30, 2013
Dec. 31, 2012
Investment Percentage in Common Stock and Preferred Stock   0.77% 1.00%
Additional Investment $ 14,000    
Unrealized Gain (Loss) on Investments   2,400,000  
Common Stock [Member]
     
Cost Method Investments   2,701,000 0
Preferred Stock [Member]
     
Cost Method Investments   0 2,687,000
Mevion S250 [Member]
     
Cost Method Investments $ 55,000,000